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Introduction and Review of the Literature
1.1 Overview
Synovial joints are composed of different tissues (cartilage, calcified cartilage, subchondral bone, 
synovium, and intra- and extra-articular ligaments). In the normal joint, these tissues interact to 
maintain function and physiological balance. In disease, when one tissue deteriorates, there is an 
effect on the other tissues such that osteoarthritis may be considered a form of "organ disease".
Much of the research emphasis in osteoarthritis (OA) has been placed on the biological and 
mechanical mechanisms of cartilage breakdown. Subchondral bone involvement has traditionally 
been viewed as a secondary event, resulting from progression of the pathology of the articular 
cartilage. However, this classical view of OA has been questioned and the time frame of 
subchondral bone injury in OA remains a point of debate. The questions remain whether the 
articular cartilage is affected first, then the subchondral bone, or vice versa. Furthermore, the 
mechanisms by which subchondral bone interact with articular cartilage and how this occurs in vivo 
are at present unclear.
1.2 Anatomy of the Synovial Joint
The articular cartilage provides the primary weight-bearing surface in the synovial joint. The 
cartilage is composed of a collagen (predominantly type-ll, but also types- VI, IX, X and XI) and 
proteoglycan matrix, with chondrocytes as the cellular component and up to 80% water (Buckwalter 
and Mankin 1998). The tidemark forms the junction between the articular cartilage and the 
underlying calcified cartilage layer. Deep to the calcified cartilage lies the subchondral bone plate, 
which is cortical bone (Burr 2004). The subchondral bone plate is supported from beneath by the 
trabecular subchondral bone. Therefore, the joint contains three mineralised tissues (calcified 
cartilage, subchondral bone plate and subchondral trabecular bone), which differ mechanically and 
physiologically, and respond to drugs and mechanical forces in different ways (Burr 2004).
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It has been shown that although the hyaline articular cartilage is avascular and there is no direct 
vascular connection between subchondral bone and articular cartilage, there is not an absolute 
barrier to diffusion of nutrients between the two structures (Imhof et al. 1999). Furthermore, the 
presence of clefts running across the subchondral bone into the calcified cartilage and deep layers of 
articular cartilage, have been described in the literature under a number of synonymous names 
including vascular invasion (Harrison et ai. 1953), vascular channels (Clark 1990), microcracks (Mori 
et al. 1993; Sokoloff 1993) and subchondral bone resorption pits (Chambers et al. 1984). 
Subchondral bone resorption pits have been implicated in cartilage nutrition and cross-talk between 
subchondral bone and cartilage (Lajeunesse and Reboul 2003) and recently have been shown to 
express MMPs and degrade proteoglycan from the articular cartilage around the tip of the invasion 
(Shibakawa et al. 2005).
1.3 Pathophysiology of Osteoarthritis
OA is characterised by degeneration of articular cartilage, intra-articular inflammation with synovitis, 
and changes in peri-articular and subchondral bone (Goldring and Goldring 2007). The pathogenesis 
of OA is multifactorial including ageing, mechanical factors, and genetic factors, and may be 
considered to result from abnormal loading of a normal joint, or normal loading of an abnormal joint 
(Figure 1.1)
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Figure 1.1: Mechanisms involved in the pathogenesis of osteoarthritis
OA can be considered to be a progressive disease, commencing with initiation, continuing through 
early stage disease and culminating in late-stage, irreversible pathological changes in hyaline 
articular cartilage. Various inflammatory cytokines are involved in the disease process and the 
cellular and morphological changes in hyaline articular cartilage are as outlined in Figure 1.2 
(Goldring and Goldring 2007).
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Figure 1.2: Events involved in the initiation of OA and progression to late stage OA. Potential 
causative factors and cellular and morphological alterations are listed.
In the early stage of disease there may be an upregulation of synthetic activity mediated via a 
chondrocyte response. In the human the earliest changes in the cartilage of an unstable knee joint 
have been reported to be enhanced synthesis of matrix with an increased content of aggrecan 
(McDevitt et at. 1977). This is followed by a phase of increased matrix turnover with net depletion of 
principal matrix components. Finally, in the severe and end stages of disease, damage to and loss of 
the collagen network is observed (Brandt et al. 1991; Guilak et a!. 1994; Nelson et al. 2006; Setton et 
al. 1994).
Metalloproteinases and aggrecanases are generally considered to play a principal role in the 
cleavage of matrix macromolecules, including type II collagen and the cartilage proteoglycan 
aggrecan. Collagenases (MMP -1, -8, -13 and -14) cleave type II collagen at a specific site, resulting in 
denaturation of the a chains, which are then susceptible to secondary cleavage by collagenases and
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other MMPs such as MMP-3, -2 and -9. Aggrecan is cleaved by various MMPs and also ADAMTS -4 
and -5 (Moskowitz et at. 2007).
Collagenase activity, the denaturation of type II collagen and its associated loss are much increased 
in osteoarthritic cartilage (Billinghurst et al. 1997; Hollander et at. 1995; Squires et al. 2003). In 
established, or end-stage OA, the synthesis of type II collagen is simultaneously markedly increased 
(Aigner et al. 1993; Aurich et al. 2005; Matyas et al. 1997; Nelson et al. 1998). However, the newly 
synthesised molecules, as well as the pre-existing collagen are subjected to excessive proteolysis 
(Dahlberg et al. 2000). Aggrecan synthesis is also increased in OA, but is concurrently subjected to 
excessive proteolysis (Rizkalla et al. 1992).
Proteolysis can be potentiated as a result of degradation products of matrix molecules stimulating 
degradation through chondrocyte and synovial cell-mediated activation, thus setting up a chronic 
cycle (Moskowitz et al. 2007). Fibronectin is produced in increased amounts in OA cartilage 
(Chevalier et al. 1996) and it has been shown that different fragments of fibronectin can stimulate 
chondrocyte-mediated cartilage resorption by cell surface receptor activation (Homandberg et al. 
1992; Yasuda and Poole 2002). Similarly, fragments of type II collagen have also been shown to be 
capable of inducing matrix resorption (Yasuda etal. 2006).
1.4 Models of Osteoarthritis
The understanding of the pathogenesis of OA lies not only in investigation of late stage disease, but 
also investigation of the early stages of disease. In human studies, ex vivo tissue is obtained 
predominantly from arthroplasty (e.g. knee replacement) patients whereby there are already pre­
existing severe changes in the hyaline articular cartilage and subchondral bone. As tissue from early 
stage disease is rarely available for research purposes, there is a large degree of reliance on animal 
models.
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Over the last 2 years, studies on at least 25 different models of OA have been reported (Ameye and 
Young 2006). Each has their own advantages, disadvantages, proponents and opponents, suggesting 
that no one model is completely ideal for investigation of OA. Various models have been used to 
describe simultaneous osteoarthritic changes in cartilage and bone of various experimental species 
(Table 1.1). Techniques commonly utilised include surgically induced instability models such as 
partial menisectomy (Moskowitz et al. 1973) and anterior cruciate ligament transaction (Pond and 
Nuki 1973) and models using animals known to be affected by naturally occurring spontaneous OA 
e.g. the Hartley guinea pig (Bendele and Hulman 1988).
More recently, in an attempt to characterise the differences between bone and cartilage induced 
OA, further models of OA have been developed. The canine groove model (Mastbergen et al. 2006) 
whereby OA is induced by the surgical creation of defects in the articular cartilage without damage 
to the underlying subchondral bone or creation of joint instability, is an example of a primarily 
cartilage-driven OA. Another canine model (Lahm et al. 2005; Lahm et al. 2004; Mrosek et al. 2006) 
may also be used to investigate subchondral bone driven OA. In this model, impact is applied to the 
subchondral bone without surgical invasion of the joint and without damage to the articular 
cartilage. After impact, there is immediate evidence of subchondral bleeding, oedema and 
microfractures, with cartilage degeneration developing over subsequent months.
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Type of Model Species References
Surgicallv Induced
Anterior cruciate ligament 
resection
Mouse, rat, rabbit, dog ,cat (Boyd et al 2005; Clements et 
al. 2003; DeGroot et al. 2004; 
Hayami et al. 2006; Inoue et al. 
2006; Kamekura etal. 2005)
Menisectomy Mouse, sheep, guinea pig, rat (Cake et al. 2004; Kamekura et 
al. 2005; Moore et al. 2005; 
Quasnichka etal. 2005)
Ovariectomy Rat, sheep (Cake et al. 2005; Hoegh- 
Andersen et al. 2004)
Articular groove Dog (Mastbergen et al. 2006)
Partial and full cartilaginous 
thickness defect
Rabbit, rat (Kuroda et al. 2006; Yamamoto 
et al. 2004)
Transarticular impact to induce 
trauma
Dog (Lahm et al. 2004)
Carpal chip fracture Horse (Frisbie et al. 2002)
Collateral metacarpophalangeal 
and lateral collateral 
sesamoidean ligament 
resection
Horse (Simmons et al. 1999)
Enzvmaticallv/Chemicallv Induced
Collagenase induced Mouse (Blom et al. 2004)
TGF(3 Mouse (van Lentet al. 2004)
lodoacetate injection Mouse, horse (Bove etal. 2003; Fernihough et 
al. 2004; Gustafson etal. 1992)
Lipolysaccharide injection Mouse, horse (Todhunter et al. 1996; 
Tsuchiya et al. 2005)
Soontaneous
STR/ort Mouse (Regan et al. 2005)
Natural ageing Rat, mouse, guinea pig, ewe (Blaney Davidson et al. 2005; 
Cake et al. 2005; Jallali et al. 
2005; Johnson et al. 2004; 
Quasnichka et al. 2005)
Geneticallv Modified
ADAMTS-5 knockout Mouse (Glasson et al. 2005; Stanton et 
al. 2005)
Dell transgenic Mouse (Morkoetal. 2004)
Cathepsin K transgenic Mouse (Morko etal. 2005)
BMP receptor type la Mouse (Rountree etal. 2004)
Mig Mouse (Zhang et al. 2005)
Biglycan/fibromodulin
knockout
Mouse (Ameye et al. 2002; Wadhwa et 
al. 2005)
IL-6 knockout Mouse (de Hooge et al. 2005)
Chol+ Mouse (Xu et al. 2005)
ILlf3, ILlfJ converting enzyme, 
inducible NO synthase
Mouse (Clements et al. 2003)
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Drues/ SuDolements
Aledronate Rat (Hayami et al. 2004)
PD-0200347 Dog (Boileau et al. 2005)
S-34219 Guinea pig (Sabatini etal. 2005)
Pioglatazone Guinea pig (Kobayashi etal. 2005)
Vitamin C Guinea pig (Kraus etal. 2004)
Table 1.1: Animal models used in the study of osteoarthritis. Adapted from Ameye and Young(2006)
1.5 The Role of Subchondral Bone in Osteoarthritis
1.5.1 Historical Perspective
The subchondral bone plate provides both mechanical and nutrient support for the overlying 
articular cartilage. Early work by Simon et ai. (1972) and Radin et al. (1984) showed that thickening 
of the subchondral bone occurred in response to loading in both guinea pig and rabbit models. 
Radin and Rose (1986) subsequently suggested that the thickening of the underlying subchondral 
bone could occur as a result of healing microfractures, which in turn increased the stiffness of the 
subchondral bone, reducing the shock absorbing capacity of that joint and placing the overlying 
cartilage at increased risk of injury.
This hypothesis was questioned by the findings of two studies, one in guinea pigs (Layton et al. 1988) 
and the other using the anterior cruciate ligament transaction model in dogs (Dedrick et al. 1993). In 
these experiments, the subchondral bone was evaluated using microscopic computerised 
tomography and the overlying articular cartilage was assessed for morphological and biochemical 
changes. Although thickening of the trabecular bone and subchondral bone plate were evident as 
OA progressed, these changes did not appear to precede those in the articular cartilage.
1.5.2 Alterations of Subchondral Bone in OA - Diagnostic Imaging
The radiographic alterations of the subchondral bone in OA are well documented and described 
(Jacobson et al. 2008). However, developments in diagnostic imaging modalities have provided the 
opportunity to investigate OA at an earlier and more dynamic stage. Dieppe et ai. (1993)
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demonstrated that increased activity of subchondral bone, as shown by increased uptake of 
technetium-labelled bisphosphonate, not only preceded radiographic evidence of progression of OA, 
but also acted as a reliable prognostic indicator for progression of osteoarthritic changes. More 
recently, MRI has come into routine use and has been shown to be able to detect changes in 
cartilage, synovial membrane (Fernandez-Madrid et al. 1995; Ostergaard et al. 1997; Ostergaard et 
al. 1998; Pelletier et al. 2008), ligaments (Hill et al. 2005; Mohana-Borges et al. 2005) and 
subchondral bone (Bealle and Johnson 2000; Guymer et al. 2007; Raynauld et al. 2008).
Alterations in bone marrow signal on MRI have been described using a number of terms including 
bone bruises (Yao and Lee 1988), bone marrow oedema (Wilson et al. 1988), bone contusions 
(Stafford et al. 1986) and occult bone lesions (Labovitz and Schweitzer 1998). Although the term 
bone marrow oedema is widely used, its histological definition of replacement of bone marrow fat 
by materia! containing hydrogen ions in the form of water (Alanen et al. 1998) is not appropriate in 
every case. Histological abnormalities found in areas showing oedema-like signal patterns on MRI 
also include bone marrow fibrosis, necrosis and trabecular abnormalities with very little bone 
marrow oedema (Zanetti et al. 2000), such that the term bone marrow lesion has emerged and is 
considered more appropriate in many cases (Felson et al. 2001; Hunter et al. 2006; Roemer et al. 
2009).
Correlations between increased uptake of radionucleotide on nuclear scintigraphy and bone marrow 
lesions on MRI have been demonstrated by Boegard et al. (1999) and McAlindon et al. (1991). 
Subsequently, in a longitudinal study, Felson et al. (2003) compared bone marrow lesions identified 
on MRI to progression of OA on follow-up radiography. These investigators found strong 
associations between bone marrow lesions and the progression of OA within the same joint 
compartment. Conversely, Pessis et al. (2003) demonstrated that absence of subchondral bone
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abnormalities and bone marrow lesions on initial MRI assessment predicted absence of progression
of chondropathy at follow-up at 1 year.
Using their model of subchondral bone impact, Lahm et al. (2005) demonstrated using MRI that 
immediately after impact there was intact cartilage and subchondral fractures represented by 
bleeding, microfractures and fragmented bone trabecules. Ligaments and menisci were shown to be 
intact. These MRI findings were supported by histological examination revealing microfractures of 
cancellous bone and weight-bearing trabeculae. In a further study (Lahm et al. 2006) the same 
group demonstrated that on follow-up MRI assessment six months after the initial trauma there was 
thinning, signal changes and surface interruptions in the cartilage above the former subchondral 
fractures.
1.5.3 Alterations of Subchondral Bone in Osteoarthritis- Mechanical Properties 
Although subchondral bone thickening is a hallmark of OA, subchondral bone affected by OA has 
been shown to be hypomineralised as compared to age matched and young controls (Grynpas et al. 
1991). Li and Aspden (1997) demonstrated that although osteoarthritic subchondral bone was 
significantly thicker than normal or osteoperotic subchondral bone, the stiffness and density of 
osteoarthritic subchondral bone were significantly less than that of normal samples. On
examination of the composition of the subchondral bone, it was found that osteoarthritic samples 
had a significantly reduced fraction of mineral and an increased mass fraction of water.
The concept of hypomineralisation and altered biochemical composition of the matrix of 
osteoarthritic bone is important, as it explains the difference between the structural and material 
properties of bone. Apparent density is a structural property that may be defined as bone 
mass/total volume. Material density is defined as bone mass/bone volume. Apparent density can 
increase in response to either an increase in mineralisation of the tissue, or an increase in bone
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volume. Material density can decrease with increased bone volume if the mineralisation of the 
tissue has decreased (Burr 2004). Therefore, it is apparent density which is seen radiographically as 
sclerosis, but this gives no indication as to the material density of that tissue.
1.5.4 Alterations of Subchondral Bone in Osteoarthritis - Bone Matrix Composition and Cellular 
Metabolism
It has been shown previously that subchondral bone from patients with OA has increased levels of 
alkaline phosphatase protein (Mansell et al. 1997) and mRNA expression (Truong et al. 2006). Levels 
of osteocalcin in osteoarthritic subchondral bone are also elevated, both at protein level (Gevers and 
Dequeker 1987; Raymaekers et al. 1992) and mRNA level (Kuliwaba et al. 2000; Pullig et al. 2000; 
Truong etal. 2006).
Alterations in the collagen metabolism have been investigated (Mansell and Bailey 1998) and it was 
found that type I collagen synthesis was increased in osteoarthritic subchondral bone as was the 
collagen content, although this collagen was significantly less mineralised than normal subchondral 
bone. This group then went on to describe how the ratio of al chains: a2 chains increased 
significantly in OA subchondral bone as compared to normal controls (Bailey et al. 2002) and 
concluded that the disorganised collagen matrix with reduced mineralisation found in osteoarthritic 
bone could be explained by an alteration in the osteoblast phenotype in osteoarthritic bone resulted 
in production of collagen type I homotrimer. Interestingly, this change in the ratio of collagen-1 al: 
collagen-1 a2 has also been demonstrated in the gene expression of osteoarthritic subchondral bone 
(Truong et al. 2006). The importance of collagen type I in the pathogenesis of OA has recently been 
further demonstrated using the Brittle IV (Brtl) mouse, a knock-in model in which defective type I 
collagen is expressed in bone (Blair-Levy et al. 2008). Using this model, it was shown that initially 
mice had normal cartilage but decreased subchondral bone integrity. However by the second month 
of life, all Brtl mice had evidence of osteoarthritic changes within the articular cartilage.
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In vitro, increased osteocalcin and alkaline phosphatase levels have also been shown in primary 
osteoarthritic osteoblasts, thus mimicking the in vivo situation (Hilal et al. 1998). Various in vitro co­
culture systems have been used to investigate alterations in the phenotype of osteoblasts affected 
by OA, and how these altered cells may interact with cartilage. Westacott et al. (1997) 
demonstrated the ability of osteoblasts isolated from osteoarthritic subchondral bone to increase 
giycosaminoglycan release from cartilage, as compared to cells obtained from normal subchondral 
bone. It has also been shown that osteoblasts isolated from sclerotic areas of subchondral bone 
from joints affected by OA could initiate a change in chondrocyte phenotype shift towards 
hypertrophy (Sanchez et al. 2005b). Subsequently, the same authors also demonstrated that 
sclerotic subchondral osteoblasts could contribute to cartilage degradation by stimulating 
chondrocytes to produce more MMP-3 and MMP-13 and by inhibiting aggrecan synthesis (Sanchez 
et al. 2005a).
Although there has been a considerable research drive towards changes in subchondral remodelling 
with regards to alterations in the osteoblast phenotype, comparatively little data is available on the 
role of the osteoclast. However, it has been shown that aledronate, a nitrogen-containing 
bisphosphonate and a potent inhibitor of osteoclastic bone resorption, is able to inhibit subchondral 
bone sclerosis, osteophyte formation and articular cartilage degeneration in an anterior cruciate 
ligament transaction model of OA in the rat (Hayami et al. 2004). Further work is necessary to 
further describe the role of the osteoclast in OA, however it would appear that osteoclastic bone 
resorption, bone formation by osteoblasts and signals from both osteoblasts and osetoclasts may be 
important in the pathogenesis of subchondral bone disease, and consequently of OA (Karsdal et al. 
2008).
12
Various studies have investigated the role of cytokines in remodelling of the subchondral bone in 
OA. Among the findings are that TGF-fJ has been found to be increased in osteoarthritic bone, and 
this may represent a stimulus for increased collagen synthesis (Mansell and Bailey 1998; Mansell et 
al. 2007). lnterieukin-6 has been shown to play a role in modulation of various chemokines 
produced by osteoblasts in OA: IL-8, monocyte chemoattractant protein 1 (MCP-1) and chemokine 
(C-C motif) ligand 5 (previously known as RAIMTES) (Lisignoli et al. 2002). These authors concluded 
that as well as being target cells in bone, osteoblasts also acted as primary effector cells and were 
therefore able to mediate physiological and pathophysiological immune-related processes. 
Interleukin-6 and 11-1(3 have also been implicated in involvement in the crosstalk between 
subchondral bone and cartilage (Sanchez et al. 2005a).
1.6 Interaction between Subchondral Bone and Articular Cartilage
There is mounting evidence of alterations in the subchondral bone in OA, at gross, microscopic, 
biomolecular and cellular level. Various investigators have endeavoured to identify exactly if, and 
indeed how, these changes in subchondral bone can affect the overlying cartilage.
The first hypothesis is that of a mechanical effect. As discussed previously, Radio's original 
hypothesis was that increased stiffness in the subchondral bone led to cartilage degeneration (Radin 
and Rose 1986). This hypothesis has to a large extent been disproven, by various studies 
demonstrating that the subchondral bone is in fact less dense and less stiff in OA as compared to 
normal controls (Li and Aspden 1997). A more recent study by Day et al. (2001) showed that bone 
stiffness was decreased and bone quantity was increased in the presence of OA. They suggest that 
the reduction in tissue stiffness caused greater tissue deformation than was compensated for by 
increased bone volume, and that this led to a loss of normal mechanical equilibrium between 
cartilage and bone mechanical properties.
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The second hypothesis regards a local biological effect of the abnormal osteoblasts on the overlying 
articular cartilage. As previously discussed, the altered phenotype of osteoblasts in OA has been 
well described, and these cells have been shown to secrete more alkaline phopsphatase, osteocalcin, 
IL-6, TGFfJl, insulin-like growth factor and prostaglandin PGE2 than normal osteoblasts (Hilal et al. 
1999; Hilal et al. 1998; Massicotte et al. 2002). In addition, in vitro osteoblasts obtained from the 
subchondral bone of osteoarthritic patients have been shown to have an effect on cartilage 
degradation and the phenotype of articular chondrocytes (Sanchez et al. 2005b; Westacott et ai. 
1997). Degradation of articular cartilage has been shown to be mediated to a large extent by the 
increased activity of tissue metalloproteinases (Cawston and Wilson 2006). It has been shown that 
MIVIPs-3 and -9; IL-lot, -8 and -10 and TNFa were upregulated in osteoarthritic subchondral bone 
(Hulejova et al. 2007) and suggested that these cytokines and MMPs may have an effect on adjacent 
cartilage.
It is generally accepted that cartilage loss in OA occurs from the surface down, therefore it would 
seem unlikely that bone cell-derived metalloproteinases could have an effect on cartilage loss 
(Westacott 2002). However, as was shown by Sanchez et al. in vitro (2005a, b), it would seem more 
plausible that cytokines produced by osteoblasts during subchondral bone remodelling could have 
an effect on the phenotype of overlying chondrocytes, with the finding that more superficial 
cartilage layers are affected first in OA being explained by differences in response to cytokines by 
chondrocytes at different levels of the articular surface (Westacott 2002).
How then do the cytokines gain access from the subchondral bone to the articular cartilage? This 
would seem impossible if the long-held view that adult cartilage does not receive blood supply and 
nutrition (and also therefore a potential source of delivery of cytokines) from the subchondral bone 
plate and relies solely on nutrition from synovial fluid, were true. Although the calcified cartilage has 
been described as being not normally vascular, if at all (Burr 2004), it has also been argued that
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there is in fact not an absolute barrier to diffusion of nutrients between subchondral bone and
articular cartilage (Imhof et aL 1999). The anatomy and distribution of vascular channels in the 
normal subchondral plate were investigated using scanning electron microscopy (Clark 1990) who 
found that although most of the capillaries resided within the subchondral bone, a minority of the 
subchondral bone vessels opened into the calcified articular cartilage and there were preceded by 
cells which appeared to be cutting into the articular cartilage. The importance of contact between 
the subchondral bone and the overlying articular cartilage, and further evidence that they function 
as a single unit was demonstrated in a study using osteochondral grafts in baboons. In those grafts 
where direct contact between the subchondral bone of the autograft and of the host were 
prevented by methylmethacrylate coating, cartilage degeneration was found to develop over a 
lengthy time period of 3 years (Malinin and Ouellette 2000).
It would appear that direct communication between the subchondral bone and articular cartilage 
are important for normal joint health, and that there are vascular channels between the subchondral 
bone and articular cartilage even in the healthy adult. Therefore, cross-talk between articular 
cartilage and its underlying subchondral bone as has been demonstrated in vitro, is not only 
possible, but also plausible in vivo.
1.7 Palmar Osteochondral Disease as a Model for Subchondral Bone Mediated Osteoarthritis
1.7.1 Pathogenesis of Palmar Osteochondral Disease
The clinical condition of pain associated with subchondral bone injury of the distal condyles of 
MC/MTIII is recognised in most racing breeds including Thoroughbreds, Standardbreds, Quarter 
Horses and Scandinavian Cold-Blooded Trotters (Ross and Dyson 2003). The condition has been 
previously referred to as traumatic osteochondrosis (Pool 1996), although we prefer the term 
palmar osteochondral disease (POD) (Barr et al. 2009) as this term avoids any confusion with the 
developmental condition of osteochondrosis dissecans.
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Grossly the lesions are characterised as small, ovoid defects in the palmar or plantar articular surface 
of the condyle of approximate 2-4mm diameter (Pool 1996). Lesions are centred about 5-8mm 
proximal to the transverse ridge and may be located 3-15mm from the sagittal ridge on either the 
medial or lateral condylar surfaces (Pool 1996). Lesions appear to vary in severity. Early findings 
include a focus of bluish discolouration of the subchondral bone visible through grossly normal 
articular cartilage. More severe changes include physical disruption of the subchondral bone 
associated with varying degrees of pathology of the overlying articular cartilage. Ultimately there 
may be collapse of the subchondral bone with ulceration of the articular cartilage (Barr et al. 2009; 
Riggs 2006). In some cases these lesions have been reported to be associated with catastrophic 
condylar fracture (Krookand Maylin 1988).
The condition is of clinical as well as research importance. The pathological changes are clinically 
evident as a performance limiting lameness which may be bilateral or, in some cases, quadrilateral 
and as a result the affected horse may present with a poor action rather than overt lameness (Ross 
and Dyson 2003). The condition may be difficult to diagnose due to an inconsistent response to 
intra-articular analgesia and because only severe lesions are appreciable on routine radiography of 
the metacarpophalangeal (MCP) and metatarsophalangeal (MTP) joints (Ross and Dyson 2003). 
More specialised radiographic views may aid diagnosis (O'Brien et al. 1981; Pilsworth et al. 1988) 
and specialised imaging modalities such as nuclear scintigraphy (Ross 1998), computed tomography 
(Byron and Goetz 2007; Morgan et al. 2006) and magnetic resonance imaging (Zubrod et al. 2004) 
are extremely useful in diagnosis of POD. Visualization of the predilection site for POD lesions on the 
palmar/plantar aspect of the condyles of MC/MTIII is physically impossible during routine 
arthroscopic examination of the MCP/MTP joints. Consequently, many lesions remain undiagnosed 
until the later stages of disease, by which time the changes are irreversible and will result in chronic 
joint disease.
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1.7.2 Reasons for using POD as a Model of Osteoarthritis
As outlined in Table 1.1, various experimental models for investigating OA in vivo using the horse 
have been described including; osteochondral chip fragmentation of the radial carpal bone (Frisbie 
et al. 2002), an instability model of the metacarpophalangeal joint (Simmons et al. 1999), synovitis 
induced by lipopolysaccharide (Todhunter et al. 1996) and chemical injury of articular cartilage using 
sodium monoiodoaceate (Gustafson et al. 1992). These techniques are useful in re-creating 
experimental forms of equine OA however have drawbacks as the resulting osteoarthritic process is 
often more aggressive than the naturally occurring disease. The ideal model of OA would follow a 
more natural pattern of disease and also allow investigation of the early stages of pathology.
POD has been described previously as a model of overload arthrosis, with the equine palmar 
metacarpal condyle providing a reliable site at which microfracture and subchondral bone failure 
may occur, although attempts to re-create the disease in treadmill exercise horses resulted in mild 
lesions only (Norrdin et al. 1998). Given that POD can manifest in a range of severities of disease 
from mild, early-stage disease, through moderately affected joints, to late, end-stage disease as 
outlined in Chapter 5 (Post Mortem Evaluation of Palmar Osteochondral Disease (Traumatic 
Osteochondrosis) of the Metacarpo-/Metatarsophalangeal Joint in Thoroughbred Racehorses) it is 
considered that the condition can be utilised as a naturally occurring ex vivo condition to allow the 
investigation of OA at various stages of pathology. Further, since the disease process is thought to 
originate in the subchondral bone as opposed to the overlying hyaline articular cartilage, the disease 
has the potential to act as a model for subchondral bone driven joint disease and also to provide 
information as to the relationship between hyaline articular cartilage and subchondral bone disease 
and how these two closely related but anatomically separate tissues interact within the joint.
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1.8 Aims and Hypotheses of the Thesis
Utilising knowledge from the previously published literature as outlined above, the aims of the PhD 
project were to:
1) set up and validate an in vitro co-culture system of equine osteoblasts and chondrocytes
2) utilise this co-cuiture system to investigate interactions between equine osteoblasts and 
chondrocytes in vitro at gene and metabolome level
3) investigate further the pathogenesis of a naturally occurring equine osteochondral disease 
process utilising data derived from post mortem examination, histology examination and 
gene expression experimental studies.
It was hypothesised that:
1) osteoblasts could be isolated from equine SCB, undergo reliable proliferation and 
differentiation and respond to ILlp such that the osteoblasts showed an osteoarthritic 
phenotype in vitro
2) co-culture of equine osteoblasts pre-treated with 111(3 with cartilage explants from joints 
unaffected by OA would result in an altered chondrocyte phenotype and evidence of 
cartilage matrix degradation
3) there would be detectable differences in the metabolic profiles of conditioned culture media 
from various equine osteoblast and equine osteoblast and chondrocyte co-culture models, 
and that useful biomarkers could be identified after analysis of the spectra
4) POD would have a high prevalence at post mortem examination of a population of 
intensively raced Thoroughbreds with a predilection sites for these pathologies. Further, 
that there would be an association between POD and other pathologies affecting the distal 
condyles of MC/MTII1 and a correlation between prevalence of POD and pathologies of the 
dorsodistal aspect of MC/MTIII, suggestive of MCP/MTP joint hyperextension
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5) POD would have a characteristic and well-defined histological appearance and that the 
OOCHAS scoring system would be more reliable in analysis of cartilage pathology in samples 
of condyles affected by POD
6) there would be increases in gene expression of matrix proteinases in SCB, hyaline articular 
cartilage (HAG) and synovial membrane affected by POD and alterations in expression of 
genes involved in matrix synthesis in SCB and HAG
7) there would be correlations between expression of genes in the various articular tissues 
(SCB, HAG and synovial membrane)
8) there would be an increase in expression of non-collagenous matrix protein genes in early 
disease (Grade X POD) with a reduction in expression of non-collagenous matrix protein 
genes in later/more severely affected SCB (Grades 2 and 3)
9) there would be an increase in expression of genes involved in osteoclastic activity in SCB 
affected by POD, particularly more severe grades of POD (Grades 2 and 3), as compared to 
SCB unaffected by POD (Grade 0).
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Culture of Equine Osteoblasts and Response to Interleukin IS
2.1 Introduction
The in vitro culture of osteoblast-like cells is a long standing technique in cell biology and bone 
metabolism research (Robey and Termine 1985). Osteoblast-like culture models may be based on 
immortalised cell lines, either derived from retroviral delivery of cDNA (Heath et ol. 1989) or from 
sarcomas (Heremans et ol. 1978; McAllister et al. 1971); primary cultures obtained through explant 
culturing (Beresford et al. 1984; Beresford et ai. 1986); or bone marrow cultures where osteoblasts 
are differentiated from precursors in the marrow stroma (Beresford 1989).
While immortalised cell lines have advantages in terms of ease of availability in human studies, they 
do not necessarily provide a representative model of the osteoblastic phenotype (Clover and Gowen 
1994). In the equine, a supply of suitable cadaver material is more readily available such that 
obtaining primary cultures of osteoblast-like cells is easily achievable. However, although there are 
numerous descriptions of studies on osteogenic cells isolated from both human and laboratory 
animals, there is relatively much less published literature on culture of equine osteoblasts. What has 
been reported is related to viability and osteoprogenitor potential of bone grafts (McDuffee and 
Anderson 2003; McDuffee et al. 2006) rather than to the basic biology of equine osteoblast-like cells 
in vitro. Therefore, in order to develop a co-culture system for equine osteoblasts and cartilage 
explants, it was important to validate a system whereby equine osteoblasts could undergo reliable 
proliferation and differentiation. It was also important to identify suitable culture media for the 
differentiation and treatment steps and to ascertain whether once differentiated the osteoblasts 
were remaining viable in response to changes in various culture media which would be used for 
subsequent co-culture experiments (See Chapter 3). The response of equine osteoblasts to 
treatment with interleukin 1(3 (111(3) had also to be investigated as this has not been described 
previously in the literature.
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It was hypothesised that osteoblasts could be isolated from equine SCB, undergo reliable 
proliferation and differentiation and respond to IL1(3 such that the osteoblasts showed an 
osteoarthritic phenotype in vitro.
2.2 Materials and Methods
For all materials and methods; reagents were obtained from Sigma-Aldrich (Dorset, UK) unless 
stated otherwise.
2.2.1 Experimental Design
Experiment 1: Choice of Osteogenic Media
Primary osteoblasts isolated from bone explants from one donor were cultured for a further 12 days 
in one of 3 culture media, with medium changes every 2-3 days:
1) Dulbecco's Modified Eagle Medium (DMEM) supplemented with lOOU/ml penicillin, 
lOOpg/ml streptomycin, 500ng/ml amphotericin B,10mM HEPES, 2% Ultroser G, 10'8M 
l,25(OH)2vitamin D3, 50pg/ml ascorbic acid and 2mM proline (Sanchez et ai. 2005)
2) DMEM supplemented with 10% foetal bovine serum (FBS), lOOU/ml penicillin, lOOpg/ml 
streptomycin, 500ng/ml amphotericin B, lOmM (3 glycerophoshate, O.lmM L-ascorbic acid- 
2-phoshate and lOnM dexamethasone (Jonsson etal 1999)
3) DMEM supplemented with 10% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml 
amphotericin B (negative control)
Differentiation of osteoblasts was assessed by staining with Alizarin Red and Von Kossa, quantitative 
real time PCR (RT-qPCR) analysis of expression of osteocalcin [BGLAP) and cellular alkaline 
phosphatase assay. Confirmation that cells were not adipocytes was assessed by negative staining 
for Oil Red 0.
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Experiment 2: Do osteoblasts show alterations in gene expression in response to !L16, and if so 
what is the optimum concentration of IL16 to drive a degradative phenotype?
Primary osteoblasts from bone explants from one donor were isolated and on reaching confluence 
were differentiated in osteogenic medium for 10 days (DMEM supplemented with 10% FBS, 
lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/m! amphotericin B, lOmM [3 glycerophoshate, 
O.lmM L-ascorbic acid-2-phoshate and lOnM dexamethasone). Cells were cultured without 111(3, or 
with lOng/ml IL1(3 or lOOng/ml IL1(3 and were harvested at 24 hours, 48 hours or 72 hours.
Outcome was measured by RT-qPCR analysis of expression of BGLAP, MMP3 and COL1A2.
Experiment 3: Do osteoblasts remain differentiated and retain altered gene expression if IL16 
treatment is applied for 24hours then removed?
Primary osteoblasts from bone explants from three donors were isolated and on reaching 
confluence were differentiated in osteogenic medium for 10 days (DMEM supplemented with 10% 
FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B, lOmM (3 
glycerophoshate, O.lmM L-ascorbic acid-2-phoshate and lOnM dexamethasone ). After 
differentiation, cells were cultured for 24 hours in DMEM serum free medium either with or without 
treatment with lOng/ml IL1(3. After 24 hours of IL1(3 treatment, cells were washed in Hank's 
Balanced Salt Solution (HBSS) before culturing in DMEM serum free medium for 72 hours. Cells 
were harvested at 24,48 and 72 hour time points.
Outcome was measured by RT-qPCR analysis of expression of BGLAP, MMP3 and COL1A2; cellular 
alkaline phosphatase activity and staining for Alizarin Red.
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Experiment 4: Does pre-treatment of osteoblasts with IL16 have an effect on gene expression on a 
panel of genes involved in matrix synthesis, proteinoses and inhibitors of proteinoses?
Primary osteoblasts were isolated from bone explants from 3 separate donors and differentiated as 
before. After differentiation, ceils were cultured for 24 hours in serum free medium with or without 
the addition of lOng/ml ILlp. After IL1(3 pre-treatment, cells were washed and cultured for a further 
72 hours in serum-free medium. At the end of this period cells were harvested in Tri-reagent®.
Outcome was measured by RT-qPCR analysis of expression of biglycan {BGN), BGLAP, C0L1A2, 
COL2A1, MMP1, MMP3, MMP13, ADAMTS4, ADAMTS5 and TIMP3.
Experiment 5: In longer cell culture systems, is viability and maintenance of osteoblast 
differentiation supported by the addition ofserum/ITS+ to the culture medium?
Primary osteoblasts were isolated from bone explants and differentiated as before. After 
differentiation, cells were cultured for 24 hours in one of the 4 cell culture media listed below, either 
with or without treatment with lOng/ml ILip.
1) DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml 
amphotericin B (serum free medium)
2) DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml
amphotericin B and 1% ITS+ (1% ITS+ medium)
3) DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml
amphotericin B and 1% FBS (1% FBS medium)
4) DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml
amphotericin B and 10% FBS (10% FBS medium)
After 24 hours of ILlp treatment, cells were washed in Flank's Balanced Salt Solution (HBSS) before 
culturing in the same culture medium as before. Ceils were harvested at T=0 (directly after
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osteogenic differentiation); T=72h (+/- Hip pre-treatment) and T=144h (+/- ILlp pre-treatment). 
The time point of 72 hours was chosen as this would be the length of the gene expression co-culture 
and the time point of 144 hours was chosen as this would be the length of the GAG release co­
culture.
Outcome was measured as live/dead viability staining, Alizarin Red and Von Kossa staining of the 
osteoblasts.
2.2.2 Tissue Collection
Material was collected either from horses euthanased at The University of Liverpool Equine Hospital 
for reasons unrelated to orthopaedic disease/osteoarthritis and where owners had given informed 
consent for use of samples from their horse, or from healthy horses euthanased at a local abattoir. 
All material was harvested within 12 hours of the horse's death. Although exact signalment of 
abattoir cases was not available, all subjects were mature and all joints from which samples were 
obtained were grossly free of osteoarthritis. Subchondral bone was obtained from either the 
metacarpo- or metatarsophalangeal joint. Cartilage was removed from the distal condyles and after 
removal of the superficial calcified cartilage, the subchondral bone plate was removed from the 
palmar/plantar aspect of both lateral and media! distal condyles by sterile dissection with a chisel, 
such that small fragments of bone with dimensions approximately 3mm x 3mm were obtained.
2.2.3 Subchondral Osteoblasts in Monolayer Culture
Based on the protocols of Hilal et al. (1998) and Sanchez et al. (2005) the small pieces of subchondral 
bone were sequentially incubated in Dulbecco's modified Eagle's medium (DMEM) with 5% fetal 
bovine serum (FBS) at 37°C, initially with 0.5mg/ml hyaluronidase type IV S for 20 minutes then with 
0.6mg/ml collagenase IA for 4 hours. The digested bone pieces were then washed in Hank's 
Balanced Salt Solution (HBSS) before culturing in T-75 flasks in DMEM supplemented with 10% FBS, 
lOOU/ml penicillin, lOOpg/ml streptomycin and 500ng/ml amphotericin B. Medium was changed 
twice weekly until cells were observed to have migrated from the bone explants and had reached
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confluence. At this point cells were collected by trypsinisation, seeded at 20,000 cells/cm2 in 12 well 
plates and grown for 12 days in an osteogenic differentiation medium.
Osteoblasts were cultured for a further 10-12 days in one of 3 differentiation media as detailed in 
experiment 1, with medium changes every 2-3 days. On the basis of the results of this experiment, 
thereafter cells were differentiated by culturing for 10-12 days in DMEM supplemented with 10% 
FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B, lOmM 3 
glycerophoshate, O.lmM L-ascorbic acid-2-phoshate and lOnM dexamethasone, with media changes 
every 2-3 days.
2.2.4 Alizarin Red, Von Kossa's and Oil Red O Staining
Alizarin Red and Von Kossa's Staining were performed to ascertain differentiation of the osteoblasts 
and confirm osteoblast phenotype. Oil Red O staining was performed to identify any adipogenic 
differentiation. For all stains, media was removed from the wells and cells were washed twice in 
phosphate buffered saline (PBS) prior to fixing of the cells with 4% formaldehyde for 10 minutes. 
Cells were washed twice in ultra-pure water before application of the stain. For the Alizarin Red 
stain, 1% Alizarin Red S was applied for 5 minutes then washed twice in ultra pure water. For the 
Von Kossa stain, 1% silver nitrate was applied to the cells and then cells were placed under 
ultraviolet light for 40 minutes. Cells were washed in distilled water then treated with 3% sodium 
thiosulphate for 5 minutes. For the Oil Red O stain, a stock of 0.5% Oil Red O in propan-2-ol was 
diluted 3 in 5 in ultra pure water, then applied to the cells and incubated at room temperature for 1 
hour. Staining was assessed by examination by microscope (Nikon Eclipse TS100; Nikon, Kingston 
Upon Thames, UK) and digital pictures were obtained.
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2.2.5 Alkaline Phosphatase Assay
Alkaline phosphatase (ALP) activity was quantified in the cellular fraction of the osteoblast culture. 
Media was removed at the end of the co-culture period (72h). Cells were washed in PBS then lysed 
in 1ml 0.2% Triton X-100 and the Triton-X/cell lysate mixture was collected. Cell extract (5pL) was 
incubated with 195pL of a lOmM p-Nitrophenyl phosphate working solution (BioAssay Systems). A 
standard solution of tartrazine was used as a calibrator, according to the kit's instructions. In the 
presence of alkaline phosphatase, p-Nitrophenyl phosphate is converted to p-nitrophenol and 
inorganic phosphate, with the rate of the reaction being directly proportional to the enzyme activity. 
The absorbance of p-nitrophenol was measured at405nm on a Multiskan EX photometric multiplate 
absorbance reader (Thermo Electron Corp, Vantaa, Finland)at room temperature at t=0 and t=4 
minutes. ALP activity of the sample is measured according to the kit's instructions as:
ALP flU/L) = (OP sample t-OD sample 0) x Reaction Volume x 40.4 
(OD calibrator - OD H20) x Sample Volume x t
Alkaline phosphatase activity was normalised to total protein content of the cellular fraction.
2.2.6 Total Protein Assay
Total protein content of the osteoblast cellular fraction collected in 0.2% Triton X-100 was measured 
using the BCA Protein Assay Kit (Pierce Biotechnology, Thermo Scientific, Rockford, Illinois) according 
to the manufacturer's instructions. This technique is based on the reduction of Cu2+ to Cu1+ by 
protein in an alkaline medium. Cu1+ is detected in the presence of bicinchoninic acid (BCA) by the 
chelation of 2 molecules of BCA with one Cu1+ ion resulting in a purple-coloured reaction product. 
The assay was measured on a Multiskan EX photometric multiplate absorbance reader (Thermo 
Electron Corp, Vantaa, Finland) at 570nm relative to standards of albumin with known protein 
concentration.
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2.2.7 Live/Dead Staining
Media was removed from osteoblasts in monolayer and cells were washed in sterile PBS. Twenty |iL 
of 2mM ethidium homodimer (EthD-1) was added to 10mi of sterile PBS, and to this mixture SjiL of 
4mM calcein AM stock solution was added according to the kit's instructions (Live/Dead 
Viability/Cytotoxicity Kit for mammalian cells; Invitrogen Ltd, Paisley, UK). This gave a final solution 
of 2[iM calcein AM and 4|iM EthD-1 which was added directly to the wells of the 12-well plate 
containing the washed cells. Cells were incubated for 30 minutes at room temperature in the dark. 
After incubation, cells were examined under a fluorescence microscope (Nikon Eclipse TS100; Nikon, 
Kingston Upon Thames, UK). Live cells were visualised using an excitation filter of 460-500nm and 
emission of 510-560nm. Dead ceils were visualised using an excitation filter of 540-580nm and 
emission of 600-660nm. Digital images were obtained and stored.
2.2.8 Quantitative Real-Time PCR
2.2.8.1 RNA extraction and Reverse Transcription
Osteoblasts were harvested in Tri-Reagent (Ambion, Applied Biosystems, Warrington, UK). RNA 
extraction was performed using a standard chloroform and ethanol extraction followed by the 
RNeasy (Qiagen, Crawley, UK) column technique, incorporating a DNase treatment stage. RNA was 
quantified using a Nanodrop (Thermo Scientific, Wilmington, USA) and Ipg of RNA or the maximum 
volume for the reaction (12.4|iL) where RNA concentration was < 80.6ng/pl, was used as the 
template for the reverse transcriptase reaction. cDNA strands were generated from the RNA in a 
25pi volume reaction using Random Primers (Promega, Southampton, UK), RT buffer, lOmM of 
dNTPs, M-MLV RT enzyme and RNase inhibitor.
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2.2.8.2 Primer Preparation
Equine specific PCR primers were designed by obtaining equine RNA and DNA sequences from the 
NCBI database (http://www.ncbi.nlm.nih.fiov/). Where the equine sequence was unavailable, a 
multiple species alignment was performed (http://www.ebi.ac.uk/Tools/clustalw2/index.html) and 
primers designed where there was sequence homology across species. Exon boundaries were 
identified (http://www.ensembl.org/index.html) and where possible primers were designed to 
amplify across exon-intron boundaries to allow discrimination of genomic DNA and cDNA. As this 
was not possible in all cases, the DNase treatment stage was incorporated in the RNA extraction 
technique as above. Primers were designed based on the sequences acquired using Primer Express 
software (Applied Biosystems) or Primer 3 software (http://frodo.wi.mit.edu/cgi-- 
bin/primer3/primer3 www.cgi). Primer efficiencies were validated using a standard curve derived 
from equine cDNA using a 10-fold dilution series with 5 measuring points. A dissociation curve was 
included in validation to ensure primers were specific and amplified only one product. Primer 
efficiency is optimal at a slope of -3.32. The primers used for the target and housekeeping genes 
and their efficiencies are as shown in Table 2.1.
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Gene Primer Sequence Accession Code Efficiency
GAPDH F: GCATCGTGGAGGGACTCA
R: GCCACATCTTCCCAGAGG
AF157626 -3.32
ADAMTS4 F: CAGCCTGGCTCCTTCAAAAA
R: CCGCAGGAATAGTGACCACAT
NM_001111299 -3.23
ADAMTS5 F: ACCG ATCCT G C AGT GT C AC A
R: CTGCTCATGGCGAAAAGATTT
EU025851 -3.13
MMP1 F: GGTGAAGGAAGGTCAAGTTCTGAT
R: AGT CTT CT ACTTT G G AA AAG AG CTT CT CT
NM_001081847 -3.36
MM P-3 F: TCTTGCCGGTCAGCTTCATATAT
R: CCTATGGAAGGTGACTCCATGTG
NM_001082495 -3.63
MMP 13 F: CTGGAGCTGGGCACCTACTG
R: ATTTGCCTGAGTCATTATGAACAAGAT
NM_001081804 -3.51
TIM P-3 F: CTGCAACTTCGTGGAGAGGT
R: ACT C GTT CTT G G AG GT C AC G
NM_001081870 -3.54
Collagen 1 a2 F: GCACATGCCGTGACTTGAGA
R: CATCCATAGTGCATCCTTGATTAGG
XM_001492939 -3.31
Collagen II ctl F: TCAAGTCCCTCAACAACCAGATC
R: GT C AAT CC AGT AGT CT CCGCT CTT
NM__001081764 -3.21
Biglycan F: TCACCTTCCAGCCCCTAGAGT
R:AGAAGCAGCCCCTCCTCAA
NM_001081839 -3.71
Osteocalcin F: T CAACCC AG ACT GT G ACG AG
R: CAGCTAGGGACGATGAGGAC
XM_001915727 -3.80
Table 1: Primer sequences used for quantitative real-time PCR
F= Forward primer, R= Reverse primer
2.2.83 Quantitative Real-Time Polymerase Chain Reaction
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed in a 25p.L volume using 
SYBR® Green PCR master mix (Applied Biosystems, Warrington, UK) and BOOnM primer 
concentration and processed by 7300 Real Time PCR system (Applied Biosystems, Warrington, UK). 
Conditions for amplification were 2 minutes at 50°C, 10 minutes at 95°C, followed by 40 cycles of 15 
seconds at 95°C, and 60 seconds at 60°C for primer annealing and elongation. This was followed by 
a dissociation stage for 15 seconds at 95°C, 30 seconds at 60°C and 15 seconds at 95°C to ensure the 
presence of a single amplicon. Data was analysed using SDS software (Applied Biosystems). PCR 
products were measured and normalised against GAPDH as a housekeeping gene.
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2.2.9 Data Analysis
Data was plotted and tested for normality using the Kolmogrov-Smirnov test then logged as 
required (Minitab v.15; Minitab Inc., Pennsylvania). Where appropriate, mixed effects linear 
regression (SPlus v6.1; T1BCO Software Inc, California) was used to test for significant differences 
between groups while allowing for the clustering of samples within donor. Significance was set at 
P<0.05 unless multiple comparisons were made on the same sample (i.e. gene expression data), 
where the P-value was adjusted using Sidak's formula (Sidak 1967):
otPT- 1 — (l-apF)1/c
where a is the probability of making a Type l error, apT is the a per test, apF is the a per family of 
tests and c is the number of comparisons. Therefore if we assume that the required apF is 0.05, 
then:
aPT= 1 - (l-0.05)1/c
2.3 Results
2.3.1 Experiment 1: Choice of Osteogenic Media
Cell staining (Alizarin Red, Von Kossa, Oil Red 0), qRT-PCR for osteocalcin and cellular alkaline 
phosphatase assay were performed in triplicate from one donor. Results for cell staining in the 
various differentiation media are as shown in Table 2.2. Images of the cell staining are as shown in 
Figures 2.1-2.6. Gene expression of osteocalcin was increased in cells differentiated in medium 
containing j3-g!ycerophosphate, ascorbic acid and dexamethasone (Figure 2.7) as compared to the 
other media. Alkaline phosphatase assays showed markedly increased cellular levels of alkaline
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phosphatase in cells cultured in both osteogenic differentiation media as compared to the negative
control (Figure 2.8).
Stain Culture Media: DMEM, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml 
amphotericin B plus:
lOmM HEPES, 2% Ultroser 
G, 10'8M l,25(OH)2vitamin 
D3, 50pg/ml ascorbic acid 
and 2mM proline
10% FBS, lOmM $ 
glycerophoshate, O.lmM L- 
ascorbic acid-2-phoshate 
and lOnM dexamethasone
10% FBS (negative 
control)
Alizarin Red negative positive negative
Oil Red O negative negative negative
Von Kossa mildly positive positive negative
Table 2.2: Response to staining after differentiation of cells in various culture media
Figure 2.1: Positive (red) staining for Alizarin Red in osteoblasts differentiated in DMEM 
supplemented with 10% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B, 
WmM 6 glycerophoshate, 0.1mM L-ascorbic acid-2-phoshate and lOnM dexamethasone
Figure 2.2: Negative staining for Alizarin Red in osteoblasts differentiated in DMEM supplemented 
with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B,10mM HEPES, 2% 
Ultroser G, 10'8M l,25(OH)2vitamin D3, 50pg/ml ascorbic acid and 2m M pro line
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Figure 2.3: Negative staining for Alizarin Red in osteoblasts differentiated in DM EM supplemented 
with 10% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B (negative 
control)
Figure 2.4: Positive staining for Von Kossa in osteoblasts differentiated in DMEM supplemented with 
10% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B, WmM 6 
glycerophoshate, O.lmM L-ascorbic acid-2-phoshate and lOnM dexamethasone
Figure 2.5: Mildly positive staining for Von Kossa in osteoblasts differentiated in DMEM 
supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B,10mM 
HEPES, 2% Ultroser G, 10~8M l,25(OH)2vitamin D* 50pg/ml ascorbic acid and 2mM proline
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Figure 2.6: Negative staining for Von Kossa in osteoblasts differentiated in DM EM supplemented with 
10% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B (negative control)
Figure 2.7: Osteocalcin expression in osteoblasts after 10 days in various differentiation media. Diff 
Media 1: DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml 
amphotericin B,10mM HEPES, 2% Ultroser G, 10'8M l,25(OH)2vitamin Ds, 50pg/ml ascorbic acid and 
2mM proline; Diff Media 2: DMEM supplemented with 10% FBS, lOOU/ml penicillin, lOOpg/ml 
streptomycin, 500ng/ml amphotericin B, lOmM 6 glycerophoshate, O.lmM L-ascorbic acid-2- 
phoshate and lOnM dexamethasone; 10% FCS: DMEM supplemented with 10% FBS, lOOU/ml 
penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B (negative control)
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Figure 2.8: Alkaline Phosphatase content of cells cultured in Differentiation Media 1; DMEM 
supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B,10mM 
HEPES, 2% Ultroser G, 10'8M l,25(OH)2\/itamin D* 50pg/ml ascorbic acid and 2mM praline; 
Differentiation Media 2: DMEM supplemented with 10% FBS, lOOU/ml penicillin, lOOpg/ml 
streptomycin, 500ng/ml amphotericin B, lOmM 6 glycerophoshate, O.lmM L-ascorbic acid-2- 
phoshate and lOnM dexamethasone; 10% FCS: DMEM supplemented with 10% FBS, lOOU/ml 
penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B (negative control)
It was concluded that using culture medium 2 (DMEM supplemented with 10% FBS, lOOU/ml 
penicillin, 100p.g/ml streptomycin, 500ng/ml amphotericin B, lOmM 3-glycerophoshate, O.lmM L- 
ascorbic acid-2-phoshate and lOnM dexamethasone) resulted in the most reliable differentiation of 
primary osteoblast-like cells for use in future experiments.
2.3.2 Experiment 2: Do osteoblasts show alterations in gene expression in response to IL16, and if 
so what is the optimum concentration ofILIB?
Quantitative RT-PCR to measure expression of BGLAP, MMP3 and COL1A2 for osteoblasts treated 
with Ong/mL, lOng/mL and lOOng/mL and harvested at times 0, 24, 48 and 72 hours were performed
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in triplicate from cells grown from one donor. Because only one donor was used in this experiment,
statistical analysis was not performed. Results are as shown in Figures 2.9-2.11.
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Figure 2.9: COL1A2 expression relative to GAPDH as a housekeeping gene (shown as a log value) at 
times 0, 24, 48 and 72 hours without IL16 treatment and with lOng/mL and lOOng/mL IL16 added to 
the culture media
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Figure 2.10: MMP3 expression relative to GAPDFI (shown as a log value) at times 0, 24, 48 and 72 
hours without IL16 treatment and with lOng/mL and lOOng/mL IL16 added to the culture media.
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Figure 2.11: Osteocalcin expression relative to GAPDH (shown as a log value) at times 0, 24, 48 and 
72 hours without IL16 treatment and with lOng/mL and lOOng/mL IL16 added to the culture media.
MMP3 expression was up-regulated after treatment with both lOng/mL and lOOng/mL IL13 at all 
time points. BGLAP expression was decreased after osteoblasts were treated with both lOng/mL 
and lOOng/mL ILlp at all time points. COL1A2 expression was decreased after treatment with ILlp 
at time points 24 and 48 hours, with a more pronounced decrease in expression at the higher 
concentration of lOOng/mL. By 72 hours, expression of COL1A2 was similar in all treatment groups 
(without IL1(3, lOng/mL ILip and lOOng/mL IL1(3).
From these results it was concluded that the lower concentration of lOng/mL ILip should be used 
for stimulation of osteoblasts towards an osteoarthritic phenotype in subsequent experiments.
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2.3.3 Experiment 3: Do osteoblasts remain differentiated and retain altered gene expression iflL16 
treatment is applied for 24hours then removed?
Previously it was shown that there were alterations in expression of various genes in osteoblasts 
treated with lOng/mL ILip for 72 hours. For development of the co-culture system, it was necessary 
to investigate how equine osteoblasts would respond to 24 hours of ILip treatment at lOng/mL 
followed by removal of this stimulus.
Experiments were performed in triplicate on primary osteoblasts obtained from 3 separate donors. 
Gene expression of MMP3, COL1A2 and BGLAP are as shown in Figures 2.12-2.14, expressed as fold 
difference in gene expression normalised to the osteoblasts not pre-treated with ILip at 24 hours. 
The Sidak corrected level of significance was calculated as P<0.02. Where differences in gene 
expression are significant between treatment groups at each time point, these are shown on the
P<0.0001
P<0.0001
P=0.0001
IL13 preILip pre TxIL13 pre Tx No Tx T=72No Tx T=48No Tx T=24
TxT=72T=24
Culture Condition and Time of Cell Harvest
Figure 2.12: MMP3 expression from 3 donors in osteoblasts pre-treated or not with IL16 for 24 hours, 
then washed and cultured in serum free media for a further 72 hours maximum. Culture times are 
expressed as time after washing of cells and removal of IL16 or washing of non-treated controls. 
Gene expression is expressed as fold increase in gene expression normalised to the osteoblasts not 
pre-treated with IL16 at T=24 hours. Error bars indicate standard error.
49
1.4
<N 0) II
C ^
S 15 
^ 43 
“o J2
o S
LL. 4->'—- Irt
C o
.2 -o </» <jji/> *->
<u njw (U
AJ Ca> o c c
n O D *->
M T3 < ai
1.2
1
0.8
0.6
0.4
0.2
0
P=0.01
No Tx T=24 ILlp pre Tx NoTxT=48 ILlppreTx No Tx T=72 ILlp pre TxT=72 
T=24 T=48
Culture Condition and Time of Cell Harvest
Figure 2.13: Collagen-1 expression from 3 donors in osteoblasts pre-treated or not with IL16 for 24 
hours, then washed and cultured in serum free media for a further 72 hours maximum. Culture times 
are expressed as time after washing of cells and removal of IL16 or washing of non-treated controls. 
Gene expression is expressed as fold increase in gene expression normalised to the osteoblasts not 
pre-treated with IL16 at T=24 hours. Error bars indicate standard error.
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Figure 2.14: Osteocalcin expression from 3 donors in osteoblasts pre-treated or not with IL16 for 24 
hours, then washed and cultured in serum free media for a further 72 hours maximum. Culture times 
are expressed as time after washing of cells and removal of IL16 or washing of non-treated controls. 
Gene expression is expressed as fold increase in gene expression normalised to the osteoblasts not 
pre-treated with IL16 at T=24 hours. Error bars indicate standard error.
MMP3 expression was significantly increased in the IL1(3 pre-treated osteoblasts at all time points 
measured. COL1A2 expression was significantly decreased in ILip pre-treated cells at 24 hours, but 
there was no significant difference between groups in C0L1A2 expression at 48 or 72 hours. BGLAP 
expression was significantly decreased in ILip pre-treated cells at all time points.
Results of alkaline phosphatase assays are as shown in Figure 2.15. There were no significant 
differences in alkaline phosphatase levels between IL1(3 pre-treated and non IL1(3 pre-treated 
osteoblasts at any time point. Thus pre-treatment of osteoblasts with ILip did not appear to have 
an effect on alkaline phosphatase content of the cells.
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Figure 2.15: Alkaline phosphatase content of the osteoblast cellular fraction normalised to total 
protein content of samples from 3 donors expressed as lU/L/mg TP. Error bars indicate standard 
error.
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Osteoblasts which were pre-treated with IL13 showed an apparent reduction in Alizarin Red staining 
at 24 hours (Figure 2.16) as compared to osteoblasts which had not been pre-treated (Figure 2.17). 
By 48 hours however, the difference between ILip pre-treated and non pre-treated osteoblasts was 
much less evident (Figures 2.18 and 2.19).
Figure 2.17: Alizarin Red staining of osteoblasts not pre-treated with IL16 at 24 hours of culture in 
serum free media
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Figure 2.18: Alizarin Red staining of osteoblasts pre-treated with IL16 at 48 hours of culture in serum 
free media
Figure 2.19: Alizarin Red staining of osteoblasts not pre-treated with IL16 at 48 hours of culture in 
serum free media
2.3.4 Experiment 4: Does pre-treatment of osteoblasts with IL16 have an effect on gene expression 
on a panel of genes involved in matrix synthesis, proteinoses and inhibitors of proteinoses?
Experiments were performed in triplicate on primary osteoblasts obtained from 3 separate donors. 
Differentiated osteoblasts were either pre-treated with lOng/mL or not pre-treated with ILlp for 24 
hours, washed, then cultured for a further 72 hours in serum free medium. Expression of a panel of 
genes of interest (MMP1, MMP3, MMP13, ADAMTS4, ADAMTS5 and TIMP3) in osteoblasts pre­
treated or not with IL1(3 are as shown in Figure 2.20. Expression of each gene is shown for 
osteoblasts pre-treated with ILip as a fold difference to the expression of that gene in differentiated
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osteoblasts grown in monolayer but not pre-treated with IL13- The Sidak corrected level of
significance was calculated as P<0.009.
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Figure 20: Gene expression with significant differences in osteoblasts pre-treated with IL16 as 
compared to osteoblasts not treated with IL16. Values for gene expression are shown as a fold 
differences compared to expression in the untreated osteoblasts. Significance of differences in 
expression are shown on each graph.
In the IL13 pre-treated osteoblasts there was a significant increase in expression of MMP1 
(P=0.0001), MMP3 (P=0.003), MMP13 (P=0.001). There was a significant decrease in expression of 
COL2A1 (P=0.0002) in the ILip pre-treated osteoblasts. There was no significant difference in 
expression of COL1A2, BGN, BGLAP, ADAMTS4, ADAMTS5 or TIMP3 between the ILip pre-treated 
and non pre-treated osteoblasts.
3.5 Experiment 5: In longer cell culture systems, is viability and maintenance of osteoblast 
differentiation supported by the addition of serum/!TS+ to the culture medium?
Response of osteoblasts to live/dead. Alizarin Red and Von Kossa staining with and without pre­
treatment with ILip at 72 hours and 144 hours in DMEM, DMEM with 1% ITS+, DMEM with 1% PCS
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and DMEM with 10% PCS are as shown in Figures 2.21-2.36. Primary osteoblasts were grown from 
one donor.
Figure 2.21: Non IL16 pre-treated osteoblasts cultured for 72 hours in serum free DMEM. Clockwise 
from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
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Figure2. 22: IL16 pre-treated osteoblasts cultured for 72 hours in serum free DM EM. Clockwise from 
top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
Figure 2.23: Non IL16 pre-treated osteoblasts cultured for 72 hours in DM EM with addition of 1% 
ITS+. Clockwise from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
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Figure 2.24: IL16 pre-treated osteoblasts cultured for 72 hours in DM EM with addition of 1% ITS+. 
Clockwise from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
Figure 2.25: Non IL16 pre-treated osteoblasts cultured for 72 hours in DM EM with addition of 1% 
FBS. Clockwise from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
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Figure 2.26: IL16 pre-treated osteoblasts cultured for 72 hours in DMEM with addition of 1% FBS. 
Clockwise from top left: live staining, dead staining, Von Kossa staining. Alizarin Red staining.
Figure 2.27: Non IL16 pre-treated osteoblasts cultured for 72 hours in DMEM with addition of 10% 
FBS. Clockwise from top left: live staining, dead staining. Von Kossa staining, Alizarin Red staining.
58
Figure 2.28: IL16 pre-treated osteoblasts cultured for 72 hours in DM EM with addition of 10% FBS. 
Clockwise from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
Figure 2.29: Non IL16 pre-treated osteoblasts cultured for 144 hours in serum free DM EM. Clockwise 
from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
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Figure 2.30: IL16 pre-treated osteoblasts cultured for 144 hours in serum free DMEM. Clockwise 
from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
Figure 2.31: Non IL16 pre-treated osteoblasts cultured for 144 hours in DMEM with addition of 1% 
ITS+. Clockwise from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
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Figure 2.32: IL16 pre-treated osteoblasts cultured for 144 hours in DMEM with addition of 1% ITS+. 
Clockwise from top left: live staining, dead staining. Von Kossa staining, Alizarin Red staining.
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Figure 2.34: IL16 pre-treated osteoblasts cultured for 144 hours in DM EM with addition of 1% FBS. 
Clockwise from top left: live staining, dead staining. Von Kossa staining, Alizarin Red staining.
Figure 2.35: Non IL16 pre-treated osteoblasts cultured for 144 hours in DM EM with addition of 10% 
FBS. Clockwise from top left: live staining, dead staining. Von Kossa staining. Alizarin Red staining.
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Figure 2.36: IL16 pre-treated osteoblasts cultured for 144 hours in DMEM with addition of 10% FBS. 
Clockwise from top left: live staining, dead staining, Von Kossa staining. Alizarin Red staining.
2.3.5.1 Seventy two hours culture
Subjectively, at 72 hours culture there was increased dead staining in ILlp pre-treated osteoblasts 
cultured in serum free DMEM as compared to all other culture conditions. In the live staining, there 
was evidence of more obvious bone nodule formation and bone autofluorescence in the osteoblasts 
cultured in DMEM supplemented with 1% ITS+ and 10% FBS as compared to serum free and 1%FBS. 
Generally, Alizarin Red staining was good for all culture conditions regardless of media used or 
whether the cells were pre-treated with IL13. Von Kossa staining was subjectively less marked in 
both IL13 pre-treated and non pre-treated osteoblasts cultured in serum free DMEM as compared to 
the other 3 culture media.
2.3.5.2 One hundred and forty four hours culture
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Live staining appeared reduced in cells cultured for 144 hours in serum free DMEM, In the other S 
culture media, live/dead staining was similar regardless of whether cells had been pre-treated or not 
with I Lip. Increased dead staining was observed in all culture media and treatments at 144 hours 
compared to 72 hours. There was a marked decrease in Alizarin Red staining in the ILlp pre-treated 
osteoblasts at 144 hours tn all culture media as compared to at 72 hours. Although there were 
isolated nodules of positive Alizarin Red stain in these cells, particularly in the 1% ITS+, 1% FBS and 
10% FBS cultures, the characteristic diffuse red staining was lost. Non ILlp pre-treated osteoblasts 
continued to stain diffusely positively for Alizarin Red in all culture media examined. Von Kossa 
staining was also reduced in the ILip pre-treated osteoblasts in all media, and this effect was most 
marked in the serum free medium.
2.4 Discussion
Bone formation comprises a complex and ordered sequence of events involving the proliferation and 
differentiation of osteoblastic precursor cells ultimately leading to the formation of a calcified 
extracellular matrix (Stein et at. 1989). Although the process may be observed in vivo, it is difficult to 
study at the molecular level under these conditions, thus various in vitro models have been 
developed to facilitate such studies (Scutt et af. 1992). While much is known about these models in 
the human and laboratory animals, there is very little published data in the equine. Cells grown 
from explants at first passage are a mixed cell population containing osteoprogenitor cells from the 
bone matrix, further differentiated osteogenic cells, fibroblasts, chondrogenic cells and pluripotent 
cells (Ashton et al. 1985). This mixed population thus requires further differentiation before it can 
be effectively used in experiments to investigate the biology of the equine osteoblast.
As a first step in these experiments, the use of two published osteogenic differentiation media were 
compared to determine which was most appropriate for use with equine cells. There is no one 
reliable measurement of osteoblast phenotype, therefore a combination of methods is required.
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Those utilised in this set of experiments included measurement of osteocalcin expression at gene 
level, measurement of cellular alkaline phosphatase at protein level, and histochemical staining of 
the cells and their mineralised matrix.
Osteocalcin has been shown to be an accurate marker of osteoblast phenotype which is expressed 
during the matrix maturation and mineralisation phases of bone development (Stein et al. 1989). 
Protein levels of osteocalcin were not considered here, but previous authors have shown that gene 
expression of osteocalcin begins to increase after 7 days of differentiation with a resultant 
exponential increase in levels of osteocalcin in the culture medium after this point (Sanchez et al. 
2008).
Alkaline phosphatase is a useful marker of osteoblast phenotype and bone formation, being 
expressed during the early stages of differentiation and bone matrix deposition, with down- 
regulation of expression and production during the later stages of matrix mineralisation (Stein et al. 
1989).
Alizarin Red and von Kossa are histochemical staining methods used to identify mineralisation of the 
matrix. Both staining methods were used as neither staining method is absolutely reliable in the 
identification of mineralisation and discrepancies have been found between the two techniques 
(Puchtler et al. 1969). Von Kossa staining has been shown to detect phosphate rather than 
calcification and the presence of phosphate per se does not necessarily imply the presence of 
calcium or of hydroxyapetite (Bonewald et al. 2003). Alizarin Red staining is not specific for calcium 
with alizarin reacting with other cations and the anion of the salt can affect the colour of the alizarin- 
metal compound, furthermore the colour of the alizarin-metal compound can alter with pH of the 
solution (Puchtler eto/. 1969).
The culture medium containing (3-glycerophosphate, L-ascorbic acid and dexamethasone resulted in 
the most effective differentiation of primary equine osteoblast-like cells. (3-glycerophosphate is
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utilised as a source of additional phosphate ions after it was shown by Tenenbaum and Heersche 
(1982) that addition of (3-glycerophosphate to the culture media was required for effective 
mineralisation to occur in vitro. The rationale of utilising (3-giycerophosphate as the additional 
source of phosphate ions is that the possibility of nonspecific mineral precipitation is reduced 
(Tenenbaum and Heersche 1982) since phosphate ions are made available through enzymatic 
hydrolysis of |3-glycerophosphate by alkaline phosphatase produced by osteoblasts. Some authors 
have questioned the physiological relevance of a cell culture system which requires addition of 
apparently unphysiological levels of phosphate ions (Beresford et ol. 1993), however, it has been 
argued that although inorganic phosphate levels are within the physiologic range (ImM) in culture 
medium, the organic phosphate levels (4mM) are in fact well below the normal physiologic levels 
(lOmM) and supplementation is a viable means of mimicking the physiological situation (Tenenbaum 
and Heersche 1982).
L-ascorbic acid is required in cell culture of appropriate cells to stimulate the formation and 
hydroxylation of collagen, thus allowing the deposition of a collagenous matrix (Barnes 1975). While 
it has been shown that bone nodules were formed in vitro by cells obtained from rat calvaria 
cultured with L-ascorbic acid, these nodules were unmineralised and it was concluded that addition 
of both L-ascorbic acid and 3-glycerophosphate was required for production of mineralised osteoid 
nodules in this cell culture system(Bellows et at. 1986).
Dexamethasone was added to the culture medium in this series of experiments. It has previously 
been shown that glucocorticoids at physiological doses enhance osteogenic differentiation by 
increasing the formation of bone nodules and the expression of genes associated with osteoblast 
phenotype in primary rat osteoblast cultures (Bellows and Aubin 1989; Bellows et al. 1987; Bellows 
et al. 1990; Shalhoub et al. 1992). It appears that low dose glucocorticoids promote changes in cell­
cell and cell-extracellular matrix signalling such that growth and differentiation of cells capable of 
osteogenic phenotype development is supported, while growth of cells that cannot progress to the
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mature osteoblast phenotype is inhibited (Shalhoub etol. 1992). Further, it has been suggested that 
a potential mechanism for these effects is modulation of expression and action of the bone 
morphogenic proteins, which are secreted proteins capable of inducing cartilage or bone formation 
(Cooper et o/. 1999).
Pre-treatment of bone explants with hyaluronidase and collagenase was performed prior to further 
culture as described previously (Hilal et al. 1998; Sanchez et al. 2005). Collagenase pre-treatment 
was previously described by Robey and Termine (1985) and Robey (1995), who showed that 
collagenase pre-treatment of bone fragments to be used in explant culture resulted in removal of all 
ceils other than those immediately adjacent to the bone surface. This therefore gives a purer 
osteoblastic cell population by removing adherent and remaining bone marrow cells (Robey 1995). 
Whether collagenase treatment of explants is necessary is debatable as three isolation techniques 
have been compared (Jonsson et al. 1999) and it was shown that human cells grown from explants 
had similar phenotypical characteristics regardless of collagenase treatment. The cells obtained 
from bone explant culture were shown to differ significantly from those obtained from bone marrow 
stromal cells by expressing lower levels of alkaline phosphatase, higher levels of type l collagen and 
higher levels of vitamin D stimulated osteocalcin secretion.
It was demonstrated that pre-treatment of osteoblasts with ILip resulted in no significant effect on 
cellular alkaline phosphatase levels. These results support those of Evans et al, (1989) who cultured 
human osteoblasts with ILip. In combination with the results of Alizarin Red and Von Kossa staining 
of cells at 72 hours, it can be proposed that ILip treatment did not have a detrimental effect on 
osteoblast differentiation at the end of the culture period. Similarly, there was no reduction in 
expression of bone specific COL1A2 or of the proteoglycan biglycan which may indicate that cells 
maintained an osteoblast phenotype in vitro after pre-treatment with 111(3. Interestingly, expression 
of COL2A1 was significantly decreased in response to IL1[3 pre-treatment, which is the same 
response as has been reported in equine chondrocytes (Richardson and Dodge 2000). This may
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indicate that equine osteoblasts in cell culture are responding to ILlp in a similar fashion to other 
cells of mesenchymal origin. Alternatively, there may be a mixed population of cells such that there 
are still some undifferentiated fibroblasts in the cell culture. As described above, osteoblast 
phenotype and differentiation were determined. It would also have been useful to determine 
fibroblast phenotype, but no marker is available for fibroblast differentiation in the equine.
Increases in expression of mRNA for various matrix metalloproteinases [MMP1, MMP3 and MMP13) 
were demonstrated after treatment of osteoblasts with ILlfS. Although previously the osteoclast 
was considered to be the main producer of proteinases in bone, there is now mounting evidence of 
the importance of the role of the osteoblast in production of these enzymes. The osteoblast has the 
capacity therefore to synthesise a range of matrix proteins and has the ability to remodel its own 
extracellular matrix through the secretion of a range of proteinases (Bilezikian et at. 2008). In an 
experiment with time points looking at MMP3 expression, it was shown that gene expression was 
time-dependent, being highest 24 hours after 111(3 removal, decreasing at 48 hours and decreasing 
again at 72 hours. However, gene expression remained significantly higher at 72 hours after IL1(3 
removal as compared to basal levels in untreated osteoblasts. In a subsequent experiment it was 
demonstrated that significant increases in gene expression were evident for all MMPs measured 
[MMP1, MMP3 and MMP13) at 72 hours of further culture after the IL1(3 was removed. How this 
corresponds with the levels of protein and of active and inactive enzyme was not investigated in 
these experiments, although this would have been a useful adjunct and has been addressed using 
MMR13 assays of the media in co-culture experiments in Chapter 3. Previous authors have 
measured secretion of MMP1 and MMP3 and failed to show secretion of these proteins in the 
medium of normal human osteoblasts cultured with IL1(3 (Rifas et at. 1994).
No alteration in ADAMTS 4 or ADAMTS5 expression in response to IL1[3 were observed in this model 
despite the previous implication of ADAMTS5 in subchondral bone disease and osteoarthritis (Botter
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et al. 2009). ADAMTS5 gene expression has previously been shown to increase in response to ILip in 
bovine chondrocytes (Chan et al. 2006; Cortial et al. 2006) and ADAMTS4 gene expression has been 
shown to increase in response to I Lip in human chondrocytes (Bau et al. 2002; Moulharat et al. 
2004), bovine chondrocytes (Cortial et al. 2006) and human synovial fibroblasts. While it has been 
shown that the osteoblast expresses ADAMTS4 and ADAMTS5 in rat bone (Nakamura et al. 2005), 
there is no published data in any species on alterations in expression of these genes in response to 
ILip. Therefore the failure to show any alterations in expression of ADAMTS4 orADAMTSS in equine 
osteoblasts in response to ILip may be as a result of species differences, or because ADAMTS4 and 
ADAMTS5 expression in the osteoblast are indeed not mediated via ILip.
Pre-treatment of osteoblasts with lOng/ml ILip for 24 hours prior to a further period of 72 hours of 
culture in non-osteogenic media does not appear to have a detrimental effect on osteoblast 
differentiation. Alterations in gene expression were evident in response to application of ILip and 
remained for 72 hours after removal of ILip. When culture times after removal of ILip were 
extended to 144 hours, osteoblast survival and differentiation appeared to benefit from addition of 
1% ITS+, 1% PCS or 10% PCS to the culture medium. At 144 hours of culture after removal of ILip in 
those osteoblasts that were pre-treated, there was evidence of decreased mineralisation of the 
matrix characterised by reduced von Kossa and Alizarin Red staining. As this was not seen in the 
osteoblasts not pre-treated with ILip at 144 hours or in either the ILip pre-treated or not pre­
treated group at 72 hours, it is difficult to explain how the osteoblasts can lay down a mineralised 
matrix, only for this to disappear after a further period of culture. The use of live/dead staining gave 
some indication as to the survival cells, however this technique was limited in this system by the lack 
of quantitative data and by the autofluorescence of bone/mineralised matrix.
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2.5 Conclusion
It has been shown that osteoblasts can be grown from equine subchondral osteoblasts and have an 
ability to differentiate and lay down a mineralised matrix when cultured in the presence of an 
osteogenic culture media containing |3-g!ycerophosphate, dexamethasone and L-ascorbic acid at 
physiological levels. These cells respond to ILlfS and this model may be used for further 
investigation of the cell biology of subchondral bone disease in osteoarthritis.
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Co-Culture System of Equine Osteoblasts and Chondrocytes
3.X Introduction
Clinically, the role of subchondral bone in the pathogenesis of osteoarthritis {OA) is well recognised 
and in vitro there is mounting evidence of an association between the altered phenotypes of the 
chondrocytes and osteoblasts in the development of disease. Westacott et al. (1997) showed that 
OA osteoblasts grown in monolayer increased glycosaminoglycan release from cartilage explants, 
whereas normal cells did not. Sanchez et al. (2005a, b) showed that osteoblasts from sclerotic areas 
of osteoarthritic subchondral bone induced phenotypic changes in co-culture with osteoarthritic 
chondrocytes and that certain of these phenotypic changes could be mimicked by treating 
osteoblasts obtained from areas of non-sclerotic bone from joints affected with OA with interleukin- 
6, interleukin 1(3 and oncostatin M.
It is generally understood that cytokines such as interleukin 1(3 (1L1(3) are involved in the pathways 
leading to osteoarthritis. The effect of 111(3 on equine chondrocytes has previously been 
investigated (David et al. 2007; May et al. 1992; Richardson and Dodge 2000). The effect of co­
culture of equine cartilage explants with synoviocytes has also been described (Gregg et al. 2006). 
However, to our knowledge, there have been no previous reports of co-culture of equine cartilage 
explants with osteoblasts. The advantage of using equine tissue is that normal subchondral bone 
and cartilage tissue from individuals not affected by osteoarthritis can be obtained more readily, 
unlike studies using human tissue where material largely comes from patients undergoing joint 
replacement where osteoarthritis is already at end stage.
The aim of this set of experiments was to develop a co-culture system of equine osteoblasts and 
cartilage explants. It had been previously shown (Chapter 2) that the phenotype of equine 
differentiated osteoblasts was altered in response to stimulation with IL1|3, with increases in 
expression of genes involved in matrix proteolysis. It was hypothesised that co-culture of equine
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osteoblasts pre-treated with ILlj3 with cartilage explants from joints unaffected by OA would result 
in an altered chondrocyte phenotype and evidence of cartilage matrix degradation.
3.2 Materials and Methods
3.2.1 Tissue Collection
Material was collected either from horses euthanased at The University of Liverpool Equine Hospital 
for reasons unrelated to orthopaedic disease/osteoarthritis and where owners had given informed 
consent for use of samples from their horse, or from healthy horses euthanased at a local abattoir. 
All material was gathered within 12 hours of the horse's death. Although exact ages of abattoir 
cases were not available, all subjects were mature and all joints from which samples were obtained 
were grossly free of osteoarthritis. Cartilage and subchondral bone were obtained from either the 
metacarpo- or metatarsophalangeal joint. Full-thickness cartilage from was obtained from the 
dorsal and palmar/plantar aspects of both lateral and medial condyles by sterile dissection with a 
scalpel blade. The subchondral bone plate was removed from the palmar/plantar aspect of both 
lateral and medial distal condyles by sterile dissection with a chisel, such that small fragments of 
bone with dimensions approximately 3mm x 3mm were obtained.
3.2.2 Subchondral Osteoblasts in Monolayer Culture
Unless stated otherwise, all reagents were supplied by Sigma-Aldrich (Dorset, UK). Based on the 
protocols of Hilal et al. (1998) and Sanchez et al. (2005) the small pieces of subchondral bone were 
sequentially incubated in Dulbecco's modified Eagle's medium (DMEM) with 5% fetal bovine serum 
(FBS) at 37°C, initially with 0.5mg/ml hyaluronidase type IV S for 20 minutes then with 0.6mg/ml 
collagenase IA for 4 hours. The digested bone pieces were then washed in Hank's Balanced Salt 
Solution (HBSS) before culturing in T-75 flasks in DMEM supplemented with 10% FBS, lOOU/ml 
penicillin, 100p.g/ml streptomycin and 500ng/mi amphotericin B. Medium was changed twice 
weekly until cells were observed to have migrated from the bone explants and had reached
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confluence. At this point cells were collected by trypsinisation, seeded at 20,000 cells/cm2 in 12 well 
plates and grown for 12 days in an osteogenic differentiation medium, composed of DM EM 
supplemented with 10% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B, 
lOmM p glycerophoshate, O.lmM L-ascorbic acid-2-phoshate and lOnM dexamethasone. At the end 
of this differentiation period, cells were shown to have an osteoblastic phenotype characterised by 
the production of alkaline phosphatase, gene expression of osteocalcin and positive staining with 
Alizarin Red and von Kossa stains. At the end of the differentiation period and after washings in 
HBSS, half of the plates of osteoblasts were treated with lOng/ml ILip in DMEM supplemented with 
lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B and 1% ITS+ for a period of 24 
hours. The remainder of the plates of osteoblasts were washed in HBSS and cultured in DMEM 
supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B and 1% 
ITS+ for the same 24 hour period. Prior to setting up the co-culture experiments, all osteoblasts 
were washed 3 times in HBSS.
3.2.3 Cartilage Explants
Cartilage was obtained on the same day as 111(3 stimulation of the osteoblasts. Explants were cut 
into small pieces (5mm x 5mm approx) and left overnight at 37°C in DMEM supplemented with 
lOOU/ml penicillin, 100p.g/ml streptomycin and 500ng/m! amphotericin B. Cartilage explants were 
then washed and utilised in the co-culture system.
3.2.4 Osteoblasts/Cartilage Expiant Co-Culture
Co-cultures were set up with allogeneic cartilage explants (1 per co-culture) being placed in a co­
culture insert with a pore size of 1pm (Greiner-Bio, Stonehouse, UK) and co-cultured with 
osteoblasts. Experimental design of cultures was as follows:
1) Osteoblasts previously incubated with IL1(3 co-cultured with cartilage explants (O+ILl+C)
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2) Osteoblasts not previously incubated with IL13 co-cultured with cartilage explants (O-ILl+C)
3) Osteoblasts previously incubated with IL1(3 (O+ILl-C)
4) Osteoblasts not previously incubated with IL1(3 (O-ILl-C)
5) Cartilage explants cultured alone without osteoblasts (C-O)
6) Cartilage explants cultured with IL1(3 (C+IL1)
Cultures were carried out for 72 hours (gene expression, MMP 13 assays, alkaline phosphatase 
assays) or 6 days with media collection every 48 hours (GAG assays). The media used for the 72 hour 
co-cultures was DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml 
amphotericin B and 1% ITS+ and that for the GAG assays was DMEM supplemented with lOOU/ml 
penicillin, 100p,g/ml streptomycin, 500ng/ml amphotericin B and 1% FBS (see Appendix A). For each 
part of the experiment, cultures were performed in triplicate. In total co-cultures were performed 4 
times, with subchondral bone and cartilage being retrieved from different donors in each co-culture 
such that a total of 8 donors were used.
3.2.5 Alizarin Red and Von Kossa's Staining
Alizarin Red and von Kossa's Staining were performed to ascertain differentiation of the osteoblasts 
and confirm osteoblast phenotype. Media was removed from the wells and cells were washed twice 
in phosphate buffered saline (PBS) prior to fixing of the cells in 4% formaldehyde for 10 minutes. 
Cells were washed twice in ultra-pure water before application of the stain. For the Alizarin Red 
stain, 1% Alizarin Red was applied for 5 minutes then washed twice in ultra pure water. For the von 
Kossa stain, 1% silver nitrate was applied to the cells and then placed under ultraviolet light for 40 
minutes. Cells were washed in distilled water then treated with 3% sodium thiosulphate for 5 
minutes.
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3.2.6 Alkaline Phosphatase Assay
Alkaline phosphatase (ALP) activity was quantified in the cellular fraction of the osteoblast culture. 
Media was removed at the end of the co-culture period (72h). Cells were washed in PBS then lysed 
in 1ml 0.2% Triton X-100 and the Triton-X/cell lysate mixture was collected. Cell extract (5pl) was 
incubated with 195pl of a lOmM p-Nitrophenyl phosphate working solution {BioAssay Systems, 
Hayward, USA). A standard solution of tartrazine was used as a calibrator, according to the kit's 
instructions. In the presence of alkaline phosphatase, p-Nitrophenyl phosphate is converted to p~ 
nitrophenol and inorganic phosphate, with the rate of the reaction being directly proportional to the 
enzyme activity. The absorbance of p-nitrophenol was measured at 405nm on a Multiskan EX 
photometric multiplate absorbance reader (Thermo Electron Corp, Vantaa, Finland)at room 
temperature at t=0 and t=4 minutes. ALP activity of the sample is measured according to the kit's 
instructions as:
ALP (IU/D = fOD sample t-OD sample 0) x Reaction Volume x 40.4 
(OD calibrator- OD H20) x Sample Volume x t
Alkaline phosphatase activity was normalised to total protein content of the cellular fraction.
3.2.7 Total Protein Assay
Total protein content of the osteoblast cellular fraction collected in 0.2% Triton X-100 was measured 
using the BCA Protein Assay Kit (Pierce Biotechnology, Thermo Scientific, Rockford, Illinois) according 
to the manufacturer's instructions. This technique is based on the reduction of Cu2+ to Cu1+ by 
protein in an alkaline medium. Cu1+ is detected in the presence of bicinchoninic acid (BCA) by the 
chelation of 2 molecules of BCA with one Cu1+ ion resulting in a purple-coloured reaction product. 
The assay was measured on a Multiskan EX photometric multiplate absorbance reader (Thermo 
Electron Corp, Vantaa, Finland) at 570nm relative to standards of albumin with known protein 
concentration.
79
3.2.8 Quantitative Real-Time PCR
3.2.8.1 RNA extraction and Reverse Transcription
Co-cultures were terminated at 72 hours. Osteoblasts were harvested in TRI® Reagent. Cartilage 
explants were stored in RNA later (Ambion, Applied Biosystems, Warrington, UK), and subsequently 
dismembranated then stored in TRI® Reagent. RNA extraction was performed using a standard 
chloroform and ethanol extraction followed by the RNeasy (Qiagen, Crawley, UK) column technique, 
incorporating a DNase treatment stage. RNA was quantified using a Nanodrop (Thermo Scientific, 
Wilmington, USA) and Ijig of RNA or the maximum volume for the reaction (12.4p.L) where RNA 
concentration was < 80.6ng/pi, was used as the template for the reverse transcriptase reaction. 
cDNA strands were generated from the RNA in a 25^1 volume reaction using Random Primer 
(Promega, Southampton, UK), RT buffer, lOmM of dNTPs, M-MLV RT enzyme and RNase inhibitor.
3.2.8.2 Primer Preparation
Equine specific PCR primers were designed by obtaining equine RNA and DNA sequences from the 
NCBl database (http://www.ncbi.nlm.nih.gov/). Where the equine sequence was unavailable, a 
multiple species alignment was performed (http://www.ebi.ac.uk/Tools/clustaiw2/index.html) and 
primers designed where there was sequence homology across species. Exon boundaries were 
identified (http://www.ensembl.org/index.html) and where possible primers were designed to 
amplify across exon-intron boundaries to allow discrimination of genomic DNA and cDNA. As this 
was not possible in all cases, the DNase treatment stage was incorporated in the RNA extraction 
technique as above. Primers were designed based on the sequences acquired using Primer Express 
software (Applied Biosystems) or Primer 3 software f http://frodo.wi.mit.edu/cgi- 
bin/primer3/primer3 www.cgi). Primer efficiencies were validated using a standard curve derived 
from equine cDNA using a 10-fold dilution series with 5 measuring points. The primers used for the 
target and housekeeping genes are as shown in Table 3.1.
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Gene Primer Sequence Accession Code Efficiency
GAPDH F: GCATCGTGGAGGGACTCA
R: GCCACATCTTCCCAGAGG
AF157626 -3.32
ADAMTS4 F: CAGCCTGGCTCCTTCAAAAA
R: CCGCAGGAATAGTGACCACAT
NM_001111299 -3.23
ADAMTS5 F: ACCG AT CCTG C AGT GT C AC A
R: CTGCTCATGGCGAAAAGATTT
EU025851 -3.13
MMP1 F: GGTGAAGGAAGGTCAAGTTCTGAT
R: AGT CTTCT ACTTT G G AA A AG AGCTT CT CT
NM_001081847 -3.36
MMP3 F: TCTTGCCGGTCAGCTTCATATAT
R: CCTATG G AAG GT G ACT CC AT GT G
NM„001082495 -3.63
MMP13 F: CTGGAGCTGGGCACCTACTG
R: ATTTGCCTGAGTCATTATGAACAAGAT
NM_001081804 -3.51
TIMP3 F: CTGCAACTTCGTGGAGAGGT
R: ACTCGTTCTTGG AG GTC ACG
NM_001081870 -3.54
Collagen 1 a2 F: GCACATGCCGTGACTTGAGA
R: CAT CC ATAGTG CAT CCTT G ATTAGG
XM_001492939 -3.31
Collagen II al F: TCAAGTCCCTCAACAACCAGATC
R:GTCAATCCAGTAGTCTCCGCTCTT
NM_001081764 -3.21
Biglycan F: TCACCTTCCAGCCCCTAGAGT
R:AGAAGCAGCCCCTCCTCAA
NM_001081839 -3.71
Aggrecan F: GAGGAGCAGGAGTTTGTCAACA
R:CCCTTCGATGGTCCTGTCAT
XM_001499504 -3.81
Osteocalcin F: T C AACCC AG ACT GT G ACG AG
R: CAGCTAGGGACGATGAGGAC
XM_001915727 -3.80
Table 3.1: Primer sequences used for quantitative real-time PCR
F= Forward primer, R= Reverse primer
3.2.83 Quantitative Real-Time Polymerase Chain Reaction
Quantitative real-time polymerase chain reaction (RT-PCR) was performed in a 25pL volume using 
SYBR® Green PCR master mix {Applied Biosystems, Warrington, UK) and BOOnM primer 
concentration and processed by 7300 Real Time PCR system (Applied Biosystems, Warrington, UK) 
using standard amplification conditions. Data was analysed using SDS software (Applied Biosystems, 
Warrington, UK). PCR products were measured and normalised against GAPDH as a housekeeping 
gene.
3.2.9 Fluorometric Activity Assay for MMP-13
The enzymatic activity of MMP-13 in the culture medium was assayed using a fluorogenic substrate 
(MCA-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2;Merck, Nottingham, UK) that specifically detects MMP-13. 
Forty pL of culture media was mixed with 50pL buffer (50mM F1EPES, 200mM NaCI, ImM CaCI2 and 
0.01% v/v Brij-35 at pH 7.3) or 50pL ImM p-aminophenylmercuric acetate (APMA) in assay buffer (as
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above) to give a final concentration of 0.5mM of APMA per well. APMA acts to activate the latent
or pro-MMPs and therefore gives a measurement of total MMP. Assays performed without the 
addition of APMA gave a measurement of the total active MMP13 in the sample. Assays were 
incubated at 37°C for 1 hour to activate the latent enzyme in those samples in which APMA had 
been added, then fluorogenic substrate was added at a final concentration of IpM per well. 
Substrate hydrolysis was measured on a FLX800 microplate fluoresecence reader (Winooski, 
Vermont, USA) with excitation and emission wavelengths set at 325 and 393nm respectively. A 
linear standard curve with dilutions of 1:2,1:4,1:8,1:16 and media control was performed to ensure 
that readings were linear and within the required range. Final readings were taken at t=120 
minutes.
3.2.10 Glycosaminoglycan Spectrophotometric Analysis
Harvested cartilage explants were incubated overnight at 60°C in SOOpL of papain (lOunits/ml) in 
digest buffer (0.1M sodium acetate, 2.4mM EDTA disodium salt and 5mM L-cysteine at pH 5.8). 
Aliquots of media (40pL) and of digested explants (2^iL diluted with 38p.L H20) were analysed for 
glycosaminoglycan (GAG) content using the 1.9-dimethylene blue (DMMB) labelling technique as 
described by Farndale et al. (1986). Briefly, aliquoted media and explant papain digests were 
incubated with 250pL DMMB (16pg/ml 1-9 dimethyl methylene blue, 2mg/ml sodium formate and 
0.2% v/v formic acid at pH 3.5). Sulphated GAG concentrations were determined by absorbance 
readings on a Multiskan EX photometric multiplate absorbance reader (Thermo Electron Corp, 
Vantaa, Finland) at 570nm relative to a shark chondroitin sulphate C standard curve (0 to 70pg/ml). 
Cumulative GAG release data was expressed as both a percentage of the total available GAG 
released into the media and as GAG loss into the media per pg DNA of the papain digest.
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3.2.11 DNA Assay
The DNA contents of papain digests of explants were determined using a Quanti-iT™ PicoGreen® 
dsDNA Assay (Invitrogen, Paisley, UK) measured on a FLx800 microplate fluoresecence reader 
(Winooski, Vermont, USA) at480nm excitation and 520nm emission.
3.2.12 Statistical Analysis
After plotting and testing for normality using the Kolmogrov-Smirnov test, data was logged where 
required using Mintab (v.15; Minitab Inc., Pennsylvania). Mixed effects linear regression (SPIus v. 
6.1; TIBCO Software Inc., California) was used to test for significant differences between groups 
whilst allowing for the clustering of samples within donor. Significance was set at P<0.05 unless 
multiple comparisons were made on the same sample (i.e. gene expression data), where the P-vaiue 
was adjusted using Sidak's formula (Sidak 1967):
OtpT= 1 — (l-Otpp)1^
where a is the probability of making a Type I error, apT is the a per test, apF is the a per family of 
tests and c is the number of comparisons. Therefore if we assume that the required apF is 0.05, 
then:
apT=l-(l-0.05)1/c
3.3 Results
3.3.1 Alizarin Red and Von Kossa Staining
Osteoblasts were found to stain positively with Alizarin Red and von Kossa stains at the end of the 
co-culture period.
3.3.2 Alkaline Phosphatase Assay
Levels of alkaline phosphatase were normalised to the total protein content of the cellular fraction in 
cultures containing osteoblasts and were expressed as lU/L/mg total protein. Levels of alkaline
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phosphatase are as shown in Figure 3.1. There was no statistically significant difference (P>0.05) 
between alkaline phosphatase levels in the cellular fraction of the osteoblasts regardless of the 
culture condition (i.e. pre-treated or not with 111(3, or co-cultured or not with cartilage explants).
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Figure 3.1: Alkaline phoshatase content of the osteoblast cellular fraction normalised to the total 
protein content of the sample and expressed as lU/L/mg total protein. Error bars indicate standard 
error. O+ILl+C = osteoblasts pre-treated with interleukin 16 and co-cultured with cartilage; O-ILl+C 
= osteoblasts not pre-treated with interleukin 16 and co-cultured with cartilage; O+ILl-C = 
osteoblasts pre-treated with interleukin 16; O-ILl-C = osteoblasts
3.3.3 Quantitative Real-Time PCR 
3.3.3.1 Chondrocytes
Expression of various markers of cartilage degradation: matrix metalloproteinase-1 (MMP1), -3 
(MMP3), -13 (MMP13)-, a disintegrin and metalloproteinase with thrombospondin motifs -4 
(ADAMTS4), -5(ADAMTS5) and tissue inhibitor of metalloproteinase-3 (TIMP3) and various markers 
of matrix synthesis: type I collagen a2 chain (COL1A2); type II collagen al chain {COL2A1); aggrecan 
(ACAN) and biglycan (BGN) were measured relative to GAPDH in chondrocytes obtained from
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cartilage explants. Differences in gene expression are shown for the chondrocytes as fold 
differences compared to the negative control i.e. cartilage explants cultured without osteoblasts (C- 
0). Alterations in gene expression of chondrocytes are as shown in Figures 3.2a) - j). Statistical 
significance between differences in gene expression for all genes in all culture conditions are as 
detailed in Table 3.2. Ten genes were tested on each sample, giving a Sidak corrected significance 
level of P<0.005.
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Figure 3.2a-j: Gene expression relative to GAPDH of chondrocytes shown as the log of fold differences 
compared to cartilage explants cultured alone (C-O). Error bars indicate standard error. C-0= 
cartilage; O+ILl+C = co-culture of osteoblasts pre-treated with interleukin 16 and cartilage; O-ILl+C = 
co-culture of osteoblasts not pre-treated with interleukin 16 and cartilage; C+IL1 = cartilage treated 
with interleukin 16. Groups with significant differences in gene expression are shown with letters on 
the graphs and corresponding P values are shown in Table 3.2.
3.3.3.1.1 Effect on chondrocytes of direct application of ILip to cartilage explants 
IL1|3 was applied directly as to cartilage explants (C+ ILlp) as a positive control and results are 
included in Figure 3.2 and Table 3.2 as above. In the C+ILip positive control, compared to the 
negative control consisting of cartilage explants (C-0), there was; increased expression of MMP1 
(P<0.0001), MMP3 (P<0.0001), MMP13 (P<0.0001), ADAMTS4 (P<0.0001) and ADAMTS5 (P=0.002); 
decreased expression of BGN (P<0.0001)and COL2A1 (P=0.0007); and no significant difference in 
expression of TIMP3, COL1A2 or ACAN.
3.3.3.1.2 Effect on chondrocytes of co-culturing cartilage explants with 111(3 pre-treated osteoblasts 
Comparing O+ILl+C chondrocytes to C-0 chondrocytes there was; significantly increased expression 
of MMP1 (P=0.001), MMP3 (P=0.005) and ADAMTS4 (P<0.0001); decreased expression of BGN 
(P=0.001) and COL2A1 (P=0.0003); and no significant difference in expression of MMP13, ADAMTS5,
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TIMP3, C0L1A2 or ACAN. There was a trend toward increased MMP13 expression, but this just
failed to reach statistical significance {P=0.006).
3.3.3.13 Effect on chondrocytes of co-cuituring cartilage explants with non IL1(3 pre-treated 
osteoblasts
Comparing O-ILl+C chondrocytes to C-0 chondrocytes there was; no significant difference in 
expression in any of the genes examined {ADAMTS4, ADAMTS5, MMP1, MMP3, MMP13, TIMP3, 
COL1A2, COL2A1, BGN and ACAN).
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Gene Cell Culture Condition, Significance of Differences in Gene 
Expression between Groups and Increase^)or Decrease 
(4/) in Expression (row compared to column)
ADAMTS4 Chondrocyte C-0 C+IL13 0-IL13+C
0+ILl(3+C P<0.0001 t P=0.01 P=0.0005 t
O-ILlp+C P=0.3 P<0.0001 4,
C+IL1P P<0.00011
Osteoblast 0-IL13-C 0+IL13-C 0-IL13+C
O+ILip+C P=0.9 P=0.3 P=0.8
O-ILlp+C P=1 P=0.2
O+ILlp-C P=0.3
ADAMTS5 Chondrocyte C-0 C+IL13 O-ILlp+C
O+ILlp+C P=0.08 P=0.2 P=0.05
0-ILl(3+C P=0.2 P=0.006 4,
C+IL13 P=0.002 ^
Osteoblast 0-IL13-C 0+IL13-C O-ILlp+C
O+ILip+C P=1 P=0.2 P=0.2
0-ILl(3+C P=0.2 P=0.03
O+ILip-C P=0.2
MMP1 Chondrocyte C-0 C+IL13 0-IL13+C
O+ILip+C P=0.0011 P=0.00024^ P<0.0001t
O-ILlp+C P=0.1 P<0.00014^
C+ILip P<0.0001 1
Osteoblast O-ILlp-C 0+IL13-C 0-IL13+C
O+ILlp+C P=0.0001 1 P=0.5 P=0.00011
0-IL13+C P=0.9 P=0.0001 ^
O+ILip-C P=0.0001 t
MMP3 Chondrocyte C-0 C+IL13 0-IL13+C
O+ILip+C P=0.005 t P=0.0034/ P=0.0002 r
0-IL13+C P=0.03 P<0.00014/
C+ILip P<0.0001 ^
Osteoblast 0-IL13-C O+ILlp-C O-ILlp+C
O+ILIP+C P=0.02 P=0.15 P=0.009
O-ILlp+C P=0.6 P=0.002 4/
O+ILlp-C P=0.003 t
MMP13 Chondrocyte C-0 C+IL13 0-IL13+C
O+ILlp+C P=0.006 P=0.00014/ P=0.0002 t
0-IL13+C P=0.03 P<0.00014/
C+IL13 P<0.00011
Osteoblast 0-IL13-C 0+IL13-C 0-IL13+C
0+IL13+C P=0.06 P=0.2 P=0.02
O-ILlp+C P=0.3 P=0.003 4/
O+ILlp-C P=0.0011
TIMP3 Chondrocyte C-0 C+IL13 O-ILlp+C
O+ILlp+C P=0.02 P=0.2 P =0.9
O-ILlp+C P=0.03 P=0.2
C+IL13 P=0.2
Osteoblast O-ILlp-C O+ILlp-C O-ILlp+C
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O+ILip+C P=0.6 P=0.9 P=0.3
O-ILlp+C P=0.5 P=0.3
O+ILlp-C P=0.7
Collagen 1 Chondrocyte C-0 C+ILlp O-ILip+C
0+ILl(3+C P=0.07 P=0.6 P=1
0-IL13+C P=0.07 P=0.6
C+ILlp P=0.2
Osteoblast O-ILip-C O+ILlp-C O-ILip+C
O+ILip+C P=0.008 P=0.06 P=0.5
O-ILip+C P=0.02 P=0.1
O+ILip-C P=0.2
Collagen II Chondrocyte C-0 C+ILlp O-ILlp+C
O+ILip+C P=0.0003 4, P=0.5 P=0.0054^
O-ILlp+C P=0.07 P=0.02
C+ILip P=0.0007 4,
Osteoblast O-ILip-C O+ILlp-C O-ILlp+C
O+ILlp+C P=0.0004 4, P=0.2 P=0.0004 4,
O-ILip+C P=0.9 P=0.0001 1
O+ILlp-C P=0.0002 4"
Biglycan Chondrocyte C-0 C+ILip O-ILip+C
O+ILip+C P=0.001 4. P=0.004 t P=0.02
O-ILip+C P=0.1 P=0.0001t
C+ILIP P<0.0001 4>
Osteoblast O-ILlp-C O+ILIP-C O-ILip+C
O+ILlp+C P=0.002 4/ P=0.04 P=0.3
O-ILip+C P=0.005 4^ P=0.2
O+ILlp-C P=0.03
Agg recan Chondrocyte C-0 C+ILip O-ILip+C
O+ILip+C P=0.03 P=0.5 P=0.0044'
O-ILip+C P=0.2 P=0.01
C+ILip P=0.09
Osteocalcin Osteoblast O-ILip-C O+ILIP-C O-ILip+C
O+ILip+C P=0.005 4/ P=0.2 P=0.04
O-ILlp+C P=0.2 P=0.3
O+ILip-C P=0.03
Table 3.2: Statistical significance of differences between gene expression of various genes relative to 
GAPDH in chondrocytes and osteoblasts in different culture conditions. Calculated using mixed 
effects linear regression, significance level P<0.005.
C-0= cartilage; 0+IL16+C = co-culture of osteoblasts pre-treated with interleukin 16 and cartilage; O- 
IL16+C = co-culture of osteoblasts not pre-treated with interleukin 16 and cartilage; C+IL16 = 
cartilage treated with interleukin 16; 0-IL16-C = osteoblasts; 0+IL16-C = osteoblasts pre-treated with 
interleukin 16.
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3.33.2 Osteoblasts
Expression of MMP1, MMP3, MMP13, ADAMTS4, ADAMTS5, TIMP3, C0L1A2, C0L2A1, BGN and 
osteocalcin {BGLAP) were measured relative to GAPDH in osteoblasts. Differences in gene 
expression are shown for the osteoblasts as fold differences compared to the negative control i.e. 
osteoblasts grown in monolayer without cartilage explants or pre-treatment with ILlp (0-lLl(3-C). 
Alterations in gene expression of chondrocytes are as shown in Figures 3.3 a) - j). Statistical 
significance between differences in gene expression for all genes in all culture conditions are as 
detailed in Table 3.2. Ten genes were tested on each sample, giving a Sidak corrected significance 
level of P<0.005.
All data is shown, but as alterations in gene expression for osteoblasts in monolayer pre-treated with 
IL1(3 have been shown and discussed in depth in a previous chapter, only the co-culture results will 
be considered in detail here.
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Figure 3.3a-j: Gene expression of osteoblasts shown as the log of fold differences compared to 
osteoblasts grown in monolayer (O-IL-C). Error bars indicate standard error. O-ILl-C = osteoblasts; 
O+ILl+C = co-culture of osteoblasts pre-treated with interleukin 16 and cartilage; O-ILl+C = co­
culture of osteoblasts not pre-treated with interleukin 16 and cartilage; O+ILl-C = osteoblasts pre-
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treated with interleukin 16. Groups with significant differences in gene expression are shown with 
letters on the graphs and corresponding P values are shown in Table 3.2.
3.3.3.2.1 Effect on osteoblasts of IL1(3 pre-treatment and co-culture with cartilage explants in 
comparison to negative control (0-IL1-C)
Comparing 0+IL1+C osteoblasts to O-ILl-C osteoblasts there was; increased expression of MMP1 
(P=0.0001); decreased expression of COL2A1 (P=0.0004)/ BGN (P=0.002) and BGLAP (P=0.005); and 
no significant difference in expression of ADAMTS4, ADAMTS5, TIIVIP3, MMP3, MMP13 or C0L1A2.
3.3.3.2.2 Effect of IL1(3 pre-treatment on osteoblasts co-cultured with cartilage explants 
Comparing O+ILl+C to O-ILl+C osteoblasts there was; increased expression of MMP1 (P=0.0001); 
decreased expression of COL2A1 {P=0.0004); and no significant difference in expression of MMP3, 
MMP13, ADAMTS4, ADAMTS5, TIMP3, COL1A2, BGN and BGLAP.
33.3.2.3 Effect of co-culture with cartilage explants on osteoblasts pre-treated with IL1(3 
Comparing O+lll+C to O+ILl-C osteoblasts there was no significant difference in expression of any 
of the genes examined {ADAMTS4, ADAMTS5, MMP1, MMP3, MMP13, TIMP3, C0L1A2, C0L2A1, 
BGN or BGLAP).
3.33.2.4 Effect of co-culture with cartilage explants on osteoblasts not pre-treated with IL13 
Comparing O-ILl+C to O-ILl-C osteoblasts there was; decreased expression of BGN (P=0.005) and no 
significant difference in expression of ADAMTS4, ADAMTS5, MMP1, MMP3, MMP13, TIMP3, 
COL2A1, COL1A2 or BGLAP.
3.3.4 Fluorometric Activity Assay for MIVIP13
MMP13 activity of the culture media was measured in fluorescence units. Total MMP13 (active and 
inactive forms) is as shown in Figure 3.4 and Active MMP13 is as shown in Figure 3.5. Average
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background count (calculated from fluorescence of culture media) was subtracted from the 
readings. P values showing the significance of differences in MMP13 activity between culture 
conditions are as shown in Table 3.3. The total MMP13 (active and inactive forms) was significantly 
greater in the media harvested from cartilage explants grown with osteoblasts pre-treated with ILip 
as compared to cartilage explants grown with osteoblasts not pre-treated with lllp. However, there 
was no significant difference in the levels of active MMP13 in the media harvested from the co­
cultures with osteoblasts pre-treated or not with IL13, with both co-cultures having elevated levels 
of MMP-13 as compared to the negative control (cartilage explant) and positive control (cartilage 
explant treated with ILip).
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Figure 3.4: Total MMP13 (inactive and active forms of MMP13). Error bars indicate standard error. 
Groups with significant differences in MMP13 activity are shown with letters on the graphs and 
corresponding P values are shown in Table 3.3.
O+ILl+C = Osteoblasts pre-treated with interleukin 16 and co-cultured with cartilage explants 
O-ILl+C = Osteoblasts not pre-treated with interleukin 16 and co-cultured with cartilage explants 
C-0 = Cartilage explants alone, without osteoblasts 
C+ILl = Cartilage explants treated with interleukin 16
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Figure 3.5: Total active MMP13 (without addition of APMA). Error bars indicate standard errors. 
Groups with significant differences in MMP13 activity are shown with letters on the graphs and 
corresponding P values are shown in Table 3.3.
O+ILl+C = Osteoblasts pre-treated with interleukin 16 and co-cultured with cartilage explants 
O-ILl+C = Osteoblasts not pre-treated with interleukin 16 and co-cultured with cartilage explants 
C-0 = Cartilage explants alone, without osteoblasts 
C+IL1 = Cartilage explants treated with interleukin 16
MMP13
Activity
Culture Condition, Significance of Differences in MMP13 Activity 
Between Groups and Increase (1s) or Decrease (>!✓) in MMP 
Activity (row compared to column)
Total MMP13 C-0 C+IL13 0-ILl(3+C
Activity 0+ILl|3+C PcO.OOOlt P = 0.0003 “T P<0.00011S
(+APMA) O-ILlp+C P = 0.2 P = 0.00024,
C+ILlp PcO.OOOlt
Active MMP13 C-0 C+ILip O-ILip+C
(-APMA) O+ILlp+C P<0.00011S P = 0.00011s P = 0.5
0-ILl|3+C P<0.0001'T PcO.00011'
C+IL1(3 P = 0.8
Table 3.3: Statistical significance of differences in MMP13 activity between groups in media collected 
from different culture conditions. Calculated using mixed effects linear regression, significance level 
P<0.05.
C-0= cartilage; 0+IL16+C = co-culture of osteoblasts pre-treated with interleukin 16 and cartilage; 0- 
IL16+C = co-culture of osteoblasts not pre-treated with interleukin 16 and cartilage; C+IL16 = 
cartilage treated with interleukin 16
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3.3.5 Glycosaminoglycan Spectrophotometric Analysis
Cumulative GAG release data was expressed as both a percentage of the total available GAG 
released into the media (as shown in Figure 3.6) and as GAG loss into the media per pg DNA of the 
papain digest (as shown in Figure 3.7). Significance of differences in GAG release between culture 
conditions at each time point as calculated using mixed effects linear regression is shown in Tables 
3.4 and 3.5. When expressed as GAG loss into the media as a percentage of total GAG in the system, 
there was a significant increase in GAG release between O+ILl+C and the cartilage negative control 
at times 48 hours, 96 hours and 144 hours. By time 144 hours, the GAG release from O-ILl+C was 
also significantly increased as compared to the negative control. When expressed as GAG loss into 
the media per pg DNA, there was no significant difference in GAG release between either O+ILl+C or 
O-ILl+C and C-0 at any time point. The positive control (C+IL1) had a significant increase in GAG 
release compared to all other culture conditions at all time points.
Figure 3.6: Cumulative GAG release over 144 hours in each culture condition expressed as percentage 
release of total GAG into the media.
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GAG release Culture Condition and Significance of Differences in GAG Release 
Between Groups and lncrease('tv)or Decrease (40 in GAG Release 
(row compared to column)
48 hours C-0 C+ILip O-ILlp+C
0+IL13+C P = 0.031" P = O.OOl^ P = 0.2
0-ILl(3+C P = 0.4 P<0.00014'
C+ILlp PcO.OOOlt
96 hours C-0 C+ILip O-ILip+C
O+ILlp+C P = 0.001t P = 0.002^ P = 0.2
O-ILip+C P = 0.05 P < 0.0001^
C+ILlp P<0.0001t
144 hours C-0 C+ILip O-ILlp+C
O+ILip+C P = 0.00081" P = 0.00044' P = 0.3
O-ILip+C P = 0.021" P< 0.00014,
C+ILip P<0.00011"
Table 3.4: Statistical significance of differences between groups in GAG release (expressed as 
percentage of total GAG) in media collected from different culture conditions. Calculated using 
mixed effects linear regression and significance level set at P<0.05.
C-0= cartilage; 0+IL16+C = co-culture of osteoblasts pre-treated with interleukin 16 and cartilage; O- 
IL16+C = co-culture of osteoblasts not pre-treated with interleukin 16 and cartilage; C+IL16 = 
cartilage treated with interleukin 16
Figure 3.7: Cumulative GAG release over 144 hours in each culture condition expressed as pg GAG in 
the media per pg of DNA in the papain digest. Error bars indicate standard errors.
0+IL1+C = Osteoblasts pre-treated with interleukin 16 and co-cultured with cartilage explants 
0-IL1+C = Osteoblasts not pre-treated with interleukin 16 and co-cultured with cartilage explants 
C-0 = Cartilage explants alone, without osteoblasts 
C+IL1 = Cartilage explants treated with interleukin 16
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GAG release Culture Condition and Significance of Differences in GAG Release 
Between Groups and lncrease(‘T‘)or Decrease (^) in GAG Release 
(row compared to column)
48 hours C-0 C+IL1P O-ILlp+C
O+ILlp+C P=0.6 P=0.0034, P=0.6
O-ILip+C P=1 P=0.00084/
C+IL1(3 P=0.0008t
96 hours C-0 C+ILip O-ILip+C
O+IL10+C P=0.3 P=0.005v|/ P=0.5
0-ILl(3+C P=0.7 P=0.0009\J/
C+ILip P=0.0003t
144 hours C-0 C+IL1(3 O-ILlp+C
0+ILl(3+C P=0.4 P=0.0024, P=0.8
O-ILip+C P=0.6 P=0.0008^t
C+IL1(3 P=0.0002t
Table 3.5: Statistical significance of differences between groups in GAG release (expressed as pg 
GAG/pg DNA in papain digest) in media collected from different culture conditions Calculated using 
mixed effects linear regression and significance level set at P<0.05..
C-0= cartilage; 0+IL16+C = co-culture of osteoblasts pre-treated with interleukin 16 and cartilage; O- 
IL16+C = co-culture of osteoblasts not pre-treated with interleukin 16 and cartilage; C+IL16 = 
cartilage treated with interleukin 16
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3.4 Discussion
With the series of experiments described, it has been shown that osteoblasts derived from normal 
equine subchondral bone when pre-treated with ILlp can induce an alteration in the phenotype of 
the chondrocytes of equine cartilage grown in co-culture without any direct communication 
between the cells. This would suggest the presence of soluble factors in the media, produced by the 
osteoblasts which are capable of inducing an effect in the gene expression of the chondrocyte.
Similar effects have been shown before, initially by Westacott et ai. (1997) who demonstrated that 
media from cultures of primary osteoblasts obtained from OA joints increased GAG release from 
normal cartilage. Subsequently Hilal et al. (1999; 1998) showed that in vitro culture of osteoblasts 
prepared from human OA subchondral bone plates showed an altered phenotype with an alteration 
of the uPA/plasmin system activity and IGF-1 levels. Sanchez et al. (2005a, b) then showed that 
subchondral osteoblasts were capable of inducing phenotypic changes in human osteoarthritic 
chondrocytes grown in alginate beads in a co-culture system, and furthermore that alterations in 
aggrecan and metalloproteinase expression in chondrocytes could be mimicked by pre-treating 
osteoblasts obtained from non-sclerotic areas of OA bone with interleukin-6, -1|3 and oncostatin M. 
This is, however, the first time that these effects have been shown in osteoblasts obtained from 
normal bone in any species and in any form of osteoblast/chondrocyte co-culture in the equine.
An in vitro equine co-culture model consisting of non-osteoarthritic osteoblasts and cartilage 
explants has been developed in an attempt to minimise the variation that may be introduced to the 
system by pre-existing disease. The model was simplified by stimulating the osteoblasts with IL1(3 
only and results of initial experiments to validate response of equine osteoblasts to ILip are shown 
in a Chapter 2 (Culture of Equine Osteoblasts and Response to Interleukin 1(3).
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It has been shown previously that chondrocytes lose their phenotype in monolayer culture (von der 
Mark et al. 1977) and subsequently various culture systems have been developed which attempt to 
maintain chondrocyte phenotype including three-dimensional culture in agarose (Benya and Shaffer 
1982), alginate (Stevens et al. 2004) and collagen (Takahashi et al. 2007) and explant cultures (Plaas 
and Sandy 1993). The effects of various culture models on phenotypic stability have also been 
investigated (Stewart et al. 2000) with the conclusion that aggregate and pellet culture models 
supported matrix protein gene expression profiles more reflective of in vivo levels, with expression 
of matrix protein genes being consistently depressed in explant cultures. In the designing of this co­
culture system, it was decided to use cartilage explants as opposed to chondrocytes in alginate 
beads. This experimental design allowed the investigation not only of alterations in chondrocyte 
phenotype at mRNA level, but also allowed investigation of GAG release from the cartilage explant 
matrix as effected by treated osteoblasts. Usage of cartilage explants was possible in this equine 
model of osteoarthritis as there is a much greater availability of large quantities of normal tissue as 
compared to the human where available tissue tends to be sparse and diseased as a result of 
harvesting from joint prosthesis surgery.
Alterations in gene expression after direct application of ILip to equine chondrocytes in suspension 
(Richardson and Dodge 2000) and monolayer (David et al. 2007) cultures have been reported 
previously, however there is no published data on the effects of ILlfJ on equine chondrocytes in 
explant culture. Richardson and Dodge (2000) showed a decrease in expression of type-ll collagen, 
coupled with a marked increase in expression of MMP1 and MMP3 in equine chondrocytes in 
response to 111(3. Interestingly, in my experiments described here, similar alterations in mRNA 
expression to those described by Richardson and Dodge (2000) were seen in equine chondrocytes in 
explant culture effected via osteoblasts pre-treated with IL1(3 and also via direct application of 111(3. 
In comparison to the results of Richardson and Dodge (2000) who showed a slight decrease in ACAN 
mRNA and minimal effects on BGN expression in chondrocytes co-cultured with IL1(3, I showed a
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significant reduction in the expression of BGN and no significant effect on expression of ACAN after 
direct application of ILip to cartilage explants and in chondrocytes co-cultured with flip pre-treated 
osteoblasts. These differences may be explained by differences in techniques utilised as Richardson 
and Dodge (2000)used suspension chondrocyte cultures and Northern blotting to detect mRNA 
while I utilised explant cultures and quantitative RT-PCR.
Our observed reduction in BGN expression in chondrocytes in the co-culture system and after direct 
application of lllp may indicate that osteoblasts are able to drive an osteoarthritic phenotype in 
chondrocytes, whereby synthesis of non-collagenous matrix proteins is reduced. It may also have 
been expected to see a reduction in ACAN expression in chondrocytes after both direct application 
of ILip and on co-culture with ILip pre-treated osteoblasts, and the lack of effect on ACAN 
expression differs from the findings of Sanchez et al. (Sanchez et al. 2005a). This may possibly be 
explained by both species difference as I used equine tissue as opposed to human, and also because 
I used normal as opposed to osteoarthritic tissue. The finding that there was no significant 
difference in expression of ACAN in chondrocytes grown with untreated osteoblasts is consistent 
with those of Jiang et al. (2005) who showed the same effect using an osteoblast and chondrocyte 
micromass model of co-culture.
Chondrocyte and chondrogenic phenotype may be considered to be related to differential 
expression of cartilage specific COL2A1 and previously it has been shown that 1L1(3 decreases 
COL2A1 production when ILip is directly applied to human chondrocytes in culture (Goldring et al. 
1988). Similarly, a reduction in COL2A1 expression was observed in equine chondrocytes both after 
direct application of ILip to explants and after co-culture with ILip pre-treated osteoblasts. I found 
no alteration in chondrocyte COL1A2 expression, which may not be surprising given that Goldring & 
Krane (1987) had previously shown that there was an increase in collagen type -I expression only 
when ambient levels of PGE2 are suppressed by indomethacin.
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The significant increases in expression of the proteolytic enzymes MMP1, MMP3 and ADAMTS4 and 
a trend towards an increase in MMP13 expression in chondrocytes grown with ILlfS pre-treated 
osteoblasts suggests that the osteoblasts are able to drive an osteoarthritic phenotype in the 
chondrocytes, and provides further evidence of the role of subchondral bone in OA. The fact that 
expression of these key proteolytic genes was not increased in chondrocytes co-cultured with 
osteoblasts not pre-treated with IL1(3 confirms that this is not an effect of co-culture alone.
Although a significant increase in ADAMTS5 expression was observed in chondrocytes from cartilage 
explants treated directly with IL1$, the actual fold difference was small. Under the co-culture 
conditions, there was a lack of alteration in ADAMTS5 expression in chondrocytes. This may be 
surprising given recent findings regarding the importance of ADAMTS5 as the major aggrecanase in 
mouse cartilage (Stanton et al. 2005). However, there appear to be species differences with regard 
to the importance of ADAMTS5 in the pathogenesis of OA. In the human, both ADAMTS4 and -5 
have been found to be implicated in aggrecan degradation (Song et al. 2007) and there is evidence 
for complex post-transcriptional control of ADAMTS5 (Bondeson et al. 2008). The situation in equine 
cartilage is less clear, with a lack of published data.
The effect on gene expression of pre-treatment of osteoblasts grown in monolayer with 111(3 
compared to osteoblasts grown in monolayer, but not pre-treated with IL1(3 has been shown and 
discussed more fully in a previous chapter, but briefly there was increased expression of MMP1, 
MMP3 and MMP13; decreased expression of COL2A1; and no difference in expression of ADAMTS4, 
ADAMTS5, TIMP3, COL1A2, B6N or BGLAP. When expression of the same panel of genes were 
compared in osteoblasts pre-treated or not with IL1(3 and grown with cartilage explants, a similar 
pattern of gene expression was seen, although the increases in MMP3 and MMP13 expression did 
not quite reach significance after correction for multiple comparisons . This would suggest that co­
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culture with cartilage explants does not greatly alter the effect of pre-treatment with ILlp on
osteoblast phenotype.
The effect of co-culture with cartilage explants on osteoblast phenotype was further assessed by 
comparing gene expression between osteoblasts pre-treated with IL1(3 cultured with and without 
cartilage explants and also non lllp pre-treated osteoblasts cultured with and without cartilage 
explants (i.e. O+ILl+C compared to O+ILl-C and O-ILl+C compared to O-ILl-C). There were limited 
effects on gene expression when the groups were compared in this manner in both the 111(3 pre­
treated osteoblasts and in the non pre-treated osteoblasts, indicating that the effect of co-culture 
with cartilage explants on osteoblast phenotype without any other manipulation is small.
The validation of differentiation of the equine osteoblast in cell culture and response to IL1(3 is 
addressed more fully in Chapter 2 {Culture of Equine Osteoblasts and Response to Interleukin 1(3), 
however it is worth noting that pre-treatment of the osteoblasts with IL1|3 in this co-culture system 
resulted in a significant decrease in BGLAP expression when 0+ILl(3+C osteoblasts were compared to 
0-ILl(3-C osteoblasts. Osteocalcin in frequently used as a marker of osteogenic phenotype and of 
the mature osteoblast (Lynch et al. 1995) and this finding may suggest that the osteoblasts were 
dedifferentiating after treatment. However, I was satisfied with differentiation of the osteoblasts in 
the co-culture given that osteocalcin was being expressed, the reduced BGLAP expression was 
observed only in one comparison of culture conditions and had a borderline significance level, 
COL1A2 was expressed in osteoblasts under all culture conditions and osteoblast phenotype was 
also confirmed by production of alkaline phosphatase and positive staining with Alizarin Red and von 
Kossa stains.
Depletion of proteoglycans from the extracellular matrix of articular cartilage is a common initial 
change in joint disease, followed by subsequent degradation of the collagen fibrils, with proteinases
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being key to this degradation process. Increases in gene expression of MMP1, MMP3, MMP13 and 
ADAMTS4 by chondrocytes had been identified. Traditionally MMP1 and MMP13 are classed as 
collagenases and MIVIP3 as a stromelysin (Cawston and Wilson 2006). Collagenases have the ability 
to cleave fibrillar collagens at a specific site, producing characteristic three-quarter and one-quarter 
sized fragments. MMPs have also been shown to have the ability to cleave aggrecan {Sandy 2006) at 
sites distinct from those utilised by the recently discovered ADAMTs group of enzymes In 
comparison (Nagase and Kashiwagi 2003). MMP3 has the ability to degrade proteoglycans and also 
activates latent collagenases (Cawston and Wilson 2006).
Depletion of matrix proteoglycan was observed in this co-culture model, shown by increased levels 
of GAG release from the cartilage explant matrix into the cell culture media on co-culture with ILlp 
pre-treated osteoblasts compared to the cartilage explant alone at T=48, T=96 and T=144 hours. 
However, at T=144 hours there was also an increase in GAG release in the cartilage explants grown 
with untreated explants. The effect of co-culture with IL1(3 pre-treated osteoblasts on the 
degradation of cartilage was therefore not as dramatic as may have been expected from the 
alterations in gene expression of the proteinases. This may be explained by the fact that the 
relationship between mRNA expression of MMPs, secretion of the latent pro-peptide and activation 
of the proMMP into its active and physiologically important form is complex and by no means linear. 
In addition, there is the added possibility of inhibition of MMP activity by TIMPs.
In investigation of cartilage matrix breakdown, I looked also at MMP13 protein levels (active and 
total) in cell culture media. It was shown that although there was a marked increase in total MMP- 
13 in the cell media from pre-treated osteoblasts co-cultured with cartilage explants, this MMP-13 
was not necessarily in its active form and in fact, levels of active MMP13 protein were similar within 
both co-culture groups (O+ILl+C and O-ILl+C), with both groups having increased active MMP-13 
levels compared to the C-0 negative control. It may have been interesting to look further at
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collagenolysis using techniques such as hydroxyproline assays or identification of cleavage by 
measurement of COL2 neoepitopes. Also, the apparent lack of correlation between increased 
expression of proteinases and the less dramatic evidence of GAG release from the cartilage matrix 
may have been further investigated using antibodies to identify various neoepitopes on aggrecan 
degradation products.
3.5 Conclusion
A repeatable co-culture model for equine osteoblasts and chondrocytes simulating osteochondral 
disease has been developed. I demonstrated alterations in the gene expression of osteoblasts pre­
treated with Hip, and that these cells were capable of inducing associated alterations in the gene 
expression of chondrocytes in co-culture. There was some evidence of cartilage matrix breakdown 
characterised by GAG release from the cartilage explants in these co-cultures. Matrix breakdown 
may have been attenuated however as the majority of the MMP-13 being produced as a result of 
increased gene expression was not cleaved to its active form.
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Chapter 3 Appendix A
Does ITS+ Prevents Cartilage Breakdown?
Introduction
Choice of cell culture media is always a contentious subject, but even more so in extended co­
culture experiments whereby two cell types must be supported for a lengthy period while at the 
same time the investigator tries to avoid the use of any media supplementation which may interfere 
with the experiment.
Defined media for cell culture of varying complexity are commercially available, but all are 
composed of essential amino acids, vitamins, salts and glucose (Freshney 1994). Serum from a 
variety of sources e.g. calf, foetal bovine, horse and human is widely added to basic cell culture 
media to support cell growth by providing a source of protein, polypeptides, hormones, nutrients 
and minerals. However, the use of serum may have disadvantages in that as a biological substance, 
the exact components of the media are unknown and may vary from batch to batch thus introducing 
variability into the experimental design. Furthermore, serum may contain growth factors such as 
TGF-p which will have a negative effect on cell proliferation. To circumvent these issues, the use of 
serum free media has been proposed and with some cell types this is successful. However, growth is 
often slower in serum-free media and ceils may require support using more complex media which 
also contain organic supplements such as proteins, peptides, nucleosides, citric acid cycle 
intermediates, pyruvate and lipids. It is possible also to use a basic cell media and supplement this 
with a commercially available and defined serum substitute (Freshney 1994). ITS+ (Sigma-Aldrich, 
Dorset, UK) is one such commercially available serum substitute containing l.Omg/ml insulin, 0.55 
mg/ml human transferrin and 0.5p.g/ml sodium selenite.
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As described in the preceding chapter, a protocol was adapted from that of Sanchez et al. (2005) 
such that a cell culture media containing DMEM and 1%ITS+ was used for the co-culture step. 
Results using this experimental design showed alterations in gene expression of both chondrocytes 
and osteoblasts and alterations in MMP-13 assays, with evidence of support of osteoblast 
phenotype based on cell staining and alkaline phosphatase assays. However, the levels of GAG 
release from the cartilage explants were extremely low, both in the co-cultures and in the positive 
control whereby interleukin 1(3 (IL1(3) was applied directly to cartilage explants. A possible reason 
for this was thought to be the addition of ITS+ to the culture medium, and the following experiment 
was performed to determine 1) if ITS+ was preventing cartilage breakdown and 2) to assess the 
effects of various concentrations of ITS+ and FBS (foetal bovine serum) in the culture medium on 
cartilage breakdown driven by IL1(3.
Materials and Methods
Cartilage explants were obtained from the metacarpophalangeal joints of horses euthanased at The 
University of Liverpool Equine Hospital for reasons unrelated to orthopaedic disease/osteoarthritis 
and where owners had given informed consent for use of samples from their horse, or from healthy 
horses euthanased at a local abattoir, as described previously. Each joint was grossly free from 
osteoarthritis. Explants were cut into small pieces (5mm x 5mm approx) and left overnight at 37°C in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with lOOU/ml penicillin, lOOpg/ml 
streptomycin and 500ng/ml amphotericin B. Cartilage explants were then washed and utilised in the 
experiment. All reagents were supplied by Sigma-Aldrich (Dorset, UK).
In the first part of the experiment, the effect of different levels of ITS+ in the media of cartilage 
explants on treatment with interleukin Ip (ILlp) was assessed. Experiments were performed in 
triplicate using 5 separate donors with explants being cultured in DMEM supplemented with 
lOOU/ml penicillin, lOOpg/ml streptomycin and 500ng/m! amphotericin B with the addition of:
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1) 1% ITS+
2) 1% 1TS+ and lOng/ml IL1(3
3) 0.1% ITS+ and lOng/ml ILip
4) 0.01% ITS+ and lOng/ml IL1J3
5) 0% ITS+ (serum free media negative control)
6) 0% ITS+ and lOng/mi Hip
In the second part of the experiment, the effect of different levels of serum in the media was 
compared to the effect of ITS+ on treatment with IL1{3. Experiments were performed in triplicate 
using 3 separate donors and in the same basic media as above with the addition of:
1) 1%ITS+ and lOng/ml ILlp
2) 1% ITS+
3) lOng/mllLip
4) Nothing (serum free media negative control)
5) 1% foetal bovine serum (FBS) and lOng/ml ILlp
6) 1% FBS
7) 10% FBS and lOng/ml 111(3
8) 10% FBS
Cultures were harvested at 5 days and glycosaminoglycan spectrophotometric analysis was 
performed on the media and cartilage explants to quantify levels of glycoasminoglycan (GAG). 
Harvested cartilage explants were digested by overnight papain incubation at 60°C. Aliquots of 
media (40p.L) and of digested explants (2pL diluted with 38pL H20) were analysed for 
glycosaminoglycan (GAG) content using the 1.9-dimethylene blue (DMMB) labelling technique as 
before. Sulphated GAG concentrations were determined by absorbance readings on a Multiskan EX 
photometric multiplate absorbance reader (Thermo Electron Corp, Vantaa, Finland) at 570nm
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relative to a shark chondroitin sulphate C standard curve (0 to 70pg/ml). Cumulative GAG release 
data was expressed as a percentage of the total available GAG in the system released into the 
media, such that:
% GAG release =_____ GAG in media_________  x 100
GAG in media + GAG in explant
Descriptive statistical analysis was performed using Mintab (v.15; Minitab Inc., Pennsylvania) and 
differences between culture groups were detected using mixed effects linear regression (SPIus v. 6.1; 
TIBCO Software Inc., California), with significance being set at P<0.05.
Results
Percentages of GAG release in the first part of the experiment (the effect of different ITS+ culture 
media concentrations on IL1(3 driven GAG release from cartilage explants) are shown for each donor 
in Figure 1 and as an average of all donors in Figure 2. Values of mean GAG loss and standard errors 
are given in Table 1, and statistical significance of differences between groups are shown in Table 2.
Ill
Figure 1: GAG loss into media expressed as a percentage of total GAG in the culture system for each 
of the donors in each of the culture conditions in part 1 of the experiment. Error bars indicate 
standard errors.
1%ITS -111 1%ITS +IL1 0.1%ITS +IL1 0.01% ITS+IL1 0% ITS-111 0%ITS+IL1
Culture Condition
Figure 2: GAG loss into media expressed as a percentage of total GAG in the culture system for each 
of the culture conditions in part 1 of the experiment averaged for all donors. Error bars indicate 
standard errors.
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Culture Condition: DMEM plus Mean GAG loss; (Standard Error)
1% ITS+ 16.1%; (+/- 2.9)
1% ITS+ and lOng/ml ILlp 18.3%; (+/- 3.3)
0.1% ITS+ and lOng/ml 111(3 23.4%; (+/- 4.3)
0.01% ITS+ and lOng/ml IL1|3 34.9%; (+/- 8.3)
0% ITS+ 24.1%; (+/-B-8)
0% ITS+ and lOng/ml IL1(3 34.1%; (+/-5.4)
Table 1: GAG loss as a response to culture condition (+/- IL16 treatment in different ITS+ 
concentrations in media)
Culture Condition and Significance of Differences in GAG Release Between Groups
1% ITS+ 0% ITS+ and
111
0% ITS+ 0.01% ITS+
and 111
0.1% ITS+
and 111
1% ITS+
and 111
P=0.2 P<0.0001 P=0.006 P<0.0001 P=0.04
0.1% ITS+
and 111
P=0.0007 P=0.0015 P=0.5 P=0.02
0.01% ITS+
and IL1
P<0.0001 P=0.3 P=0.1
0% ITS+ P=0.0001 P=0.01
0% ITS+
and 111
PcO.OOOl
Table 2: Statistical Significance between Culture Groups for GAG Release with IL16 Treatment at 
Different ITS+ Concentrations
In the absence of interleukin treatment, addition of 1% ITS+ to the culture medium was shown to 
result in significantly less GAG release than when explants were cultured in basic serum free DMEM 
without supplementation with ITS+ (0% ITS+). ITS+ was shown to protect the explants against GAG 
release in response to 111(3 treatment in a dose-dependent manner.
Results of the second part of the experiment (the effect of different concentrations of FBS in the 
culture media as compared to ITS+ on IL1(3 driven GAG release from cartilage explants) are shown 
for each donor in Figure 3 and as an average of all donors in Figure 4. Values of mean GAG loss and 
standard errors are given in Table 3, and statistical significance of differences between groups are 
shown in Table 4.
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Figure 3: GAG loss into media expressed as a percentage of total GAG in the culture system for each 
of the donors in each of the culture conditions in part 2 of the experiment. Error bars indicate 
standard errors.
Figure 4: GAG loss into media expressed as a percentage of total GAG in the culture system for each 
of the culture conditions in part 2 of the experiment averaged for all donors. Error bars indicate 
standard errors.
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Culture Condition: DMEM plus Mean GAG loss; (Standard Error)
1% ITS+ and lOng/ml ILlp 10.1% (+/-1-5)
1% ITS+ 10.0% (+/-1.5)
lOng/ml IL1(3 25.6% (+/- 4.7)
serum free media negative control 12.5% (+/-2.2)
1% FBS and lOng/ml IL1(3 21.4% (+/- 3.2)
1% FBS 12.4% (+/-1-9)
10% FBS and lOng/ml IL1(3 13.9% (+/- 3.7)
10% FBS 9.53% (+/-1-4)
Table 3: GAG loss as a response to culture condition (+/- ILip treatment in varying FCS 
concentrations and as a comparison to 1% ITS+)
Culture Condition and Significance of Differences in GAG Release Between Groups
1% ITS+
and 111
10% FBS 10% FBS
and 111
1% FBS 1% FBS
and 111
SF (neg. 
control)
SF + 111
1% ITS+ R=1 P=0.9 P=0.3 P=0.5 P=0.002 P=0.5 P<0.0001
111 P<0.0001 P<0.0001 P=0.002 P=0.0004 P=0.2 P=0.0005
SF (neg.
control)
P=0.5 P=0.4 P=0.7 P=1 P=0.01
1% FBS and
111
P=0.002 P=0.001 P=0.04 P=0.01
1% FBS P=0.5 P=0.4 P=0.7
10% FBS
and 111
P=0.3 P=0.2
10% FBS P=0.9
Table 4: Statistical Significance between Culture Groups for GAG Release with IL16 Treatment at 
Varying FCS Concentrations and as a Comparison to 1% ITS+
FBS = foetal bovine serum; SF = basic serum free DM EM media; I LI = interleukin 16
In the second set of experiments, the finding that addition of 1% ITS+ resulted in significantly less 
GAG release than culture in basic serum free DMEM was not repeated. However on treatment with 
ILlp, addition of 10% FBS to the culture medium was found to protect the explants against GAG 
release. Reducing the concentration of FBS to 1% resulted in a significant effect of ILip treatment 
on GAG release.
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Discussion
It was shown that addition of ITS+ to the basic serum-free DM EM culture medium at a concentration 
of 1% was capable of exerting an effect such that GAG release from the cartilage explants was 
significantly reduced in response to interleukin 1(3 treatment. With lower concentrations of ITS+ a 
similar effect was seen in a dose responsive manner. As stated previously, ITS+ is composed of 
insulin, transferrin and selenium. Insulin is a hormone which can affect cell metabolism via its 
effects on glucose metabolism and by activity via the insulin-like growth factor (IGF) receptor 
(Hewlett 1991). Transferrin is an iron-transport protein which can also act as a detoxifying agent by 
chelating heavy metals and selenium is a trace element which has been found to be required for cell 
growth (Hewlett 1991).
It is likely that the addition of ITS+ to the culture medium is most likely to decrease GAG release as a 
result of the increased levels of insulin. It is unclear whether ITS+ is exerting its effects via a 
decrease in GAG loss from the matrix or as a result of increased GAG production in the cartilage 
explant, as both would result in a decreased percentage of GAG loss from the system into the media. 
It has been postulated that insulin may exert an effect via the IGF receptor. IGF-1 appears to be one 
of the most important growth factors affecting the anabolism of cartilage (Martel-Peiletier et al. 
1998) and has been shown to stimulate production of chondrocyte extracellular matrix components 
(Guenther et al. 1982; McQuillan et al. 1986). IL-1 is known to be a key cytokine in degradation of 
the cartilage matrix (Dingle et al. 1979; Saklatvala et al. 1984) and is also capable of suppressing 
synthesis of aggrecan and collagen by the chondrocyte (Dingle 1984). IGF-1 has also been shown to 
directly decrease both basal and cytokine (111 and INF) stimulated degradation of proteoglycan in 
cartilage (Tyler 1989). Subsequently it was found that IGF-1 is able to reverse IL1(3 mediated 
degradation of aggrecan and repression of the aggrecan synthesis rate through up-regulation of the 
decoy receptor of IL1(3, 111 receptor II. In short therefore, it is thought that the addition of insulin in
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ITS+ may have similar effects on cartilage metabolism and in reversing 111 degradation as insulin-iike 
growth factor I.
It is therefore considered inappropriate to add ITS+ to cell culture medium in co-culture experiments 
where cartilage degradation will be examined as a response. Subsequent experiments showed that 
addition of 10% FCS to the culture medium had a similar effect on prevention of cartilage breakdown 
as 1% ITS+. As the lower concentration of 1% FCS did not interfere with 111 driven cartilage 
breakdown and had previously been shown to support osteoblast culture, this culture medium was 
therefore used for co-culture systems where glycosaminoglycan spectrophotometric analysis was to 
be performed on media and digests of cartilage explants.
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Chapter 3 Appendix B
GAG Release from Cartilage Explants in Response to Pre-Treated Osteoblasts is Mediated via the
Chondrocyte
Introduction
It has been shown that osteoblasts pre-treated with interleukin Ip have increased expression of 
various proteolytic enzymes and are in turn capable of altering the expression of proteolytic 
enzymes and markers of matrix synthesis such as coliagen-ll and aggrecan in co-cultured 
chondrocytes. It has also been shown that there is an effect of co-culture of both pre-treated and 
untreated osteoblasts on cartilage breakdown of co-cultured live cartilage explants as measured by 
glycosaminoglycan release into the media.
It is interesting to consider to what degree the effect of osteoblasts on cartilage matrix proteolysis is 
effected via a direct response of soluble mediators produced by the osteoblasts transported in the 
media to breakdown the cartilage matrix, and to what degree cartilage breakdown is driven by 
soluble mediators produced by the osteoblasts acting on the chondrocyte, which in turn produce 
enzymes which result in cartilage breakdown.
Based on previous literature which has shown that matrix depletion occurs in the presence of 
supernatants from stimulated human blood monocytes and cartilage explants with live 
chondrocytes, but not cartilage explants with dead chondrocytes (Jasin and Dingle 1981), a means of 
doing this was to compare the response of cartilage explants containing live and dead chondrocytes 
to each of the co-culture conditions as described in the preceding chapter.
Materials and Methods
The experimental design of the co-culture was as described in the preceding chapter. Briefly 
osteoblasts were isolated from the subchondral bone of the metacarpophalangeal joint of horses 
grossly unaffected by osteoarthritis and differentiated for 10 days. At the end of osteoblast 
differentiation, cells were washed and either treated with lOng/ml 111(3 or left untreated for 24
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hours. After pre-treatment, osteoblasts were again washed and then co-cultures set up with 
cartilage explants which were either live or had been killed by 3 freeze-thaw cycles in liquid nitrogen.
Culture groups were therefore:
1) Osteoblasts pre-treated with ILlp co-cultured with live cartilage explants (O+ill+C L)
2) Osteoblasts pre-treated with ILlfJ co-cultured with dead cartilage explants (O+ILl+C D)
3) Osteoblasts not pre-treated with lllp co-cultured with live cartilage explants (O-ILl+C L)
4) Osteoblasts not pre-treated with ILip co-cultured with dead cartilage explants (O-ILl+C D)
5) Live cartilage explants cultured alone without osteoblasts (C L-O)
6} Dead cartilage explants cultured alone without osteoblasts (C D-O)
7) Live cartilage expiants cultured with IL1(3 (C L+IL1)
8) Dead cartilage explants cultured with IL1(3 (C D+IL1)
The media used for this co-culture experiment was Dulbecco's modified Eagle medium (DMEM) 
supplemented with 1% FBS, lOOU/ml penicillin, lOOpg/ml streptomycin and 500ng/ml amphotericin 
B as discussed in Appendix A. Co-cultures were continued for 144 hours with media being changed 
and collected at 48 hour intervals.
Cartilage explants were digested in papain as previously described and GAG content of the explant 
digest and of the media were measured using glycosaminogiycan spectrophotometric analysis and 
the 1.9-dimethylene blue (DMMB) labelling technique as before. Cumulative GAG release data was 
expressed as a percentage of the total available GAG in the system released into the media, such 
that:
% GAG release =_____ GAG in media________  x 100
GAG in media + GAG in explant
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Descriptive statistical analysis was performed using Mintab (v.15; Minitab Inc., Pennsylvania) and 
differences between culture groups were detected using mixed effects linear regression (SPIus v. 6.1; 
TIBCO Software Inc., California), with significance being set at P<0.05.
Results
Average cumulative GAG release and average cumulative GAG release with standard errors over 144 
hours are as shown in Figures 1 and 2. Mean GAG release and standard errors are shown in Table 1. 
The statistical significance of differences between GAG release in culture condition groups are as 
shown in Table 2.
Cartilage + 
Osteoblasts + 
I LI Live
Cartilage + 
Osteoblasts + 
I LI Dead
1 1 Cartilage + 
Osteoblasts - 
I LI Live
l - Cartilage + 
Osteoblasts - 
- I LI Dead
Cartilage -
Osteoblasts
Live
Cartilage -
Osteoblasts
Dead
Cartilage + IL1 
Live
Cartilage + IL1 
Dead
Figure 1: Average cumulative GAG release over 144 hours in each culture condition expressed as 
percentage release of total GAG into the media. Error bars show standard error.
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40
I % GAG loss 48h 
% GAG loss 96h 
I % GAG loss 144h
Cartilage + Cartilage + Cartilage + Cartilage + Cartilage- Cartilage- 
Osteoblasts + Osteoblasts + Osteoblasts- Osteoblasts- Osteoblasts Osteoblasts
Cartilage + Cartilage + 
I LI Live I LI Dead
I LI Live IL1 Dead I LI Live IL1 Dead Live Dead
Figure 2: Average cumulative GAG release over 144 hours in each culture condition expressed as 
percentage release of total GAG into the media. Error bars indicate standard error.
Culture Condition Mean GAG loss; (Standard Error
T=48 hours T=96 hours T=144 hours
Live cartilage 7.6% (+/-1.1) 11.9% (+/-1.2) 14.6% (+/-13)
Live cartilage treated with IL1(3 18.4% (+/-1-4) 29.1% (+/- 2.2) 35.9% (+/- 2.4)
ILip pre-treated osteoblasts and live cartilage 11.8% (+/-1-9) 19.8% (+/- 2.6) 23.5% (+/- 2.6)
Untreated osteoblasts and live cartilage 9.4% (+/-1) 15.6% (+/-1.5) 19.7% (+/-1-7)
Dead cartilage 9.4% (+/-1.1) 14.5% (+/-1.4) 17.8% (+/-1.3)
Dead cartilage treated with IL1(3 8.73% (+/-1.1) 13.2% (+/-1-6) 16.2% (+/-1-8)
ILip pre-treated osteoblasts and dead cartilage 8.3% (+/-1.1) 12.8% (+/-1.3) 15.8% (+/-1.5)
Untreated osteoblasts and dead cartilage 8.1% (+/- 0.7) 12.7% (+/-1) 15.5% (+/-1-2)
Table 1: GAG loss (expressed as percentage of total GAG lost into media) in each culture condition
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Time Culture Cc 
Increase (/
mdition. Significance of Differences in GAG Release Between Groups and 
') or Decrease (40 in GAG Release (row compared to column)
48
hours
Cartilage +
Osteoblasts +
IL1 Live
Cartilage +IL1 
Dead
Cartilage +IL1 
Live
Cartilage
Dead
Cartilage
Live
Cartilage + 
Osteoblasts
-ILI Dead
Cartilage + 
Osteoblasts
—I LI Live
Cartilage + 
Osteoblasts
+ 111 Dead
P=0.1 P=0.8 P<0.00014^ P=0.4 P=0.4 P=0.9 P=0.4
Cartilage + 
Osteoblasts
- Ill Live
P=0.5 P=0.5 P=0.00014, P=0.9 P=0.1 P=0.4
Cartilage + 
Osteoblasts 
- IL1 Dead
P=0.1 P=0.9 P<0.00014, P=0.5 P=0.4
Cartilage Live P=0.014, P=0.3 P<0.0001vl, P=0.1
Cartilage
Dead
P=0.4 P=0.6 P=0.0001^
Cartilage 
+IL1 Live
P^.OOl'f P^.OCX)!^
Cartilage 
+IL1 Dead
P=0.2
96
hours
Cartilage + 
Osteoblasts +
IL1 Live
Cartilage +IL1 
Dead
Cartilage +IL1 
Live
Cartilage
Dead
Cartilage
Live
Cartilage + 
Osteoblasts
-1 LI Dead
Cartilage + 
Osteoblasts
—I LI Live
Cartilage + 
Osteoblasts
+ IL1 Dead
P=0.004>J, P=0.9 PcO.OOOl^ P=0.3 P=0.6 P=0.9 P=0.1
Cartilage + 
Osteoblasts
- IL1 Live
P=0.2 P=0.2 P<0.0001n|, P=0.6 PsO.041" P=0.2
Cartilage + 
Osteoblasts 
— IL1 Dead
P=0.0064, P=1 P<0.00014, P=0.4 P=0.5
Cartilage Live p=0.00074. P=0.5 PO.OOOls!, P=0.1
Cartilage
Dead
P=0.06 P=0.4 P<0.00014,
Cartilage 
+IL1 Live
P=0.002/h P<0.0001t
Cartilage 
+IL1 Dead
P=0.006vU
144
hours
Cartilage + 
Osteoblasts +
IL1 Live
Cartilage +IL1 
Dead
Cartilage +IL1 
Live
Cartilage
Dead
Cartilage
Live
Cartilage + 
Osteoblasts
- IL1 Dead
Cartilage + 
Osteoblasts
—I LI Live
Cartilage + 
Osteoblasts
+ IL1 Dead
P=0.0044, P=0.9 P<0.00014, P=0.3 P=0.5 P=1 P=0.06
Cartilage + 
Osteoblasts
- IL1 Live
P=0.3 P=0.08 P<0.0001vU P=0.4 P=0.01t P=0.06
Cartilage + 
Osteoblasts 
— IL1 Dead
P=0.0044, P=0.9 P<0.00014, P=0.3 P=0.6
Cartilage Live P=0.00064/ P=0.5 P<0.00014/ P=0.09
Cartilage
Dead
P=0.07 P=0.3 P<0.0001^
Cartilage 
+IL1 Live
P=0.0003'T P<0.00011S
Cartilage 
+IL1 Dead
P=0.0064,
Table 2: Statistical significance of differences between groups in GAG release (expressed as 
percentage of total GAG) in media collected from different culture conditions.
C = cartilage; 0 = osteoblasts; +IL1 = pre-treated with interleukin 16; -ILI = untreated
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Discussion and Conclusion
The increased GAG release from cartilage explants co-cultured with osteoblasts pre-treated with 
ILlp has been reported and discussed in the main chapter. This finding is expanded here to show 
that when co-cultured with ILlp pre-treated osteoblasts, there is a significant increase in GAG 
release from cartilage with live chondrocytes, but no significant increase in GAG release from 
cartilage from cartilage with dead chondrocytes as compared to the negative control C-0 (both dead 
and live chondrocytes). Furthermore, there was significantly greater GAG release from cartilage 
explants with live chondrocytes co-cultured with pre-treated osteoblasts as compared to cartilage 
explants with dead chondrocytes in the same culture conditions. From this we can conclude that the 
GAG release from the cartilage matrix seen in response to co-culture with pre-treated osteoblasts is 
an effect of soluble factors produced by osteoblasts, which then alter the phenotype of the 
chondrocyte ( as shown previously with alterations in gene expression of various proteolytic genes in 
the chondrocyte). It is the live chondrocyte therefore which produces the proteolytic enzymes 
responsible for cartilage matrix breakdown. The effect of osteoblasts producing soluble factors 
which are transported via the culture medium to have a direct effect on breakdown of the cartilage 
matrix would appear to be minimal.
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Metabolomic Profiles of Media from Osteoblasts treated with 1L1B and from Co-Culture Systems
4.1 Introduction
While the roots of metabolomics may be traced back to ancient Greece, where the basic idea that 
changes in tissues and biological fluids are indicative of disease originated {Nicholson and Lindon 
2008), the modern techniques of analysis of samples used in metabolomics are relatively new. In 
the post-genomic era, it has become clear that solely mapping the genes, mRNA and proteins of a 
living system does not reveal its phenotype. Consequently, researchers have turned their interest to 
the metabolome (or the metabolic complement of functional genomics) and thus metabolomics is a 
rapidly expanding post-genomic science that utilises analytical techniques to measure low molecular 
weight metabolites in biological samples (Dunn et al. 2005; Griffin 2003; Wilson et al. 2005). The 
low molecular weight metabolites represent the end products of cell regulatory processes and as 
such indicate both normal phenotype and pathology. Furthermore, low molecular weight 
metabolites offer the possibility of identifying biomarkers of disease states due to the potential for 
abnormal cellular processes to lead to disturbances in the profile of metabolite profiles (Whitfield et 
al. 2004).
The distinction between metabolomics and metabonomics has been described as being mainly 
philosophical rather than technical (Nicholson and Lindon 2008). Metabonomics is defined as the 
quantative measurement of time-related multiparametric metabolic responses of multicellular 
systems to pathophysiological stimuli or genetic modification (Nicholson et al. 1999). Metabolomics, 
on the other hand, is defined as the comprehensive analysis of all the low molecular weight 
metabolites within, or that can be secreted by, a given cell type or tissue under a given set of 
conditions (Goodacre et al. 2004; Nicholson and Wilson 2003). In practice, there is a great deal of 
overlap between the two techniques with the terms often being used interchangeably and the 
analytical and modelling procedures used being identical. Full definitions of terms used in 
metabolomics and related disciplines are as listed in Table 4.1 (Ellis et al. 2007).
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Term Definition
Metabolomics The nonbiased identification and quantification of all metabolites in a 
biological system
Metabonomics The quantitative measurement of time-related multiparametric 
metabolic responses of multicellular systems to pathophysiological 
stimuli or genetic modification
Metabolome The complete set of low molecular weight metabolites within, or that 
can be secreted by, a given cell type or tissue
Metabolic Profiling Identification and quantification of a selective number of predefined 
metabolites which are generally related to a specific metabolic pathway
Metabolic Fingerprinting Global, high-throughput analysis to provide sample classification
Table 4.1: Terminology of Metabolomics (Ellis et al. 2007)
The experimental methods employed in metabolomics studies in general involve several stages 
including sample collection, sample processing, metabolite detection, data analysis and 
interpretation (Figure 4.1).
Sample
/------------------------ \
NMR
Spectroscopy 
s______________ >
\
LC-MS
GC-MSL J
/ \ 
Spectral 
Processing and 
Metabolite 
Identification
____ J
---------- \
Multivariate 
Data Analysis
V_______ _ _J
Figure 4.1: Stages of experimental methods in metabolomics. (NMR = nuclear magnetic resonance; 
LC-MS = liquid chromatography mass spectrometry; GC-MS = gas chromatography mass 
spectrometry).
The principal analytical techniques used in metabolomics are mass spectrometry (MS) and nuclear 
magnetic resonance (NMR) spectroscopy. Both techniques can generate large amounts of data and 
complex spectral profiles, which must then be analysed using advanced bioinformatic and statistical 
methods. Samples of interest are compared with those of controls, such that the spectral features
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caused by the disease state can be determined (Nicholson and Lindon 2008). Both NMR and MS
platforms have advantages and disadvantages, and likewise their proponents and opponents. As 
compared to MS, NMR spectroscopy is non-destructive and requires little or no sample preparation, 
and is therefore capable of generating a comprehensive profile of low-molecular weight metabolites 
from intact biofluids and tissues (Reo 2002). However, in certain circumstances the 1H NMR 
spectrum is insufficient to provide information that will fully characterise a metabolite e.g. where 
analytes contain functional groups that are deficient in protons or where protons can readily 
chemically exchange with the solvent (Villas-Boas et al, 2005). MS analysis therefore, has its most 
important advantage over NMR in its considerably higher sensitivity.
MS may be combined with separation techniques (e.g. chromatography) to reduce the number of 
competitive analytes entering the mass spectrometer and to separate complex mixtures of 
metabolites. This therefore expands the capability of chemical analysis of highly complex biological 
samples (Pham-Tuan et al. 2003; Villas-Boas et al. 2005). Both liquid and gas chromatography may 
be utilised as separation techniques prior to MS. Early technical problems associated with 
introduction of liquids to a high vacuum system as required in coupling liquid chromatography (LC) 
with MS have been overcome by the introduction of technical solutions such as soft-ionisation 
techniques and by the modification of LC methods (Abian 1999; Niessen 1999; Villas-Boas et al. 
2005). LC-MS has advantages in that this platform has the ability to determine selected metabolites 
quickly and with simpler sample preparation as compared to GC-MS (Villas-Boas et al. 2005).
A limitation of gas chromatography (GC)-MS is that samples must be volatile to be separated on a GC 
column. Most naturally occurring metabolites are not sufficiently volatile to be analysed directly on 
a GC system and therefore derivatisation is required, thus adding time and increased variance to the 
analysis (Villas-Boas et al. 2005). Silylation of organic compounds is the classical and most widely 
used derivatisation procedure for metabolome analysis by GC-MS. A silyl group is introduced into 
the molecule, in most cases by the substitution of active hydrogens. Disadvantages of silylation
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include that reactions must be performed under anhydrous conditions, samples must be heated for
over 1 hour, resulting in the loss of thermo-labile metabolites and as the residual reagents in 
samples after derivatisation are not removed, a resultant decreased column lifetime (Villas-Boas et 
al. 2005).
Large and increasingly complex data sets are generated from metabolomics analysis and 
subsequently advanced statistical analysis is necessary to maximise interpretation of data. Statistical 
analysis may be performed using either supervised or unsupervised methods. In unsupervised 
methods, patterns are determined without prior knowledge of which group the samples are 
members of. In supervised methods, additional information is added, such as group or clinical data, 
and similarities and differences between groups are determined (Holmes and Antti 2002). A widely 
used unsupervised method is principal component analysis (PCA). PCA is recommended as a 
starting point for analysing multivariate data, rapidly provides an overview of information hidden in 
the data and can be used to investigate clustering tendency, detect outliers and to visualise data 
structure (Lu et al. 2008). PCA is often followed by a supervised analysis technique such as partial 
least squares discriminant analysis (PLS-DA). PLS allows analysis of multivariate data where a 
quantitative relationship between a descriptor matrix X and a response matrix Y is sought PLS-DA is 
performed to enhance the separation between groups of observations (Lu et al. 2008). Orthogonal 
projections to latent structures (O-PLS) is a further development of PLS analysis. The objective of 
this modification is to improve interpretation of PLS models and reduce model complexity (Trygg 
and Wold 2002).
In mammalian systems, metabolomics has been utilised in the analysis of a wide range of biofluids 
and tissues in mammalian tissues including cerebrospinal fluid, amniotic fluid, synovial fluid, seminal 
fluids, bile, saliva and faeces, tumour biopsies and body tissues. Plasma and urine however are the 
most commonly used materials for studies in humans and animals as they are readily accessible. 
More specifically, in the field of osteoarthritis a urinary metabolite profile has been identified in the
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guinea pig spontaneous OA model (Lamers et al. 2005). Metabolomic analysis of cell culture media 
from explant culture has been previously described for placental tissue (Heazell et al. 2008), but to 
our knowledge has not previously been described in cartilage explant or cartilage explant and 
osteoblast co-culture systems.
The aim of the experiments described in the following chapter was to investigate the metabolic 
profile of the cell culture media collected from the in vitro experiments using equine osteoblasts 
stimulated with interleukin 1(3 (Chapter 2) and from the equine osteoblast and chondrocyte co­
culture experiments (Chapter 3). Specific aims were 1) to determine whether metabolites could be 
reproducibly detected in samples of conditioned media from equine osteoblast and osteoblast and 
chondrocyte co-cultures and 2) to determine whether, after processing of the spectra, metabolite 
identification could be utilised to reveal novel biomarkers.
It was hypothesised that there would be detectable differences in the metabolic profiles of 
conditioned culture media from various equine osteoblast and equine osteoblast and chondrocyte 
co-culture models, and that useful biomarkers could be identified after analysis of the spectra.
4.2 Materials and Methods
4.2.1 Sample collection
4.2.1.1 Osteoblasts
Equine osteoblasts in monolayer were grown from subchondral bone explants and differentiated as 
described in Chapter 2 (Culture of Equine Osteoblasts and Response to Interleukin Ip). After 
differentiation, cells were cultured for 24 hours in Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B and 1% 
ITS+, with or without the addition of lOng/mL interleukin Ip (ILlp). Subsequently, cells were 
washed before culturing in DMEM supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 
500ng/ml amphotericin B and 1% ITS+, for a further 72 hours. At the end of the culture period, 1ml
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media was collected from the cultures. Experiments were performed in triplicate and repeated with
materia! obtained from 4 separate donors. Samples of the cell culture medium used in each 
experiment were also collected in triplicate and used as a negative control.
4.2.1.2 Osteoblast and Cartilage Explant Co-culture
Equine osteoblast and cartilage explant co-culture systems were set up as described in Chapter 3 
(Co-Culture System of Equine Osteoblasts and Chondrocytes). Briefly, osteoblasts were cultured 
from explants, differentiated, washed and cultured with or without the addition of lOng/ml ILlp to 
the culture media for 24 hours. Subsequently, allogeneic cartilage explants were placed in co­
culture inserts with a pore size of 1pm and co-cultures were carried out for 72 hours, with 1ml 
media being collected from each culture well at the end of the culture period. As controls, samples 
of medium were also collected from cartilage expiants cultured without osteoblasts and from 
culture medium not cultured with any cells. Medium used for co-culture experiments was DMEM 
supplemented with lOOU/ml penicillin, lOOpg/ml streptomycin, 500ng/ml amphotericin B and 1% 
ITS+. Experiments were performed in triplicate and repeated with material obtained from 4 
separate donors.
After harvesting, media was immediately frozen in liquid nitrogen and stored at -80°C. Samples were 
thawed before further extraction and analysis and utilised after one freeze-thaw cycle.
4.2.2 Preparation of Conditioned Culture Medium forGC-MS
Preparation and analysis of metabolic samples were performed in collaboration with Jennifer 
Kirwan, Faculty of Veterinary Science, University of Liverpool. Unless stated otherwise, all reagents 
were supplied by Sigma-Aldrich (Dorset, England). Conditioned culture medium was prepared for 
gas chromatography -mass spectrometry (GC- MS) analysis according to the protocol of Heazell et al. 
(2008). Two hundred pi of cell-free supernatant of conditioned culture medium was spiked with
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100^1 0.19mg/mL succinic d4 acid as a time-base calibrant. Samples were dried using a vacuum 
centrifuge (Jouan RC10.22) attached to a cold trap (Jouan RCT 90). Samples were chemically 
derivatised in a two-stage procedure. Fifty pi O-methylhyroxylamine hydrochloride in pyridine 
(20mg/mL) was added to the samples and incubated at 37°C for 90 minutes. Following this 
incubation, 50pL MSTFA {A/-acetyl-A/-(trimethylsilyl)-trifluoroacetamide) was added and heated at 
37 C for 90 minutes. Following incubation, the derivatised solution was centrifuged at 15339 xg for 
10 minutes and the supernatant was transferred to a glass vial. Samples were diluted 1:2 with 
hexane prior to GC-MS analysis. To monitor variation between batches, quality control samples (QC) 
consisting of a mixture of media from a random selection of samples were derivatised as above and 
included in the analysis. All samples were injected in duplicate.
4.2.3 GC-MS Analysis
All samples were analysed in a random order. The l.OmL derivatised sample was injected with a 
20:1 split into an Agilent 6980 GC system, which was equipped with an Agilent DB5-MS column (30m 
x 180pm x 0.18pm) (Stockport, UK). The inlet temperature was set at 250°C. Helium was used as 
the carrier gas, at a constant flow rate of l.OmL/min. To achieve good separation, the column 
temperature was held for 85°C for 2 minutes and then ramped at 15°C/minute to a final 
temperature of 300°C that was maintained for 2 minutes. The column effluent was introduced into 
the ion source of a Waters GCT premier mass spectrometer (Waters, Manchester, UK). The transfer 
line temperature was set at 250°C and the ion source temperature at 180°C. Ions were generated by 
a 70eV electron beam at a current of 3.2mA. The instrument was calibrated with heptacosa 
(perfluorotributylamine) reference. The heptacosa was also introduced as the lock mass (m/z 
218.9856) from the reference reservoir. After a solvent delay of 7 minutes mass spectra were 
acquired at a rate of 20s"1 over a mass range of m/z 50 to 650.
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4.2.4 Data Processing and Analysis
Data were collected using MassLynx applications Manager Software v4.1 (Waters). Compounds 
were identified by comparison of their mass spectra with those in the National Institute of Standards 
and Technology (NIST) 2005 mass spectral library. Metabolites with a similarity index more than 
70% were assigned an identity. The raw GC-MS data were deconvoluted and aligned within mass 
and retention time windows using the MarkerLynx (version 4.1) applications manager software 
(Waters) to generate a matrix of m/z and retention pairs with associated intensities. 
Chromatographic peaks in the raw data files were detected by extracting nominal mass 
chromatograms and tracking the apex of the peaks in the chromatograms. The spectra from each of 
the detected peaks were saved as retention time and exact mass pairs along with associated 
intensities. These data were then exported to SIMCA-P+ vll.5 (Umetrics, Sweden) for multivariate 
data analysis
4.2.5 Multivariate Data Analysis
Principal component analysis (PCA) using Pareto scaling was performed within MarkerLynx 
applications manager. In Pareto scaling, each variable is divided by the square root of the standard 
deviation with the goal of reducing the relative importance of large values while keeping the data 
structure partially intact (van den Berg et al. 2006). PCA scores plots produced in MarkerLynx 
demonstrated any groups formed by clustering of the data. A supervised statistical approach, partial 
least squares-discriminant analysis (PLS-DA) was performed by exporting the processed data to 
SIMCA-P+ vll.5 multivariate analysis software package (Umetrics, Sweden). SIMCA-P+ was also 
used to perform another supervised statistical approach, orthogonal projections to latent structures 
(OPLS). OPLS scores plots demonstrated any clustering of the data and OPLS loadings plots indicated 
which ions had the largest influence on the observed variance in the data, i.e. the variables at the 
top and the bottom of the loadings plot are those that change most, while the ones in the centre do
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not vary significantly. Based on mass to charge ratio {m/z) ions were identified from 
chromatographic peaks using the NIST 2008 spectral library. To validate the ORIS model, a training 
set was created by excluding 6 observations and their repeats at random, then using the remaining 
samples to create a new ORIS model. The 6 samples were then re-inserted as a test set to test the 
robustness of the OPL5 model. Sensitivity (defined as proportion of true positives correctly 
identified) and specificity (defined as proportion of true negatives correctly identified) of the model 
were then calculated from this test set.
Experiment 1 (stimulation of equine osteoblasts grown in monolayer with ILlf3) and Experiment 2 
(co-culture of equine chondrocytes with equine osteoblasts not pre-treated or pre-treated with IL1(3) 
were performed at separate time points, using different donors and media from different batches. 
Therefore, data were not pooled and data from Experiments 1 and 2 were analysed and presented 
separately.
4.3 Results
4.3.1 Qualitative Results
Typical GC-MS total ion chromatograms from conditioned media from osteoblasts and osteoblasts 
stimulated with 111(3 (Experiment 1) are shown in Figure 2. Visual examination of the traces revealed 
readily identifiable differences in the components of the two groups of media. Identifications of 
major peaks as numbered in Figure 2 are listed in Table 4.2.
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Peak Number RT (min) Description from best fit library
1 5.68 L-alanine
2 6.05 Ethanedioic acid (oxalic acid)
3 6.8 L-valine
4 7.34 L-leucine
5 7.56 L-isoleucine
6 7.69 Ethanedoic acid (oxalic acid)
7 8.45 L-threonine
8 9.58 L-proline
9 9.92 a-aminoadipic acid
10 10.48 L-phenylalanine
11 12.60 D-glucose
12 13.02 D-glucose
Table 4.2: Identification of major peaks on chromatograms from Experiment 1 (osteoblasts +/- IL16) 
as labelled in Figure 2. (RT= retention time)
Typical GC-MS total ion chromatograms from conditioned media from osteoblasts co-cultured with 
chondrocytes; osteoblasts pre-treated with IL1(3 and co-cultured with chondrocytes; and 
chondrocytes cultured alone (Experiment 2) are as shown in Figure 3. As in Experiment 1, visual 
examination of the traces revealed identifiable differences in the two groups of media. 
Identifications of the major peaks are as listed in Table 4.3.
There were very few peaks in the traces after retention times of approximately 15 minutes in any of 
the samples, indicating that there were no lipophilic compounds detectable in the media.
134
IO
O
-i
oo
o
N
<D
.i
.£S
X5
0J
E
■D
<D
C
g
■M
T3
Co
u
T3
C
CD
OJ
is
XIo
0)
-t-1
too
E
ro
13
0J
E
TJ
QJ
Cg
itj
T3
C
O fNJ
< X! 
'— CD
to T3 
CU 
ti=CD
C
CD
CO
u
£
o
14=
xs
0J
.£
‘CD
X!
O
to
E
CD
DOo4J
CD
Eo
JZ
u
cg
"cD
4->o
s
jO
OJt_
CD
CN
“O
_0J_
xs
jtD
to
Ji£
CD
OJ
Q_
X5
OJ4-4
JD
E
CL S 
,>■ -2 
l—* -O
o
0JCN
QJv_
3
DO
13
5
O
C
H
Fi
gu
re
 4
.3
: T
yp
ic
al
 to
ta
l io
n 
ch
ro
m
at
og
ra
m
s 
ob
ta
in
ed
 fr
om
 G
C
-M
S 
an
al
ys
is
 o
f (
A)
 c
on
di
tio
ne
d 
m
ed
ia
 fr
om
 o
st
eo
bl
as
ts
 c
o-
cu
ltu
re
d 
w
ith
 ch
on
dr
oc
yt
es
, (
B)
 
co
nd
iti
on
ed
 m
ed
ia
 fr
om
 o
st
eo
bl
as
ts
 p
re
-tr
ea
te
d 
w
ith
 IL
lp
 a
nd
 c
o-
cu
ltu
re
d 
w
ith
 ch
on
dr
oc
yt
es
 a
nd
 (C
) c
on
di
tio
ne
d 
m
ed
ia
 fr
om
 c
ho
nd
ro
cy
te
s.
 Pe
ak
s l
ab
el
le
d 
1-
16
 a
re
 id
en
tif
ie
d 
in
 T
ab
le
 3
Peak Number RT (min) Description from best fit library
1 5.79 Propanoic acid
2 6.21 L-alanine
3 6.58 Ethanedoic acid (oxalic acid)
4 7.32 L-valine
5 7.85 L-leucine
6 8.05 L-isoleucine
7 8.19 Propanoic acid
8 8.95 L-threonine
9 9.73 L-aspartic acid
10 10.08 L-proline
11 10.40 a-aminoadipic acid
12 10.81 Heptanedioic acid (pimelicacid)
13 10.97 L-phenylalanine
14 13.00 D-glucose
15 13.12 L-lysine
16 13.44 D-glucose
Table 4.3: Identification of major peaks on chromatograms from Experiment 2 (osteoblasts co­
cultured with chondrocytes) as labelled in Figure 4.3. (RT= retention time)
4.3.2 Quantitative Results
Further analyses of differences between groups were assessed using statistical methods. Prior to 
performing statistical analysis using PCA, PLS-DA and OPLS, data was pre-treated using the Pareto 
scaling method. Scores plots for Experiment 1 are shown for analysis using: PCA (Figure 4.4), PLS-DA 
(Figure 4.5) and OPLS (Figure 4.6). Scores plots of Experiment 2 are shown for analysis using: PCA 
(Figure 4.7), PLS-DA (Figure 4.8) and OPLS (Figure 4.9).
On PCA analysis, QC and media negative control samples (Experiment 1) and QC, media negative 
control and chondrocyte control samples (Experiment 2) were found to be well clustered showing 
minimal variation during runs and between batches. For further statistical analysis methods (PCA, 
PL-SDA and OPLS) only the groups of interest involving osteoblast culture were compared, i.e. 
osteoblasts grown in monolayer and pre-treated or not with ILlp (Experiment 1) or osteoblasts 
grown in monolayer, pre-treated or not with ILlfJ then co-cultured with chondrocytes (Experiment 
2). Some separation of groups was seen on PCA and good separation of groups was shown with
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both PLS-DA and OPLS for Experiment 1. In Experiment 2, separation using the unsupervised 
technique of PCA was relatively poor but better using the supervised methods. Reasonable 
separation between groups was shown using PLS-DA for Experiment 2 and more marked separation 
between groups was found using OPLS.
SIMCA-P* 12 - 2009-09-10 16 26 39 (UTC«0)
Figure 4.4: Pareto scaled PCA scores plots obtained for data derived from GC-MS analysis of media 
samples obtained from cultures of osteoblasts treated with IL16 (red) and cultures of osteoblasts not 
treated with IL16 (blue)
Figure 4.5: (A) 2D model and (B) 3D model of PLS-DA scores plots to 2 components obtained for data 
derived from GC-MS analysis of media samples obtained from cultures of osteoblasts treated with 
IL16 (red) and cultures of osteoblasts not treated with IL16 (blue)
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Figure 4.6: (A) 2D model and (B )3D model of Pareto scaled OPLS scores plots obtained for data 
derived from GC-MS analysis of media samples obtained from cultures of osteoblasts treated with 
IL16 (red) and cultures of osteoblasts not treated with IL16 (blue).
Figure 4.7: Pareto scaled PCA scores plots obtained for data derived from GC-MS analysis of media 
samples obtained from cultures of osteoblasts pre-treated with IL16 and co-cultured with 
chondrocytes (red) and cultures of osteoblasts not pre-treated with IL16 and co-cultured with 
chondrocytes (blue)
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Figure 4.8: (A) 2D model and (B) 3D model of PLS-DA scores plots to 2 components obtained for data 
derived from GC-MS analysis of media samples obtained from cultures of osteoblasts pre-treated 
with IL16 and co-cultured with chondrocytes (red squares) and cultures of osteoblasts not pre-treated 
with IL16 and co-cultured with chondrocytes (blue squares).
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Figure 4.9: (A) 2D model and (B) 3D model of Pareto scaled OPLS scores plots obtained for data 
derived from GC-MS analysis of media samples obtained from cultures of osteoblasts pre-treated 
with IL16 and co-cultured with chondrocytes (red squares) and cultures of osteoblasts not pre-treated 
with IL16 and co-cultured with chondrocytes (blue squares)
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OPLS loadings plots are as shown in Figures 4.10 and 4.11 (Experiments 1 and 2 respectively).
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Figure 4.10: Pareto scaled OPLS loadings plot for data derived from GC-MS analysis of media samples 
obtained from cultures of osteoblasts treated and not treated with IL16. Ions having the largest 
effect on variance of the data are those at the top and bottom of the plot and are marked with blue 
and red squares. Numbers represent the retention time and mass to charge ratio (m/z)
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Figure 4.11: Pareto scaled OPLS loadings plot for data derived from GC-MS analysis of media samples 
obtained from cultures of osteoblasts pre-treated with IL16 and co-cultured with chondrocytes, and 
cultures of osteoblasts not pre-treated with IL16 and co-cultured with chondrocytes. Ions having the 
largest effect on variance of the data are those at the top and bottom of the plot and are marked 
with blue and red squares. Numbers represent the retention time and mass to charge ratio (m/z)
Ions having the largest effect on the variance of the data were identified using the NIST 2008 
spectral library are shown in full in Tables 4.4-4.7. Briefly, in the monolayer osteoblast experiment, 
there was increased L-valine, L-isoleucine, glycine and L-proline; and decreased L-alanine and D- 
glucose in the media of the osteoblasts pre-treated with IL1(3. In the co-culture experiment there 
was increased propanoic acid; and decreased L-alanine, L-valine, L-leucine, glycine, L-aspartic acid 
and D-glucose in the media of the osteoblasts pre-treated with IL1(3 and co-cultured with 
chondrocytes.
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RT
(min)
Principal ions
observed (m/z)
Elemental
composition
MW Description from best library 
fit
6.80 144, 73 CllH27N02Si2 261 L-Valine
7.54 73 Ci2H29N02Si2 275 L-lsoleucine
7.68 147,148, 76, 251 CnH29N02Si3 291 Glycine
9.58 147, 156, 157,
158, 230, 258
CllH23N03Si2 273 L-Proline
Table 4.4: Compounds detected by GC/MS as being increased in the media of osteoblasts pre-treated 
with IL16 as compared to osteoblasts not pre-treated with IL16. The table shows the principal ions 
observed and the description from best library fit 
(RT = retention time)
RT
(min)
Principal ions
observed (m/z)
Elemental
composition
MW Description from best library 
fit
5.68 116 C9H23N02Si2 233 L-Alanine
13.01 73, 191, 204, 217 C2lH5206Si5 540 D-Glucose
Table 4.5: Compounds detected by GC/MS as being decreased in the media of osteoblasts pre-treated 
with IL16 as compared to osteoblasts not pre-treated with IL16. The table shows the principal ions 
observed and the description from best library fit.
(RT = retention time)
RT
(min)
Principal ions
observed (m/z)
Elemental
composition
MW Description from best library 
fit
5.76 117, 118, 133, 147, 
190,191
C9H22C>3Si2 234 Propanoic acid
Table 4.6: Compounds detected by GC/MS as being increased in the media of osteoblasts pre-treated 
with IL16 and co-cultured with chondrocytes, as compared to osteoblasts not pre-treated with IL16 
and co-cultured with chondrocytes. The table shows the principal ions observed and the description 
from best library fit.
(RT = retention time)
RT
(min)
Principal ions
observed (m/z)
Elemental
composition
MW Description from best library 
fit
6.18 116 C9H23N02Si2 233 L-Aianine
7.29 144 CnH27N02Si2 261 L-Valine
7.82 158 Ci2H29N02Si2 275 L-Leucine
8.20 174 CnH29N02Si3 291 Glycine
9.71 232 Cl3H3lN04Si3 349 L-Aspartic acid,
12.96 204 C22H55N06Si5 569 D-Glucose
Table 4.7: Compounds detected by GC/MS as being decreased in the media of osteoblasts pre-treated 
with IL16 and co-cultured with chondrocytes, as compared to osteoblasts not pre-treated with IL16 
and co-cultured with chondrocytes. The table shows the principal ions observed and the description 
from best library fit 
(RT = retention time)
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On validation of the OPLS models by creating training and test sets, it was shown that the sensitivity
and specificity of the OPLS models were 71% and 100% respectively for Experiment 1, and 75% and 
100% respectively for Experiment 2.
4.4 Discussion
It has been shown that GC-MS is capable of discriminating between samples of media conditioned 
by 1) culture of equine osteoblasts and equine osteoblasts stimulated by IL1(3 and 2) co-culture of 
equine osteoblasts pre-treated or not with ILlp and equine chondrocytes. Previous experiments 
have shown various in-vitro effects of the equine osteoblast and the equine osteoblast stimulated by 
application of ILlfJ at gene level and also in terms of MIV1P-13 protein production and GAG release 
from the extracellular matrix of cartilage explants (see Chapter 3). It has also been shown that 
cartilage matrix degradation effects are mediated via the chondrocyte via a soluble factor in the cell 
culture media (See Chapter 3 Appendix B) and (Jasin and Dingle 1981; Westacott 2002).
Analysis of the GC-MS data derived from the cell media, indicated that there were alterations in 
various biochemically relevant biomarkers when osteoblasts were pre-treated with Hip and also 
when osteoblasts were pre-treated with ILlfJ and co-cultured with chondrocytes. Interestingly, 
although there were similarities in the alterations in compounds between experiments, the 
alterations were not identical.
In both the osteoblast and co-culture experiments, there was decreased D-glucose in the media 
conditioned by osteoblasts pre-treated with 111(3 as compared to osteoblasts not undergoing IL1(3 
treatment. IL1(3 has been used as a driver of the osteoarthritic phenotype in this sequence of 
experiments, and its decrease as observed may indicate that in this in vitro model of OA there are 
alterations of glucose metabolism. The decreased glucose in the media may be explained by the 
equine osteoblasts stimulated with 1L1(3 having increased uptake of glucose, as has been shown
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previously to occur in human fibroblasts {Bird et al. 1990), synoviocytes (Taylor et ol. 1988) and 
chondrocytes (Hemvann etal. 1996).
As well as alterations in glucose, changes in amino-acid content of the cell culture medium were also 
observed. Although alterations in amino acid utilisation and formation have not been shown in 
osteoblasts in cell culture to our knowledge, previously it has been shown that chicken growth plate 
epiphyseal chondrocytes in short term culture release alanine, glycine, proline and aspartate into 
the cell culture medium (Ishikawa et al. 1985). Our results add further information to these previous 
findings. In both the osteoblast and the co-culture experiments, there was decreased alanine in the 
medium of the cultures where the osteoblasts had been driven towards an osteoarthritic phenotype 
via pre-treatment with IL1(3. Alanine is a non-essential amino acid which is not routinely present in 
DM EM culture medium. Therefore the reduction of the compound identified in the culture medium 
may indicate a true reduction in synthesis by the osteoblasts pre-treated with ILip in both 
monolayer and under co-culture with chondrocytes conditions.
The response of valine and glycine is interesting in that these amino acids were increased in the 
media of osteoblasts pre-treated with IL1(3 as compared to osteoblasts not pre-treated with IL1(3, 
but in the co-culture experiment these same amino acids were decreased in the media of 
osteoblasts pre-treated with ILip and co-cultured with chondrocytes as compared to osteoblasts not 
pre-treated with dip and co-cultured with chondrocytes. Valine is an essential amino acid which 
therefore must be added to cell culture media for cell survival (Eagle 1959) and is included in 
commercially available DMEM. Although glycine is not an essential amino acid, it is also routinely 
added to commercially available DMEM. The relative increase and decrease in the cell culture 
medium of these amino acids may represent a reduced and increased utilisation respectively by the 
cells in the various culture conditions. It is suggested that the difference between experiments may 
be associated with co-culture with chondrocytes as this was only difference in the experimental 
design. Potentially, although utilisation is decreased in the 111(3 pre-treated osteoblasts, when these
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IL1(3 driven osteoblasts are co-cultured with chondrocytes, the phenotype of the chondrocyte is 
altered such that valine and glycine utilisation are increased, resulting in a relative decrease in these 
amino acids in the culture medium. Conversely, another explanation for the reduced glycine content 
of the media in the co-cultures of ILlp pre-treated osteoblasts and chondrocytes may be a reduction 
in synthesis by the chondrocytes. This is of particular interest in this in vitro model of osteoarthritis 
as collagen is composed of approximately 35% glycine (Nelson and Cox 2005).
4.5 Conclusion
In conclusion, the technique of GC-MS has been shown to be capable of allowing identification of 
detectable differences in the metabolic profiles of conditioned culture media. Biologically relevant 
markers in the culture media of this model of osteoblast driven osteoarthritis have been identified. 
Cell metabolism has been altered as observed via changes in both glucose and glucose metabolism. 
Alterations in compounds in the cell culture media were different in the osteoblast +/- ILip pre­
treatment experiment as compared to the osteoblast +/- IL1(3 pre-treatment co-culture with 
chondrocytes experiment, indicating an effect of co-culture with chondrocytes.
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Post Mortem Evaluation of Palmar Osteochondral Disease (Traumatic Osteochondrosis) of
the Metacarpo-ZMetatarsophalangeal Joint in Thoroughbred Racehorses
5.X Introduction
The condition which we refer to as palmar/plantar osteochondral disease (POD) of the third 
metacarpal and metatarsal (MC/MTIII) condyles has previously been referred to as traumatic 
osteochondrosis (Pool 1996) in the equine veterinary literature. Although initially 
considered to be a manifestation of osteochondritis dissecans (Hornof et al. 1981), this 
condition is now believed to be a biomechanical disorder, resulting from repetitive overload 
trauma in horses undergoing cyclic high intensity exercise (Pool 1996).
The clinical condition of pain associated with subchondral bone injury of the distal condyles 
of MC/MTIII is recognised in most racing breeds including Thoroughbreds (Arthur et al. 2003; 
Pilsworth 2003), Standardbreds (Mitchell et al. 2003; Torre 2003), Quarter Horses (Lewis 
2003) and Scandinavian Cold-Blooded Trotters (Ertola and Houttu 2003). Grossly the lesions 
are characterised as small, ovoid defects in the palmar or plantar articular surface of the 
condyle of approximate 2-4mm diameter (Pool 1996). Lesions are centred about 5-8mm 
proximal to the transverse ridge and may be located 3-15mm from the sagittal ridge on 
either the medial or lateral condylar surfaces (Pool 1996). Lesions appear to vary in severity. 
Early findings include a focus of bluish discolouration of the subchondral bone visible 
through grossly normal articular cartilage. More severe changes include physical disruption 
of the subchondral bone associated with varying degrees of pathology of the overlying 
articular cartilage. Ultimately there may be collapse of the subchondral bone with ulceration 
of the articular cartilage (Riggs 2006). In some cases these lesions have been reported to be 
associated with catastrophic condylar fracture. (Krook and Maylin 1988).
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The pathological changes are clinically evident as a performance limiting lameness which 
may be bilateral or, in some cases, quadrilateral and as a result the affected horse may 
present with a poor action rather than overt lameness (Pilsworth 2003). The condition may 
be difficult to diagnose due to an inconsistent response to intra-articular analgesia and 
because only severe lesions are appreciable on routine radiography of the 
metacarpophalangeal (MCP) and metatarsophalangeal (MTP) joints (Richardson 2003). 
More specialised radiographic views may aid diagnosis (O'Brien et al. 1981; Pilsworth et al. 
1988) and specialised imaging modalities such as nuclear scintigraphy (Ross 1998; 
Richardson 2003), computed tomography (Byron and Goetze 2007; Morgan et al. 2006) and 
magnetic resonance imaging (Zubrod et al. 2004) are extremely useful in diagnosis of POD. 
Visualization of the predilection site for POD lesions on the palmar/plantar aspect of the 
condyles of MC/MTIII is physically impossible during routine arthroscopic examination of the 
MCP/MTP joints. Consequently, many lesions remain undiagnosed until the later stages of 
disease, by which time the changes are irreversible and will result in chronic joint disease.
The aims of the study were to 1) to evaluate gross pathology of the distal condyles of 
MC/MTIII of Thoroughbred racehorses at post-mortem examination and develop a scoring 
system to document relevant findings, 2) to describe the prevalence and distribution of POD 
lesions within a population of flat racing Thoroughbreds and 3) to determine any 
relationship between pathologies of the condyles of MC/MTIII (wear lines, cartilage 
loss/ulceration, marginal remodelling, linear fissures and dorsal impact injuries) and POD. It 
was hypothesised that: 1) POD will have a high prevalence in a population of intensively 
raced Thoroughbreds, 2) There will be predilection sites for these pathologies, 3) there will 
be an association between POD and other pathologies affecting the distal condyles of 
MC/MTIII and 4) There will be a correlation between prevalence of POD and pathologies of 
the dorsodistal aspect of MC/MTIII, suggestive of MCP/MTP joint hyperextension.
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5.2 Materials and Methods
Material was examined from 64 Thoroughbred racehorses that were in active race training 
or had been retired from active race training at the Hong Kong Jockey Club and required 
euthanasia over a 15 month period. Material collection and gross post-mortem grading 
were performed by collaborators at the Hong Kong Jockey Club (Dr Christopher Riggs, Peter 
Curl and Suzanne Troester). Forty nine/64 horses were euthanased as a result of 
orthopaedic disease (fracture n=14; tendon/ligament injury n=12; osteoarthritis n=ll; 
miscellaneous lameness n=ll; laminitis n=l). The remainder of horses (13/64) were 
euthanased for reasons unrelated to orthopaedic disease.
The distal articular surface of MC/MTIII was examined by gross observation at post mortem 
examination performed immediately after death by one observer (CMR). A scoring system 
was developed and each condyle was assigned a score for POD, wear lines, cartilage loss, 
marginal remodelling, linear fissures and dorsal impact injuries (Table 5.1). Examples of 
affected condyles and their scoring are as shown in Figures 5.1 a-d.
Scores were entered into an Excel for Microsoft Office 2003 (Microsoft Corp, Redmond, USA) 
database and descriptive data obtained. The statistical significance of distribution of lesions 
and POD was determined using the Chi-square test of association. The statistical significance 
of the relationships between grades of pathologies at the condylar level was determined 
using the Chi - squared test, the Gamma statistic for ordinal data and ordinal logistic 
regression. SPSS for Windows 14.0 (SPSS Inc, Chicago, USA) and Minitab for Windows 14.0 
(Minitab Inc, Pennsylvania, USA) were used for statistical analysis.
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Feature Score Description
Palmar/Plantar
osteochondral
disease
0 No evidence of POD
1 Discolouration (bruising) of subchondral bone only, no or 
minimal disruption of overlying articular cartilage
2 Discolouration (bruising) with mild to moderate disruption 
of articular cartilage
3 Established POD lesions. Discolouration and
disruption/collapse of articular surface
Wear lines in
cartilage
0 Wear lines absent
1 Partial thickness wear lines in cartilage
2 Full thickness wear lines in cartilage
Cartilage loss -
associated with
transverse ridge,
condylar groove and 
central condylar
region
0 No evidence of cartilage loss
1 Partial thickness cartilage loss (fibrillation)
2 Full thickness cartilage loss (ulceration) with minor 
exposure of calcified cartilage/subchondral bone
3 Extensive full thickness cartilage loss with exposure of the 
subchondral bone over an area >5mm in diameter
Linear fissures 
(within condylar
grooves)
0 No evidence of linear fissures
1 Faint groove with intact cartilage visible along length
2 Well defined groove with partial thickness split in cartilage
3 Well defined groove with full-thickness split in cartilage
Marginal remodelling 0 Marginal remodelling absent
1 Marginal remodelling present
Dorsal impact injury 0 No evidence of dorsal impact injury
1 Mild (thickening/inflammation of synovial pad and mild 
erosion of underlying MC/MTIII, mild erosion 
dorsoproximal PI)
2 Severe (thickened, inflamed synovial pad and marked 
erosion MC/MTIII, full thickness cartilage loss and/or chip 
fracture of dorsoproximal PI)
Table 5.1: Scoring system for metacarpo/metatarsophalangeal pathology
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Figure 5.1a: Example of the plantar aspect of a distal metatarsus (lateral to the right) from a 6 year 
old Thoroughbred that had 32 race starts during its career. This was graded as having grade 0 
palmar ostechondral disease (both condyles). Grade 0 wear lines (both condyles). Grade 0 cartilage 
loss (both condyles) and Grade 2 linear fissures (medial condyle. Arrow 1) and Grade 1 linear fissures 
(lateral condyle. Arrow 2)
4 4
3 3
Figure 5.1b: Example of the plantar aspect of a distal metatarsus (lateral to the right) from a 7 year 
old Thoroughbred that had 45 race starts during its career. This was graded as having Grade 1 
palmar ostechondral disease (medial condyle. Arrow 1), Grade 2 palmar osteochondral disease 
(lateral condyle. Arrow 2), Grade 1 wear lines (both condyles. Arrows 3), Grade 1 cartilage loss (both 
condyles. Arrows 4), Grade 1 linear fissures (medial condyle. Arrow 5), Grade 0 linear fissure (lateral 
condyle)
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Figure 5.1c: Example of the palmar aspect of a distal metacarpus (lateral to the right) from a 7 year 
old Thoroughbred that had 45 race starts during its career (the same horse as lb). This was graded 
as having Grade 1 palmar ostechondral disease (medial condyle. Arrow 1), Grade 2 palmar 
osteochondral disease (lateral condyle. Arrow 2), Grade 1 wear lines (both condyles. Arrows 3), 
Grade 1 cartilage loss (both condyles. Arrows 4) and Grade 0 linear fissures (both condyles)
45
Figure 5.Id: Example of the palmar aspect of a distal metacarpus (lateral to the left) from a 7 year 
old Thoroughbred that had 48 race starts during its career. This was graded as having Grade 3 
palmar ostechondral disease (medial condyle. Arrow 1), Grade 0 palmar osteochondral disease 
(lateral condyle). Grade 1 wear lines (lateral condyle. Arrow 2), Grade 2 wear lines (medial condyle. 
Arrow 3), Grade 3 cartilage loss (medial condyle. Arrow 4), Grade 2 cartilage loss (lateral condyle, 
Arrow 5) and Grade 0 linear fissures (both condyles)
5.3 Results
Sixty four horses were examined. There were 62 geldings and 2 colts. The mean age at retirement 
was 6.1 years (range 3-10 years) and the mean age at euthanasia was 6.95 years (range 3-18 years). 
POD was recorded (Grade 1-3 on at least one condyle) in 43/64 of horses, giving a prevalence by 
individual of 67% (95% Cl 54.3, 78.4). A total of 499 of 512
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condyles were examined. Two hundred and ninety seven condyles (59.5%) had Grade 0 POD, 
118 condyles (23.6%) had Grade 1 POD, 70 condyles (14%) had Grade 2 POD and 14 condyles 
(2.8%) had Grade 3 POD. It was not possible to accurately score all features of the condyles 
in every case on account of extensive pathology associated with acute trauma to the joint: 
condylar fracture (number of horses=2), proximal sesamoid bone fracture (n=2), rupture of 
the distal sesamoid ligaments (n=l), septic joint (n=l). Data was omitted for the affected 
limb in each case. In three horses (7 condyles) we found evidence of discrete areas 
(approximately 2mm in diameter) of opaque but intact cartilage at the site commonly 
affected by POD lesions. This region of cartilage was smooth and well integrated with the 
surrounding hyaline cartilage and the underlying subchondral bone appeared grossly 
normal. Since these could not be graded as normal (POD Grade 0), nor did the pathology 
fulfil the criteria of POD as the underlying bone was normal, we also omitted them from 
further analysis in this study.
The distribution of POD lesions was such that POD was present on 98/249 right limb 
condyles and 104/250 left limb condyles; POD was present on 107/250 forelimb condyles 
and 95/249 hind limb condyles; POD was present in 93/248 lateral condyles and 109/251 
medial condyles. There was no significant correlation between the distribution of POD 
lesions on left vs right condyles (P=0.6), fore vs hind limb condyles (P=0.3) and lateral vs 
medial condyles (P=0.2).
When fore and hind limbs were assessed separately, it was found that within the forelimbs 
47/125 lateral condyles and 60/125 medial condyles were affected by POD. This gave a trend 
towards POD lesions occurring more commonly in the medial condyle (P=0.1), but this was 
not significant. In the hind limbs 46/123 lateral and 49/126 medial condyles were affected 
by POD. Therefore there was no significant difference between medial and lateral condyles
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in the hind limbs (P=0.8). When the effect of left or right limb was assessed separately 
within the fore and hind limbs, it was found that 52/125 right forelimb condyles and 55/125 
left forelimb condyles were affected. Forty six/124 right hind limb condyles were affected 
and 49/124 left hind limb condyles were affected. Therefore, there was no significant 
difference in POD lesion distribution between left and right (P=0.7 forelimbs and P=0.7 hind 
limbs).
The number of condyles affected at horse level and the distribution of the lesions are shown 
in Table 5.2. Briefly 1 condyle was affected in 7 horses (10.9%), 2 condyles were affected in 
6 horses (9.4%), 3 condyles were affected in 6 horses (9.4%), 4 condyles were affected in 3 
horses (4.7%), 5 condyles were affected in 1 horse (1.6%), 6 condyles were affected in 8 
horses (12.5%), 7 condyles were affected in 4 horses (6.3%) and all 8 condyles were affected 
in 9 horses (14.1%).
Total Condyle
number of Left Left Right Right Left Left Right Right Number
condyles MCIII MCIII MCIII MCIII MTIII MTIII MTIII MTIII of horses
affected medial lateral medial lateral medial lateral medial lateral (% total)
0 - - - - - - - - 20
(31.3%)
1 3 1 0 1 0 0 2 0 7 (10.9%)
2 1 2 1 2 2 2 1 1 6 (9.4%)
3 4 1 3 3 1 2 2 2 6 (9.4%)
4 3 2 2 2 2 0 1 0 3 (4.7%)
5 0 0 1 1 1 1 0 1 1 (1.6%)
6 8 4 8 4 7 6 5 6 8 (12.5%)
7 4 4 4 2 4 3 3 4 4 (6.3%)
8 9 9 9 9 9 9 9 9 9 (14.1%)
Number 32 23 28 24 26 23 23 23
of
condyles 
(% total)
(15.8%) (11.4%) (13.9%) (11.9%) (12.9%) (11.4%) (11.4%) (11.4%)
Table 5.2: Number of condyles affected by palmar osteochondral disease and distribution of 
lesions
MCMI = third metacarpal; MTIII = third metatarsal
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The grades of POD, linear fissures and dorsal impact injuries were recorded in 499 of 512 
condyles, wear lines and cartilage loss were recorded in 506 of 512 condyles and marginal 
remodelling was recorded in 496 of 512 condyles. The numbers of condyles affected by 
each grade of pathology are summarised in Table 5.3.
Number of Condyles in Each Grade (% total row)
Pathology Grade 0 Grade 1 Grade 2 Grade 3 Total
Palmar
Osteochondral
Disease
297 (59.5%) 118 (23.6%) 70 (14%) 14 (2.8%) 499
Wear Lines 158 (31.2%) 246 (48.6%) 102 (20.2%) - 506
Cartilage Loss 263 (52%) 230 (45.5%) 6 (1.2%) 7 (1.4%) 506
Linear Fissures 248 (49.7%) 189 (37.9%) 62 (12.4%) - 499
Dorsal Impact Injury 357 (71.5%) 102 (20.4%) 40 (8%) - 499
Marginal
Remodelling
471 (95%) 25 (5%) - - 496
Table 5.3: Summary of numbers of condyles affected by each grade of pathology
There was a significant linear relationship (Gamma statistic P-value <0.001) between grade 
of POD and grades of wear lines, cartilage ulceration and dorsal impact injuries i.e. as the 
grade of POD increased, the grades of these pathologies increased. There was a significant 
relationship between grade of POD and grade of linear fissures (Chi-squared P value = 0.008) 
however this was not linear (GS P value =0.2). There was no relationship between grade of 
POD and grade of marginal remodelling (GS P value = 0,6; Chi-squared p value = 0.85). This 
is shown in Tables. 4.
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Metacarpo/metatarsophalangeal Pathology Palmar Osteochondral Disease
0 1 2 3
Wear Lines 0 Number of Condyles 
(column %)
128
(43.2%)
20
(16.9%)
10
(14.3%)
0
(0%)
1 Number of Condyles 114
(38.5%)
84
(71.2%)
40
(57.1%)
7
(50%)
2 Number of Condyles 54
(18.2%)
14
(11.9%)
20
(28.6%)
7
(50%)
Total Number of Condyles 296 118 70 14
Chi-Square P Value
GS P Value Wear Lines vs POD
<0.001
<0.001
Ulceration 0 Number of Condyles 180
(60.8%)
58
(49.2%)
19
(27.1%)
5
(35.7%)
1 Number of Condyles 112
(37.8%)
58
(49.2%)
49
(70.0%)
6
(42.9%)
2 Number of Condyles 2
(0.7%)
2
(1.7%)
1
(1.4%)
0
(0%)
3 Number of Condyles 2
(0.7%)
0
(0%)
1
(1.4%)
3
(21.4%)
Total Number of Condyles 296 118 70 14
Chi-Square P Value
GS P Value Ulceration vs POD
<0.001
<0.001
Linear
Fissures
0 Number of Condyles 139
(46.8%)
49
(43.8%)
43
(62.3%)
11
(84.6%)
1 Number of Condyles 125
(42.1%)
45
(40.2%)
16
(23.2%)
1
(7.7%)
2 Number of Condyles 33
(11.1%)
18
(16.1%)
10
(14.5%)
1
(7.7%)
Total Number of Condyles 297 112 69 13
Chi-Square P Value
GS P Value Linear Fissures vs POD
=0.008
=0.2
Marginal
Remodelling
0 Number of Condyles 280
(94.9%)
105
(95.5%)
62
(95.4%)
14
100.0%
1 Number of Condyles 15
(5.1%)
5
(4.5%)
3
(4.6%)
0
(0%)
Total Number of Condyles 295 110 65 14
Chi-Square P Value
GS P Value Marginal Remodelling vs POD
=0.85
=0.6
Dorsal
impact
Injuries
0 Number of Condyles 239
(80.7%)
66
(58.4%)
43
(63.2%)
5
(35.7%)
1 Number of Condyles 44
(14.9%)
33
(29.2%)
16
(23.5%)
6
(42.9%)
2 Number of Condyles 13
(4.4%)
14
(12.4%)
9
(13.2%)
3
(21.4%)
Total Number of Condyles 296 113 68 14
Chi-Square P Value
GS P Value Dorsal Impact Injury vs POD
<0.001
<0.001
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Table 5.4: Distribution of grades of MC/MTIII condylar pathology with grades of palmar 
osteochondral disease and statistical significance of the relationships between pathologies 
POD = palmar osteochondral disease; GS = Gamma statistic
The column % represents the percentage of each grade of pathology within each grade of 
palmar osteochondral disease
The relationship between grade of POD and grade of linear fissures was further investigated 
using ordinal logistic regression. It was found that condyles with Grade 1 linear fissures were 
significantly more likely to have lower grades of POD than either condyles with Grade 0 or 
Grade 2 linear fissures (P=0.007). This is shown in Table 5.5.
Coefficient (s.e.) Odds ratio (95% 
Cl odds ratio)
P-value
Linear fissures
0
0.5 (0.2) 1.7 (1.2, 2.5) 0.007
2 -0.03 (0.3) 1.0 (0.6,1.6) 0.9
Table 5.5; Ordinal logistic regression model of linear fissures compared to grade of palmar 
osteochondral disease
The odds ratios presented are from ordinal logistic regression with the lowest POD category 
being zero; an 0R<1 indicates increased probability of being in the higher POD categories; an 
0R>1 indicates increased probability of being in the lower POD categories.
* A comparison of grade 1 to 2 linear fissures showed that grade 1 linear fissures were also 
more likely to have lower POD grades than grade 2 linear fissures (OR 1.8 95% Ci 1.0,3.11; P- 
value 0.05)
5.4 Discussion
Palmar osteochondral disease was common in this sample of animals presented for post 
mortem from a population of racing Thoroughbreds. Whilst 67% of all horses had POD 
lesions in at least one condyle, most of the identified lesions were not severe (23.6% of 
affected condyles grade 1, 14% grade 2, 2.8% grade 3). The clinical relevance of these 
different grades of POD has yet to be established. While it is reasonable to suspect that 
lesions may progress in severity, this is as yet unproven, as is whether they can resolve.
An interesting and unexpected finding of the study was the discovery of discrete areas of 
opaque, smooth well integrated cartilage at the site of POD lesions. To our knowledge these
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have not been previously described and since we remain unsure of the aetiology of these 
lesions, these were omitted from analysis. These lesions may be areas of fibrocartilage at 
the site of a previous POD lesion, or could have some form of developmental aetiology.
No significant difference was found between the distribution of POD lesions on fore vs hind 
limbs, left vs right limbs or medial vs lateral condyles. This contradicts the previous clinical 
impressions of Pool (1996) who stated that POD/traumatic osteochondrosis was more 
common in the forelimbs and that involvement of the medial or lateral condyle appeared to 
be random. Furthermore, there was no apparent left/right limb bias in either the fore or 
hind limbs which is surprising given that this population of horses train and race almost 
exclusively in a clock-wise direction. The association of orthopaedic disease and limb 
affected/direction of racing has been investigated previously in studies on limb fracture 
during racing. Our finding of a lack of association between limb affected and direction of 
racing is supported by Parkin et al. (2006) in work relating to catastrophic distal limb 
fractures. However earlier descriptive data has suggested that there may be some 
association between limb injured and racing direction with studies showing a predilection 
for fracture of the left (inside) forelimb in horses which raced predominantly in an anti­
clockwise direction (Rick et al. 1983; Rooney 1983).
As well as showing the high prevalence of POD in this population of racing Thoroughbreds, 
this study also revealed a high prevalence of wear lines and cartilage loss affecting the distal 
condyle of MC/MTIII. However, the more severe forms of cartilage loss (i.e. full thickness 
cartilage damage and exposure of the underlying subchondral bone) were comparatively 
rare.
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The Gamma statistic was utilised to determine linear correlations between condylar
pathology and POD lesion grades. Where significant this indicated that as the grade of POD 
increased, the grade of other pathology also increased in a linear fashion. It was found that 
a significant linear relationship existed between POD grade and grades of cartilage 
ulceration and wear lines, therefore supporting our hypothesis that increasing grades of POD 
are associated with progression of generalised joint disease within the MCP/MTP joint. 
However, we failed to show a relationship between POD and marginal remodelling. Only 
small numbers of condyles (5%) were recorded as being affected with marginal remodelling. 
It is likely that the true prevalence of marginal remodelling of the joint in general was 
underestimated as the margins of the condyle of MC/MTIII are less commonly affected than 
other sites within the joint (e.g. base of the proximal sesamoid bones). Failure to recognise 
marginal remodelling at post mortem may therefore explain the lack of significant 
correlation with POD. A further larger sample is now being examined, which includes scoring 
of marginal remodelling at other relevant sites within the joint.
In this study, the post mortem finding of "dorsal impact injury" encompassed both pathology 
of the dorsal synovial pad and associated damage to the underlying MC/MTIII. Both chronic 
proliferative synovitis and traumatic injury to the dorsodistal MC/MTIII are thought to occur 
in racehorses as a result of repeated overextension and cyclic impaction of the MCP/MTP 
joint (Pool 1996; Richardson 2003). The finding of a linear association between POD and 
dorsal impact injuries provides further evidence that POD occurs in association with cyclical 
repetitive overextension of the MCP/MTP joint as has previously been suggested by Pool 
(1996) and Norrdin et at. (1998).
The relationship between POD and linear fissures was found to be complex. Linear fissures 
are creases in the articular cartilage, affecting to a greater or lesser extent the underlying
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subchondral bone and occur in the palmar/plantar aspect of the grooves on either side of 
the sagittal ridge of MC/MTIII (Riggs et al.1999). In this study there was a decreased severity 
of POD in animals with grade 1 linear fissures in comparison to horses with no evidence of 
linear fissures or grade 2 fissures. The reasons for this are unclear at present but may be 
associated with the biological response of subchondral bone to training. This requires 
further analysis with a larger sample of horses and further investigation of sections from the 
condyles of affected individuals using other laboratory methods such as scanning electron 
microscopy and gene expression techniques.
5.5 Conclusion
In conclusion, we have shown that POD in the racing Thoroughbred is common. The 
condition occurs in equal frequency between front and hind legs, and there is no left/right 
pre-disposition despite horses in this population training and racing predominantly in one 
direction. There is an association between severity of POD and other pathologies associated 
with generalised osteoarthritis. Further study is required to understand the basic 
pathogenesis of this common disorder and identify risk factors for its occurrence.
162
5,6 References
Arthur R.MV Ross M.W., Moloney PJ. and Cheney W.W. (2003) North American 
Thoroughbred In: Diagnosis and Management of Lameness in the Horse, Eds: M.W, Ross and 
SJ. Dyson, W.B. Saunders Co., Philadelphia, pp 868-879
Byron C.R. and Goetz T.E. (2007) Arthroscopic debridement of a palmar third metacarpal 
condyle subchondral bone injury in a Standardbred. Equine vet Educ. 19, 344-347
Ertola K. and Houttu J. (2003) The Finnish Horse and Other Sandinavian Cold-Blooded 
Trotters In: Diagnosis and Management of Lameness in the Horse, Eds: M.W. Ross and SJ. 
Dyson, W.B. Saunders Co., Philadelphia, pp 946-950
Hornof WJ., O'Brien T.R., Pool R.R. et al. (1981) Osteochondritis dissecans of the distal 
metacarpus of the adult racing Thoroughbred horse. Vet Radiol 22, 98-105
Krook L and Maylin G.A. (1988) Fractures in Thoroughbred racehorses. Cornell Vet. 78, 7-133
Lewis R.D. (2003) The Racing Quarter Horse In: Diagnosis and Management of Lameness in 
the Horse, Eds: M.W. Ross and SJ. Dyson, W.B. Saunders Co., Philadelphia, pp 927-930
Mitchell J.B., Mitchell J.S., Nolan P.M. and Ross M.W. (2003) The North American 
Standardbred In: Diagnosis and Management of Lameness in the Horse, Eds: M.W. Ross and 
SJ. Dyson, W.B. Saunders Co., Philadelphia, pp 895-912
Morgan J.W., Santschi E.M., Zekas L.J., Scollay-Ward M.C., Markel M.D., Radtke C.L, Sample 
S.J., Keuler N.S. and Muir P. (2006) Comparison of Radiography and Computed Tomography 
to Evaluate Metacarpo/Metatarsophalangeal Joint Pathology of Paired Thoroughbred Limbs 
of Thoroughbred Racehorses with Severe Condylar Fracture. VetSurg. 35, 611-617
Norrdin R.W., Kawcak C.E., Capwell B.A. and Mcllwraith C.W. (1998) Subchondral bone 
failure in an equine model of overload arthrosis. Bone22,133-9.
Norrdin R.W. and Stover S.M. (2006) Subchondral bone failure in overload arthrosis: a 
scanning electron microscopic study in horses. J Musculoskelet Neuronal Interact. 6, 251-7.
O'Brien T.R., Hornof WJ. and Meagher D.M. (1981) Radiographic detection and 
characterization of palmar lesions in the equine fetlock joint. J. Am. Vet. Med. Ass. 178, 231- 
237
Parkin T.D.H, Clegg P.D., French N.P., Proudman C.J., Riggs C.M., Singer E.R., Webbon P.M. 
and Morgan K.L. (2006) Analysis of horse race videos to identify intra-race risk factors for 
fatal distal limb fracture. Prev. Vet. Med. 74,44-55
Pilsworth R.C. (2003) The European Thoroughbred In: Diagnosis and Management of 
Lameness in the Horse, Eds: M.W. Ross and SJ. Dyson, W.B. Saunders Co., Philadelphia, pp 
879-894
Pilsworth R.C., Hopes R. and Greet T.R.C. (1988) A flexed dorso-palmar projection of the 
equine fetlock in demonstrating lesions of the distal third metacarpus. Vet. Rec. 122, 332- 
333
163
Pool R.R. (1996) Pathologic Manifestations of Joint Disease in the Athletic Horse. In Joint 
Disease in the Horse, Eds: CW Mcllwraith and GW Trotter, W.B Saunders Co, Philadelphia, 
pp87-104
Richardson D.W. (2003) The metacarpophalangeal joint. In: Diagnosis and Management of 
Lameness in the Horse, Eds: M.W. Ross and SJ. Dyson, W.B. Saunders Co., Philadelphia, pp 
348-362
Rick M.C., O'Brien T.R., Pool R.R. and Meagher D. (1983) Condylar fractures of the third 
metacarpal bone and third metatarsal bone in 75 horses: radiographic features, treatments 
and outcome. 7 Am Vet Med Assoc 183, 287-296
Riggs CM. (2006) Osteochondral injury and joint disease in the athletic horse. Equine vet 
Educ. 18,100-112
Riggs C.M., Whitehouse G.H. and Boyde A. (1999) Pathology of the third metacarpal and 
third metatarsal bones of the horse. Equine vetJ. 31,140-148
Rooney J.R. (1983) Impulse and breakdown on straights and turns in racehorses. Journal of 
Equine Veterinary Science 3,137-139
Ross M.W. (1998) Scintigraphic and clinical findings in the Standardbred 
metacarpophalangeal joint: 114 cases (1993-1995). Equine vetJ. 31,140-148
Torre F. (2003) The European and Australasian Standardbreds In: Diagnosis and 
Management of Lameness in the Horse, Eds: M.W. Ross and SJ. Dyson, W.B. Saunders Co., 
Philadelphia, pp 913-927
Zubrod C.J., Schneider R.K., Tucker R.L., Gavin P.R., Ragle C.A. and Farnsworth K.D. (2004) 
Use of magnetic resonance imaging for identifying subchondral bone damage in horses: 11 
cases (1999-2003) J. Am. Vet. Med. Ass. 224, 411-418
164
Histological Appearance and Comparison of the OOCHAS and Mankin Scoring Systems in Grading of
Cartilage Histopathology in Palmar Osteochondral Disease
6.1 Introduction
Palmar osteochondral disease (POD) is a condition affecting the palmar and plantar distal condyles 
of third metacarpal and metatarsal bones of horses and is found predominantly in racing breeds 
(Barr et al. 2009; Riggs 2006). In Chapter 5 (Palmar Osteochondral Disease as a Naturally Occurring 
Manifestation of SCB Driven Osteoarthritis in the Horse) and in the previous literature (Barr et al. 
2009; Hornof et al. 1981; Pool 1996; Riggs 2006) the gross appearance of these lesions at post 
mortem examination have been described.
Given the considerable clinical importance attached to the adaptation of the subchondral bone of 
horses in response to exercise particularly in predilection sites such as the palmar/plantar condyle of 
the distal metacarpus/metatarsus, research interest in this area has increased over the past decade 
(Kawcak et al. 2000; Norrdin et al. 1998; Riggs and Boyde 1999). The calcified cartilage and 
subchondral bone of the distal metacarpal condyle of the horse has been investigated using various 
methods such as scanning electron microscopy (Doube et al. 2007; Norrdin and Stover 2006); 
confocal scanning light microscopy (Doube et al. 2007), micro-computed tomography (Rubio- 
Martinez et al. 2008), histology using basic fuschin staining of bone blocks (Muir et al. 2008), MRI 
(Martinelli et al. 1997; Sherlock et al. 2009)and computed tomography (Young et al. 2007).
The histological appearance of normal and osteoarthritic articular cartilage of the distal metacarpus 
of horses has been previously described (Smith et al. 2006), however this study made no reference 
to the underlying subchondral bone. A previous study (Hornof et al. 1981) has looked at the 
histological appearance of the lesions which we refer to as POD, however these authors described 
the lesions as a manifestation of osteochondritis dissecans. More recently it has become generally
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believed that these lesions in fact arise as a result of trauma and overload of the palmar/plantar 
condyle (Barr et al. 2009; Pool 1996; Riggs 2006). A study describing the histological appearance of 
POD lesions as manifestations of trauma using a quantifiable system for assessing articular cartilage 
and subchondral bone has not been performed to our knowledge.
Various grading systems have been developed and utilised for assessment of osteoarthritis (OA). 
One of the most widely used of these is that developed by Mankin et al. (1971). Mankinds system 
uses a 14 point score based on a composite of cellular changes, histochemical presence of Safranin 0 
matrix staining and architectural changes (e.g. erosion, vessel penetration through the tidemark). 
This system, or an adapted version of this system, has been used widely by most investigators. 
However, as the system was developed on samples with very advanced OA, it has been found that 
the Mankin grading system is not linear for mild or early phase disease (Ostergaard et al. 1999; 
Ostergaard et al. 1997; van der Sluijs et al. 1992). In order to standardise the assessment of OA, an 
Osteoarthritis Research Society International (OARSI) Working Group developed the OARSI 
Osteoarthritis Cartilage Histopathology Assessment System (OOCHAS) (Pritzker et al. 2006). The 
OOCHAS assigns an overall score that combines an OA grade (0-6 points) and OA stage (0-4 points), 
representing a combined assessment of OA severity and extent (0-24 points). The OOCHAS has 
been found to have higher reliability than the Mankin scoring system, although both have excellent 
intra- and inter-observer reproducibility and variability and a good positive correlation between the 
scores (Custers et al. 2007).
In the human, synovia! biopsy is widely regarded to have a small role in the eventual diagnosis of 
difficult undiagnosed monoarticular arthritis, in those cases where synovial fluid analysis and other 
examinations have been non-diagnostic (Bywaters 1985). The value of synovial biopsy in differential 
diagnosis of various rheumatic diseases has been reported to be limited since histopathologic 
findings are often non-specific (Sherman 1951) however other authors (Goldenberg and Cohen
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1978) have reported that although histopathologic changes in the common rheumatic diseases 
(rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and 
osteoarthritis) are not specific, they are of diagnostic utility. Synovial membrane biopsy is not 
routinely used as a diagnostic procedure in the equine and there is therefore a paucity of published 
data on the appearance of this tissue in disease.
The aim of the investigations described in this chapter was to describe the histological appearance of 
cartilage, subchondral bone and synovial membrane collected from a population of Thoroughbreds 
which had been in flat race training, and a number of which were known to be affected by POD 
based on post mortem examination. Two commonly used scoring systems for cartilage pathology 
(Mankin and OOCHAS) were applied to the samples in an attempt to compare reliability of the two 
scoring systems and to ascertain which was most appropriate for use in analysis of cartilage 
pathology in samples of palmar and plantar condyles from horses affected by POD.
It was hypothesised that POD would have a characteristic and well-defined histological appearance 
and that the OOCHAS scoring system would be more reliable in analysis of cartilage pathology in 
samples of condyles affected by POD.
6.2 Materials and Methods
Material was collected at post-mortem examination from a population of Thoroughbred racehorses 
that were in active race training or had been retired from active race training at the Hong Kong 
Jockey Club.
The distal articular surface of MC/MTIII was examined by gross observation at post mortem 
examination performed immediately after death as described in full in Chapter 5. All condyles were 
photographed immediately after disarticulation of the metacarpo-/metatarsophalangeal joint. A
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scoring system was developed and each condyle was assigned a score for POD from 0-3 as outlined 
in Table 6.1. Sections of palmar/plantar condyle were obtained from the left medial distal 
metacarpal condyle and the left lateral metatarsal condyles. Material collection and gross post­
mortem grading were performed by collaborators at the Hong Kong Jockey Club (Dr Christopher 
Riggs, Peter Curl and Suzanne Troester).
Score Description
0 No evidence of POD
1 Discolouration (bruising) of subchondral bone only. No or minimal disruption to the 
overlying cartilage
2 Discolouration (bruising) with mild to moderate disruption of the articular cartilage
3 Established POD lesions. Discolouration and disruption/collapse of the articular 
surface
Table 6.1: Gross Post Mortem Scoring System for Palmar Osteochondral Disease (POD)
After gross examination, the condyle was cut with a band saw, then two sections, each 2mm thick, 
were cut with a saline cooled diamond saw. Sections of synovial membrane were obtained from the 
dorsal aspects of the left metacarpophalangeal and metatarsophalangeal joints. Both osteochondral 
and synovial membrane samples were fixed in formalin for 48 hours then stored in ethanol. 
Osteochondral samples were decalcified in EDTA, paraffin embedded, sectioned at 6pm and stained 
with Haematoxylin & Eosin (H&E), Safranin 0 and Prussian Blue stains. Synovial membrane samples 
were paraffin embedded, sectioned at 6pm and stained with H&E. Histopathology preparation was 
performed by Sean Williams, University of Liverpool.
Sections were examined under an Eclipse 80i (Nikon UK Limited, Kingston upon Thames, UK) light 
microscope at magnifications of x4 and xlO. Images were obtained using a DS-U1 camera (Nikon UK 
Limited, Kingston upon Thames, UK). Articular cartilage histopathology was quantified using the 
Histologic/Histochemical Grading System as described by Mankin et al. (1971) (Figure 6.1) and the 
OOCHAS scoring system (Pritzker et al. 2006) (Figure 6.2). Synovial membrane samples were 
examined to determine degree of inflammation based on the criteria described by Goldenberg and 
Cohen (1978). Cartilage, subchondral bone and synovial membrane histological findings were also
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recorded in a descriptive fashion. Assistance in interpretation of histopathological findings was 
provided by Dr Udo Hetzel, University of Liverpool.
I Structure
A Normal 0
B Surface Irregularities 1
C Pannus and surface irregularities 2
D Clefts to transitional zone 3
E Clefts to radial zone 4
F Clefts to calcified zone 5
G Complete disorganisation 6
II Cells
A Normal 0
B Diffuse hypercellularity 1
C Cloning 2
D Hypocellularity 3
III Safranin 0 staining
A Normal 0
B Slight reduction 1
C Moderate reduction 2
D Severe reduction 3
E No dye noted 4
IV Tidemark integrity
A Intact 0
B Crossed by blood vessels 1
Total score
Minimal 0
Maximal 14
Figure 6.1: Mankin Scoring System (Mankin et al. 1971)
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I --Grade = depth progression into cartilage
Grade (key feature) Subgrade (optional) Associated criteria (tissue 
reaction)
Grade 0: surface intact, 
cartilage intact
No subgrade Intact, uninvolved cartilage
Grade 1: surface intact 1.0 cells intact
1.5 cell death
Matrix: superficial zone intact 
edema and/or fibrillation
Cells: proliferation (clusters), 
hypertrophy
Reaction must be more than 
superficial fibrillation only
Grade 2: surface discontinuity 2.0 Fibrillation through
superficial zone
2.5 Surface abrasion with matrix 
loss within superficial zone
As above
+ Discontinuity at superficial 
zone
+/- Cationic stain matrix 
depletion (Safranin
O or Toluidine Blue) upper 1/3 
of cartilage 
(mid zone)
+/- Disorientation of chondron 
columns
Grade 3: vertical 3.0 Simple fissures As above
fissures 3.5 Branched/complex fissures + Cationic stain depletion 
(Safranin O or
Toluidine Blue) into lower 2/3 
of cartilage 
(deep zone)
+/- New collagen formation 
(polarized light
microscopy, Piero Sirius Red 
stain)
Grade 4: erosion 4.0 Superficial zone
delamination
4.5 Mid zone excavation 
cartilage matrix
Cartilage matrix loss, cyst 
formation within cartilage 
matrix
Grade 5: denudation 5.0 Bone surface intact
5.5 Reparative tissue surface 
present
Surface is sclerotic bone or 
reparative tissue 
including fibrocartilage
Grade 6: deformation 6.0 Joint margin osteophytes
6.5 Joint margin and central 
osteophytes
Bone remodelling. Deformation 
of articular
surface contour (more than
osteophyte
formation only)
Includes: microfracture and 
repair
II - Stage = extent of joint/sample involvement
Stage % Involvement (surface, area, volume)
Stage 0 No OA activity seen
Stage 1 <10%
Stage 2 10-25%
Stage 3 25-50%
Stage 4 >50%
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Ill Score - semi-quantitative method
Grade Stage
SI S2 S3 S4
G1 1 2 3 4
G2 2 4 6 8
G3 3 6 9 12
G4 4 8 12 16
G5 5 10 15 20
G6 6 12 18 24
Figures. 2: OOCHAS System (Pritzker et al. 2006)
As outlined in Figure 6.3, based on a combination of histopathological examination and gross 
examination at post-mortem, Osteochondral samples were given a final binary POD grade (0/1) 
indicating that the sample was either unaffected (0) or affected (1) by POD based on whether there 
was evidence of POD on gross examination on post mortem examination and/or histopathological 
evidence of POD.
Post mortem 
evidence of POD?
Histological 
evidence of 
POD?
*
%
Yes
POD 1 
(Affected)
No
POD 1 
(Affected)
'——> Histological
No evidence of
POD?
^ J
yt Yes POD 1 (Affected)
No
PODO
(Unaffected)
Figure 6.3: Flow diagram showing classification of samples into final grading for affected (1) or 
unaffected (0) for POD based on post mortem and histopathological examination.
The histological appearance of POD is described in full in the results section and in Figures 6.9-6.16, 
but briefly osteochondral samples were classified as having histological evidence of POD where 
there was fragmentation of the subchondral bone evident in the H&E stained section +/- evidence of 
increased Safranin 0 staining in the subchondral bone indicating cartilaginous elements (most likely 
fibrocartilage) within the subchondral bone plate. Loss of Safranin 0 staining from the hyaline
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articular cartilage was seen in sections affected by POD, but as this demonstrated loss of 
proteoglycans from the articular cartilage, this was a non-specific indicator of osteoarthritis and not 
a histological indicator of POD per se.
6.3 Results
Twenty four condyles and twenty four synovial membrane samples were collected from 12 horses. 
All horses were Thoroughbred racehorses that had been in flat race training.
Articular cartilage pathology was quantified using the Mankin and OOCHAS scoring systems. Using 
the Mankin scoring system, mean score was 4.2 (range 0-12). Using the OOCHAS scoring system, 
mean score was 7.7 (range 0-24). Spread of data for the Mankin and OOCHAS scoring systems 
respectively is as shown in Figures 6.4 and 6.5. Using the Mankin scoring system, data was clustered 
towards the lower and upper ends of the scaling system, with relatively fewer samples having scores 
in the middle ranges of the system. Using the OOCHAS, the spread of data was slightly more even, 
although there was still some clustering at the lower and upper limits of the scoring sytem. Two 
samples had Grade 1 pathology using the Mankin scoring system, but Grade 0 on the OOCHAS 
scoring system as a result of slight reduction in Safranin 0 staining and superficial fibrillation of the 
cartilage surface which were sufficient to achieve 1 point on the Mankin scoring system, but not 
sufficient to attain Grade 1 using the OOCHAS scoring system.
172
65
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Mankin Score
Figure 6.4: Spread of Data for Mankin Scoring System
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Figure 6.5: Spread of Data for OOCHAS Scoring System
Data for donor, limb, gross POD score, Mankin score, OOCHAS score and POD histology grade are as 
shown in Table 6.2.
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Donor Limb Gross POD Grade 
(0-3)
Mankin Grade 
(0-14)
OOCHAS Grade 
(0-24)
Final POD Grade 
(0-1)
1 LF 0 2 3 0
2 LF 3 12 24 1
3 LF 0 3 3 0
4 LF 0 3 8 0
5 LF 0 1 0 0
6 LF 1 0 0 1
7 LF 0 1 0 0
8 LF 0 3 4 0
9 LF 0 2 3 0
10 LF 3 11 24 1
11 LF 0 2 3 0
12 LF 2 12 18 1
1 LH 0 0 0 0
2 LH 0 5 6 0
3 LH 0 6 18 1
4 LH 0 12 18 1
5 LH 0 2 4 0
6 LH 3 6 12 1
7 LH 0 0 0 0
8 LH 0 0 0 0
9 LH 2 3 4 1
10 LH 3 11 24 1
11 LH 0 3 8 0
12 LH 0 0 0 0
Table 6.2: Donor, Limb, Gross POD Grade, Mankin Grade, OOCHAS Grade and Final POD Grade for 
each sample
Correlation analysis using Pearson correlation revealed a significant correlation between the grade 
of POD pathology given to the sample on gross examination at post-mortem and both the Mankin 
scoring system (P<0.0017 r=0.7) and the OOCHAS scoring system (PcO.OOl, r=0.7) (Figures 6.6 and 
6.7).
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Figure 6.6: Scatterplot showing significant correlation between gross score for palmar osteochondral 
disease at post mortem examination and Mankin score on histopathological examination (P<0.001, 
r=0.7)
Gross PM POO grade
Figure 6.7: Scatterplot showing significant correlation between gross score for palmar osteochondral 
disease at post mortem examination and OOCHAS score on histopathological examination (P<0.001, 
r=0.7)
Correlation analysis using Pearson correlation between the Mankin scoring system and OOCHAS 
revealed a significant correlation between the two scoring systems (P<0.001, r=0.95) (Figure 6.8).
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OOCHAS Score
Figure 6.8: Scatterplot showing significant correlation between Mankin Score and OOCHAS on 
histological examination (P<0.001, r=0.95)
Palmar osteochondral disease was evident histologically predominantly based on the appearance of 
the subchondral bone. In the severely affected sections (POD grades 2 and 3 at gross post mortem 
examination) there was obvious fragmentation of the subchondral bone (Figures 6.9 and 6.10). 
Dependent on the severity of the POD lesion, the overlying articular cartilage was either intact 
(Figure 6.9) or had completely lost its architecture and had collapsed (Figure 6.10). There was loss of 
Safranin 0 staining in the superficial layer of articular cartilage in all sections with evidence of 
subchondral bone fragmentation, indicating proteoglycan loss from the articular cartilage matrix. 
This was more severe in sections with collapse of the articular surface (Figures 6.9 and 6.10).
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Figure 6.9: Example of a section of condyle with evidence of POD but intact articular cartilage. In the 
H&E section at x4 magnification (A) there is fragmentation of the subchondral bone plate with 
fibrocartilage tissue formation between the osseous fragments. In the Safranin O stained section at 
x4 magnification (B) there is a mild reduction in Safranin O staining in the superficial layer of 
cartilage and deep red Safranin O staining within the subchondral bone plate indicating cartilaginous 
elements within the subchondral bone plate.
Figure 6.10: Example of a section of condyle with evidence of POD and complete collapse of the 
overlying articular cartilage. On the H&E section at x4 magnification (A) there is severe subchondral 
bone fragmentation and complete loss of architecture of the overlying articular cartilage. A normal 
tidemark is no longer identifiable. On the Safranin O section at x4 magnification (B) there is a 
marked reduction in staining in the superficial articular cartilage and deep red Safranin O staining in 
areas of the fragmented subchondral bone plate.
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At higher magnification (xlO) H&E sections it was possible to visualise areas of tidemark (transition 
zone between mineralised and non-mineralised cartilage) abnormalities. In some areas tidemark 
integrity had been lost and clefts ran across from the subchondral bone to the calcified articular 
cartilage and the deeper layers of the hyaline articular cartilage. There was evidence of debris 
within the marrow spaces. Duplication of the tidemark was also a common finding in sections 
affected by POD (Figure 6.11).
Figure 6.11: An example of an H&E section at xlO magnification showing loss of tidemark integrity 
with clefts running from the subchondral bone into the calcified cartilage and deep layers of articular 
cartilage. There is debris within the marrow spaces. Duplication of the tidemark is also evident on 
this section.
Also at higher magnification, it was possible to appreciate that there was an amorphous cellular 
infiltrate with an extracellular matrix between the osseous fragments. This tissue stained positively 
with Safranin O indicating cartilaginous elements within this tissue. This tissue was likely therefore 
to be consistent with granulation tissue and fibrocartilage formation, potentially as part of a fracture 
callus and an attempt at healing of the fractured subchondral bone plate (Figure 6.12).
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Figure 6.12: An H&E section at xlO magnification showing evidence of a cellular infiltrate with an 
amorphous extracellular matrix between the fragments of subchondral bone plate and debris within 
the marrow spaces. This may be consistent with granulation tissue and fibrocartilage formation i.e. 
callus formation and potentially an attempt at fracture healing. Duplication of the tidemark is also 
shown on this section.
At higher magnification again (x40) it was possible to identify osteoclasts actively removing 
devitalised bone (Figure 13). It is suggested that the bone is necrotic in these areas due to the 
presence of empty osteocytic lacunae and because the bone matrix is more pale staining than in a 
normal section of subchondral bone (Figure 6.13).
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Figure 6.13: An H&E section at x40 magnification showing evidence of an osteoclast (black arrow) 
actively removing devitalised bone. Numerous empty lacunae are evident within the piece of bone 
(blue arrows) and the bone matrix is pale staining compared to normal.
Although the samples graded as 2 or 3 at post mortem examination all showed histological evidence 
of POD as described above, the one sample which was graded grossly as grade 1 did not show these 
changes in the subchondral bone (Figure 6. 14). On H&E staining of the grade 1 section, there was 
no evidence of fragmentation of the subchondral bone and no loss of Safranin 0 staining in the 
hyaline articular cartilage, indicating no evidence of loss of proteoglycans from the cartilage matrix. 
The grade 1 section showed evidence of positive Prussian blue staining, indicating haemosiderin in 
the section and therefore the presence of old haemorrhage in the tissue. None of the other sections 
examined showed evidence of positive Prussian blue staining.
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BFigure 6.14: Gross post mortem picture of a distal MCI 11 condyle with Grade 1 POD on the medial 
condyle (arrow) (A) and corresponding H&E (B), Safranin 0(C) and Prussian Blue sections (D). All 
sections at x4 magnification. Although bruising of the subchondral bone is evident on gross 
examination, there is no fragmentation of the subchondral bone or loss of proteoglycan staining. 
There is evidence of previous haemorrhage in the subchondral bone shown by positive Prussian Blue 
staining.
Of the 17 condyles graded as 0 for POD on gross examination, only 15 of these samples showed no 
evidence of POD on histology. Re-examination of the original gross pathology scoring sheets and of 
the photographs taken at post-mortem examination revealed that these condyles although not 
showing classical POD lesions, were also not grossly normal. These condyles had a discrete area of 
opaque, smooth, well-integrated cartilage at the site of POD lesions of unknown aetiology as
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described previously (Barr et al. 2009). On histological examination of the H&E sections, there was 
evidence of complete loss of the tidemark, increased vascular channels within the subchondral bone 
and fibrocartilage formation within the subchondral bone as described above (Figure 6.15). The 
overlying articular cartilage appeared to be well-integrated with the fibrocartilage in the 
subchondral bone defect, but was not normal hyaline cartilage, having a disorganised cartilage 
architecture and evidence of a loss of Safranin O staining (Figure 6.15). It was considered that these 
histological findings may be consistent with a previous POD lesion that had undergone healing by 
fibrocartilage formation. Therefore these sections were classified as being affected for POD in the 
final binary POD grading system.
Figure 6.15: Example of a section of condyle classified as having a discrete area of opaque, smooth 
well-integrated cartilage at the site of POD lesions of unknown aetiology on gross post mortem 
examination on H&E section (A) and Safranin O staining (B) (both at x4 magnification). There is 
evidence of complete loss of the tidemark, increased vascular channels and fibrocartilage formation 
within the subchondral bone plate on the H&E section and a marked reduction in Safranin O staining 
indicating proteoglycan loss in the overlying articular cartilage. There is Safranin O staining of the 
tissue fibrocartilaginous tissue within the subchondral bone defect. These histological changes may 
be indicative of a previous POD lesion that has attempted healing by fibrocartilage formation within 
the fractured subchondral bone.
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Mild cartilage pathology characterised by fibrillation of the superficial zone of articular cartilage with 
depletion of Safranin O staining was common on the palmar and plantar distal MC/MT III condyles in 
this sample of Thoroughbreds in training (Figure 6.16). Of all samples (n=24), including the samples 
classified as being unaffected for POD on final grading (n=15), only 4 had a Mankin and OOCHAS 
Grade 0 score.
Figure 6.16: Example of a section of condyle without evidence of POD, but with fibrillation of the 
superficial zone of cartilage on H&E staining (A) and slight reduction of Safranin O staining (B). Both 
at x4 magnification.
The samples graded as 0 on the final POD score had a mean Mankin score of 1.8 (range 0-5) and a 
mean OOCHAS score of 2.8 (range 0-8). Samples classified as being affected for POD on final grading 
(n=9) had a mean Mankin score of 8.1 (range 0-12) and a mean OOCHAS score of 15.8 (range 0-24).
Twenty two/24 synovial membrane samples showed evidence of mild villous hyperplasia and mild 
perivascular lymphocytic synovitis, which were considered to be within normal limits for this 
population of horses (Figures 6.17 and 6.18). One synovial membrane section showed evidence of 
moderate villous hyperplasia (Figure 6.17) and one had evidence of a moderate-marked perivascular 
lymphocytic synovitis (Figure 6.18). No significant correlations between synovial membrane
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histopathology and palmar osteochondral disease could be identified due to the small number of
abnormal samples.
Figure 6.17: Examples of synovial membrane on H&E staining at x4 magnification showing (A) mild 
villous hyperplasia of the synovial membrane (B) moderate villous hyperplasia of the synovial 
membrane
Figure 6.18: Examples of synovial membrane on H&E staining at x40 magnification showing (A) mild 
perivascular lymphocytic synovitis and (B) moderate perivascular lymphocytic synovitis
6.4 Discussion
It has been shown that osteochondral samples affected by more severe grades of POD on gross post 
mortem examination have a readily identifiable histopathological appearance with fracture and 
fragmentation of the subchondral bone plate. Our histological findings were very similar to those 
described by Hornof et al. (1981) with the added interesting finding of two samples in which the 
subchondral defect had appeared to heal with fibrocartilage, which in turn had attempted 
integration with the hyaline articular cartilage. This would suggest that these lesions are in fact able
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to heal to some extent, albeit with a tissue which may be inferior to the original subchondral bone 
and hyaline articular cartilage. The appearance of the fractured subchondral bone plate with callus 
formation (granulation tissue and fibrocartilage) would also support a traumatic aetiology for POD as 
has been previously proposed by Pool (1996).
Histopathology of the palmar metacarpal condyle of the equine has been described in a recent 
paper by Drum et al. (2007). Drum et al. developed a grading system for severity of lesions on a 
scale of 0-4. Based on their description of the grading system, it would seem that their histology 
findings were similar to ours, with evidence of duplication of the tidemark and reparative 
fibrocartilage in the superficial cartilage layers. Drum et al. described pale staining of the 
subchondral bone matrix and fibrin within the subchondral bone layer, whereas I described similar 
findings as fibrocartilage formation within the subchondral bone. Differences may be due to 
personal preference in description of histopathological lesions and because in the paper by Drum et 
al. (2007) no severely affected samples were observed. I did observe sections of more severely 
affected palmar condyles and therefore was able to provide a more detailed description of these 
lesions.
The histopathological appearance of the lesions as shown in Figure 6.11 and described as loss of 
tidemark integrity with clefts running across the subchondral bone into the calcified cartilage and 
deep layers of articular cartilage, have also been described in the human osteoarthritis literature 
under a number of synonymous names including vascular invasion (Harrison et al. 1953), vascular 
channels (Clark 1990), microcracks (Mori et al. 1993; Sokoloff 1993) and subchondral bone 
resorption pits (Chambers et al. 1984). Subchondral bone resorption pits have previously been 
implicated in cartilage nutrition and cross-talk between subchondral bone and cartilage (Lajeunesse 
and Reboul 2003) and recently have been shown to express MMPs and degrade proteoglycan from 
the articular cartilage around the tip of the invasion (Shibakawa etal. 2005). The histological finding
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of subchondral bone pits in sections of palmar condyle affected by POD when considered with the 
findings of these previous studies, provides more support for the role of subchondral bone damage 
resulting in cartilage matrix proteolysis in horses affected by POD,
It was suggested that some areas of osteonecrosis were evident within subchondral bone affected 
by POD as identified by empty osteocytic lacunae. Empty lacunae have been used as an indicator of 
osteonecrosis by previous investigators (Humphreys et ol. 1989) however, some caution must be 
exercised in interpreting empty osteocytic lacunae as always being representative of osteonecrosis. 
This criterion of bone death has previously been criticised on the basis that artefactual loss of cells 
may occur during tissue processing and that nuclei may remain within lacunae long after cell death 
has occurred (Kenzora et al. 1978). However, in this case it is thought reasonable to suggest that 
osteonecrosis is histologically evident in these samples given that there is also evidence of 
osteoclasts resorbing the devitalised bone and because samples were handled identically and 
extensive loss of osteocytes from their lacunae was not seen in subchondral bone not affected by 
POD.
Unfortunately only one sample categorised grossly as Grade 1 was available for histopathological 
analysis in this study. It was interesting that in this case the subchondral bone bruising evident on 
gross examination was shown histologically as positive staining for Prussian Blue, indicating 
haemosiderin and therefore previous haemorrhage within the tissue. However, due to the fact that 
only one sample of this post mortem grade was available, no real conclusions can be drawn from 
this. Histopathological examination of more Grade 1 samples will be required to assess the 
importance of this finding, and this is ongoing as part of a larger study.
The finding of some degree of cartilage pathology on the palmar/plantar condyle of the distal 
metacarpus/-tarsus evident in the samples unaffected by POD is consistent with the findings of
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Smith et al. (2006) who reported that degenerative changes on histology were most marked in the 
palmar region of condyles affected by osteoarthritis and that mild degeneration was evident in the 
palmar regions of control (non OA) condyles.
Cartilage pathology was quantified using both the Mankin and OOCHAS scoring systems. For grading 
POD, the main advantage of the OOCHAS over the Mankin system is that it allows for pathology 
within the subchondral bone plate, including a grading classification for microfracture and 
fibrocartilaginous repair. As well as providing a grade of osteoarthritis cartilage histopathoiogy, the 
OOCHAS also allows for staging of the disease, quantified as the horizontal extent of cartilage 
involvement. Unfortunately, within the confines of this study, the samples available and the focal 
nature of POD, this staging was performed on the section of palmar/plantar of one condyle only, and 
not across the joint surface as described in the development of the system (Pritzker et al. 2006). 
Within this study however, this did not alter the results as the anatomical position and size of the 
section of condyle examined was the same in every case. Regardless of which scoring system for 
cartilage histopathoiogy was utilised, it was found that both gave identical and significant 
correlations between histology score and grade of POD on gross examination of the sample at post 
mortem examination. This would suggest that both scoring systems are appropriate for use in 
quantative analysis of sections of equine palmar/plantar metacarpal/metatarsal condyles. This may 
not be surprising as the majority of the samples with POD examined here were severely affected. 
The Mankin grading system has been found to be useful for samples with advanced OA, but more 
limited when utilised on more mildly affected samples (Ostergaard et al. 1999; Ostergaard et al. 
1997; van der Sluijs et al. 1992). As discussed above, the study is ongoing and larger numbers of 
early/mildly affected (Grade 1 on post mortem examination) samples are required and thus future 
comparison of the grading systems on these more mildly affected samples will potentially be 
enlightening.
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Histology of the synovial membrane was largely unremarkable in this group of horses and due to the 
small number of samples which were found to have histological changes in the synovial membrane, 
no significant correlations could be found between synovial membrane pathology and the presence 
or severity of POD. This may be because of the small numbers of samples involved in this initial 
study, or because the synovial membrane sample was collected from the dorsal aspect of the joint 
i.e. distant to the palmar/plantar aspect of the joint which is the site of POD lesions. If this is not 
merely an effect of insufficient sample numbers, it would appear that diffuse synovitis of the 
metacarpo-/metatarsophalangeal joint is not a feature of POD. A larger study is ongoing and should 
further clarify this finding.
6.5 Conclusion
In conclusion, the histological appearance of osteochondral sections from the palmar and plantar 
distal metacarpal and metatarsal condyles affected by POD has been described. Both the Mankin 
and OOCHAS scoring systems were found to be useful in scoring of pathology of the sections 
examined here. There is some evidence that the lesions are capable of healing by fibrocatilaginous 
tissue formation. Synovitis did not appear to be a feature of POD. A larger ongoing study should 
clarify these findings and also further characterise the less severe, and presumably earlier, POD 
lesions characterised by bruising of the subchondral bone plate without fragmentation and fracture 
formation.
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Association Between Markers of Osteoarthritis in Subchondral Bone, Cartilage and Synovial
Membrane in Horses with Palmar Osteochondral Disease
7.1 Introduction
As described in Chapter 5 (Palmar Osteochondral Disease as a Naturally Occurring Manifestation of 
Subchondral Bone Driven Osteoarthritis in the Horse), palmar osteochondral disease (POD) is a 
condition affecting the palmar and plantar distal condyles of the third metacarpal and metatarsal 
bones of horses affecting predominantly racing breeds (Barr et al. 2009; Riggs 2006). The condition 
is characterised by small, ovoid defects of approximately 2-4mm diameter centred 5-8mm proximal 
to the transverse ridge and 3-15mm from the sagittal ridge on either the medial or lateral condylar 
surfaces (Pool 1996). Early in the course of the disease, only the subchondral bone is affected, with 
bluish discolouration visible through intact cartilage. More severe changes involve varying degrees 
of physical disruption of the subchondral bone with associated pathology of the overlying cartilage. 
Ultimately there may be complete collapse of the subchondral bone.
Proteolytic damage to the collagen fibrillar network of the cartilage extracellular matrix is a key and 
perhaps irreversible stage in the pathogenesis of osteoarthritis (Eyre 2004). Metalloproteinases are 
considered to play a principal role in the cleavage of matrix macromoiecules, including type II 
collagen and the cartilage proteoglycan aggrecan. The collagenases (MMPs 1, 8, 13 and 14) are 
capable of cleaving type II collagen, resulting in denaturation of the a chains, thus rendering them 
susceptible to secondary cleavage by collagenases and other MMPs such as MMP3 (a stromelysin) 
and MMPs 2 and 9 (gelatinases) (Poole et al. 2007). Aggrecan is cleaved by various MMPs and by 
the aggrecanases ADAMTS4 and ADAMTS5.
The aim of the investigations described in this chapter was to further investigate the role of 
subchondral bone (SCB) in osteoarthritis (OA), this time in an ex vivo model using samples obtained 
from condyles affected and unaffected with POD. Quantitative expression of various genes involved
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in matrix synthesis and degradation were determined in an attempt to further our understanding as 
to the underlying pathologies involved in osteochondral disease. Palmar osteochondral disease 
provides a unique opportunity to investigate this process as SCB injury appears to be the initiating 
factor of the pathology, occurring before cartilage degradation. Furthermore, POD is a commonly 
diagnosed condition in racing breeds occurring in a repeatable and well defined site which facilitates 
sample collection and allows for excellent characterisation of the samples.
It was hypothesised that 1) there would be increases in gene expression of matrix proteinases in 
SCB, hyaline articular cartilage (HAC) and synovia! membrane affected by POD; 2) there would be 
alterations in expression of genes involved in matrix synthesis in SCB and HAC and 3) there would be 
correlations between expression of genes in the various articular tissues (SCB, HAC and synovial 
membrane).
7.2 Materials and Methods
7.2.1 Tissue Collection
Material was collected at post-mortem examination from a population of Thoroughbred racehorses 
that were in active race training or had been retired from active race training. Sample collection was 
in collaboration with Dr Chris Riggs, Suzanne Troester and Peter Curl of the Hong Kong Jockey Club 
as previously described. Condyles were scored grossly for grade of POD as described in full in 
Chapter 5 and as outlined in Table 7.1. Racing and veterinary treatment records for each horse were 
available from an existing database.
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Score Description
0 No evidence of POD
1 Discolouration (bruising) of subchondral bone only. No or minimal disruption to the 
overlying cartilage
2 Discolouration (bruising) with mild to moderate disruption of the articular cartilage
3 Established POD lesions. Discolouration and disruption/collapse of the articular 
surface
Table 7.1: Gross Post Mortem Scoring System for Palmar Osteochondral Disease (POD)
Sections of palmar/plantar condyle were obtained from the left medial distal metacarpal condyle 
and the left lateral metatarsal condyles as shown in Figure 7.1. The condyle was cut with a band 
saw, then two sections, each 2mm thick, were cut with a saline cooled diamond saw. Sections of 
synovial membrane were obtained from the dorsal aspects of the left metacarpophalangeal and 
metatarsophalangeal joints. Samples were stored in RNA later (Ambion, Applied Biosystems, 
Warrington, UK) at 4°C for 24 hours, and then stored at -80°C until further analysis.
Figure 7.1: Example of a 2mm thick section of palmar condyle as obtained at sample collection 
7.2.2. RNA Extraction and Reverse Transcription
Unless stated otherwise, all reagents were supplied by Sigma-Aldrich (Dorset, UK). Cartilage and SCB 
were dissected from the condyle sections. Cartilage was dissected sharply with a scalpel and a 
section of subchondral bone from the centre of the sample at the anatomical site of POD measuring 
approximately 15mm x 15mm was dissected using a chisel. Cartilage, SCB and synovial membrane 
were subsequently frozen in liquid nitrogen, dismembranated using a Mikro-Dismembrator U (Braun 
Biotech, Melsungen, Germany) and stored in Tri-Reagent (Ambion, Applied Biosystems, Warrington,
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UK). RNA extraction was performed using a standard chloroform and ethanol extraction followed by 
the RNeasy (Qiagen, Crawley, UK) column technique, incorporating a DNase treatment stage. RNA 
was quantified using a Nanodrop (Thermo Scientific, Wilmington, USA) and Ijig of RNA or the 
maximum volume for the reaction (12.4^1) where RNA concentration was < 80.6ng/pl, was used as 
the template for the reverse transcriptase reaction. cDNA strands were generated from the RNA in a 
25jjl volume reaction using Random Primer (Promega, Southampton, UK), RT buffer, lOmM of 
dNTPs, M-MLV RT enzyme and RNase inhibitor.
7.2.3 Quantitative Real-Time Polymerase Chain Reaction
Equine specific primers were prepared as described in Chapter 2. Briefly, RNA and DNA sequences 
were obtained from the NCBI database, or where published equine sequence was unavailable, a 
multiple species alignment was performed. Primers were designed to be exon spanning where 
possible. Primers were designed using Primer Express software (Applied Biosystems) or Primer 3 
software (Rozen and Skaletsky 2000). Primer efficiencies were validated using a standard curve 
derived from equine cDNA using a 10 fold dilution series. A dissociation curve was included in 
validation to ensure primers were specific and amplified only one product. Primer efficiency is 
optimal at a slope of -3.32. The primers used for the target and housekeeping genes and their 
efficiencies are as shown in Table 7.2.
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Gene Primer Sequence Accession Code Efficiency
GAPDH F: GCATCGTGGAGGGACTCA
R: GCCACATCTTCCCAGAGG
AF157626 -3.32
ADAMTS- 4 F: CAGCCTGGCTCCTTCAAAAA
R: CCGCAGGAAT AGT G ACC AC AT
NM_001111299 -3.23
ADAMTS- 5 F: ACCGATCCTGCAGTGTCACA
R: CTGCTCATGGCGAAAAGATTT
EU025851 -3.13
MMP-1 F: G GTG AAG G A AG GT C A AGTT CT GAT
R: AGTCTT CT ACTTT G G A A AAG AG CTT CT CT
NM„001081847 -3.36
MMP-3 F: TCTTGCCGGTCAGCTTCATATAT
R: CCTATGGAAGGTGACTCCATGTG
NM_001082495 -3.63
MMP-13 F: CTGGAGCTGGGCACCTACTG
R: ATTT G CCTG AGT C ATT AT G AAC A AG AT
NIVMX)1081804 -3.51
TIMP-3 F: CTGCAACTTCGTGGAGAGGT
R: ACTCGTTCTTGGAGGTCACG
NM_001081870 -3.54
Interleukin IfJ F: TGAAGGGCAGCTTCCAAGAC
R: GGGAGAATTGAAGCTGGATGC
D42165 -3.34
Collagen 1 a2 F: GCACATGCCGTGACTTGAGA
R: CAT CC AT AGT G CAT CCTT GATT AGG
XM_001492939.1 -3.31
Collagen II al F: T C AAGTCCCT C AACA ACC AG AT C
R:GTCAATCCAGTAGTCTCCGCTCTT
NM_001081764 -3.21
Collagen X al F: CAACATCAAGACCCGGTTCTTC
R: CACCTT GTTCTCCT CT CACT GAT ACA
XM_001504101 -3.22
Biglycan F: TCACCTTCCAGCCCCTAGAGT
R: AGAAGCAGCCCCTCCTCAA
NM_001081839 -3.71
Aggrecan F: GAGGAGCAGGAGTTTGTCAACA
R:CCCTTCGATGGTCCTGTCAT
XM_001499504 -3.81
Table 7.2: Primer sequences used for quantitative real-time PCR
F= Forward primer, R= Reverse primer
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed in a 25pL volume using 
SYBR Green PCR master mix (Applied Biosystems) and BOOnM primer concentration and processed 
by 7300 Real Time PCR system (Applied Biosystems). Conditions for amplification were 2 minutes at 
SOX 10 minutes at 95°C; followed by 40 cycles of 15 seconds at 95°C, and 60 seconds at 60°C for 
primer annealing and elongation. This was followed by a dissociation stage for 15 seconds at 95°C, 
30 seconds at 60°C and 15 seconds at 95°C to ensure the presence of a single amplicon. Data was 
analysed using SDS software (Applied Biosystems). PCR products were measured and normalised 
against GAPDFI as a housekeeping gene. Gene expression of MMP1, MMP3, MMP13, ADAMTS4, 
ADAMTS5, TIMP3 and IL1B were quantified in cartilage, SCB and synovial membrane. In addition, 
gene expression of COL1A2, COL2A1, COL10A1, biglycan (BGN) and aggrecan (ACAN) were also 
measured in cartilage and SCB.
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Primer validation, RNA extraction, reverse transcription and qRT-PCR of the initial 24 samples were 
performed by the first author. Subsequent RNA extraction, reverse transcription and qRT-PCR of 
further samples were performed in collaboration with Colette Redmond and Dr Benjamin 
McDermott, both of the University of Liverpool.
7.2.4 Statistical Analysis
Samples were grouped into grade of POD (0-3) based on grading at post mortem examination. After 
plotting for normality and logging data where required using Minitab v.15 (Minitab Inc., 
Pennsylvania, USA), mixed effects linear regression using SPIus v.6.1 (TIBCO Software Inc., California, 
USA) was used to test for significant differences between groups while allowing for the clustering of 
samples within horse. To allow for testing of multiple genes on the same sample, the P-value was 
adjusted using Sidak's formula (Sidak 1967):
C£rt~ 1 — (I-ccpf)1^0
where a is the probability of making a Type I error, apT is the a per test, aPF is the a per family of 
tests and c is the number of comparisons, in this case genes tested. Therefore if we assume that the 
required aPF is 0.05, then:
(Xpt= 1 - (l-0.05)1/c
Correlation analysis using Spearman's rank correlation co-efficient was performed to identify 
relationships between expression of each gene in the SCB, cartilage and synovial membrane using 
PASW Statistics 17 (Chicago, Illinois, USA). Statistical significance for correlation analysis was set at 
P<0.05.
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Gene expression data are presented as a box and whisker chart, with tops and bottoms of boxes
demonstrating third and first quartiles respectively. The line within the box indicates the median 
value. Whiskers extend to the highest and lowest data values. Correlation of gene expression data 
between tissues is presented as scatter plots using a log scale.
7.3 Results
7.3.1 Sample Characterisation
Seventy condyles and 70 synovial membrane samples were collected from 35 horses. All horses 
were Thoroughbreds which had been in flat race training. Thirty four condyles (48.6%) had Grade 0 
POD, 18 condyles (25.7%) had Grade 1 POD, 11 condyles (15.7%) had Grade 2 POD and 7 condyles 
(10%) had Grade 3 POD.
7.3.2 Alterations in Gene Expression in Palmar Osteochondral Disease
Seven genes were measured in synovial membrane and 12 genes were measured in cartilage and 
subchondral bone, giving a Sidak corrected significance level of P < 0.007 for synovial membrane 
samples and P < 0.004 for cartilage and subchondral bone samples.
Cartilage
In cartilage, as compared to samples unaffected by POD (Grade 0), there was a significant increase in 
expression of: MMP13 in POD Grade 3 samples (P=0.0001) (Figure 7.2) and COL1A2 in both POD 
Grade 2 (P=0.0001) and POD Grade 3 (P=0.0001) samples (Figure 7.3). There was a trend towards an 
increase in MMP13 expression in POD Grade 2 samples (P=0.007) but this just failed to reach 
statistical significance.
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Compared to POD Grade 0 samples, there was a significant decrease in expression of AC AN in POD 
Grade 1 (P=0.002), POD Grade 2 (P=0.002) and POD Grade 3 (P=0.0004) samples (Figure 7.4). There 
was a trend towards a decrease in TIMP3 expression in Grade 1 POD samples (P=0.005).
Significance of differences in gene expression in cartilage of Grades 1, 2 and 3 POD for each gene 
examined as compared to Grade 0 POD are shown in full in Table 7.3.
POD grade
Figure 7.2: Box and whisker plot of MMP13 expression in articular cartilage affected by each grade of 
POD. Asterisks show outlying results. Expression of MMP13 was significantly increased in cartilage 
from Grade 3 POD samples (P=0.0001) and there was a trend towards an increase in MMP13 
expression in Grade 2 POD samples (P=0.007).
POD grade
Figure 7.3: Box and whisker plot of CO LI A2 expression in articular cartilage affected by each grade of 
POD. Asterisks mark outlying results. Expression of COL1A2 was significantly increased in cartilage 
from Grade 2 POD samples (P=0.0001) and Grade 3 POD samples (P=0.0001).
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POO grade
Figure 7.4: Box and whisker plot of ACAN expression in articular cartilage affected by each grade of 
POD. Asterisks show outlying results. Expression of ACAN was significantly decreased in cartilage 
from Grade 1 POD samples (P=0.002). Grade 2 POD samples (P=0.002) and Grade 3 POD samples 
(P=0.0004).
Cartilage
Gene POD Grade 1 POD Grade 2 POD Grade 3
ADAMTS4 0.06 0.2 0.3
ADAMTS5 0.1 0.8 0.3
MMP1 0.5 0.01 0.6
MMP3 0.1 1 0.1
MMP13 0.8 0.007 0.00011
TIMP3 0.005 0.6 0.4
IL1(3 0.9 0.6 0.08
COL1A2 0.2 0.00011" O.OOOlt
COL2A1 0.6 1 0.5
COL10A1 1 0.2 0.1
ACAN 0.002 vt' 0.002 vj. 0.0004 vj.
BGN 0.09 0.02 0.2
Table 7.3: Significance of differences in gene expression in cartilage of Grades 1, 2 and 3 POD for 
each gene examined as compared to Grade 0 POD cartilage, as calculated using mixed effects linear 
regression, significance level P<0.004. Arrows show whether gene expression was up- or down- 
regulated.
Subchondral Bone
In subchondral bone, as compared to samples unaffected by POD (Grade 0), there was a significant 
increase in expression of COL2A1 in POD Grade 3 samples (P=0.0001) (Figure 7.5). There was a trend 
towards an increase in expression of COL2A1 in POD Grade 1 and POD Grade 2 samples (P=0.006 and
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P=0.005 respectively), but these just failed to reach statistical significance. Likewise, there was a 
trend towards an increase in COL1A2 expression in POD Grade 1 and POD Grade 3 samples (P=0.006 
and P=0.009 respectively).
As compared to Grade 0 POD samples, there was a significant decrease in expression of BGN in POD 
Grade 1 (P=0.004) and POD Grade 2 (P=0.002) samples (Figure 7.6).
Significance of differences in gene expression in cartilage of Grades 1, 2 and 3 POD for each gene 
examined as compared to Grade 0 POD are shown in full in Table 7.4.
POD grade
Figure 7.5: Box and whisker plot of COL2A1 expression in subchondral bone affected by each grade of 
POD. Asterisks show outlying results. Expression of COL2A1 was significantly increased in 
subchondral bone from Grade 3 POD samples (P=0.0001). There was a trend towards an increase in 
COL2A1 expression in subchondral bone from Grade 1 POD samples (P=0.006) and Grade 2 POD 
samples (P=0.005).
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POD grade
Figure 7.6: Box and whisker plot of BGN expression in subchondral bone affected by each grade of 
POD. Asterisks show outlying results. Expression of BGN was significantly decreased in subchondral 
bone from Grade 1 POD samples (P=0.004) and Grade 2 POD samples (P=0.002).
Subchondral Bone
Gene POD Grade 1 POD Grade 2 POD Grade 3
ADAMTS4 0.6 0.9 0.5
ADAMTS5 0.7 0.9 0.8
MMP1 0.05 0.08 0.04
MMP3 0.2 0.6 0.04
MMP13 0.3 0.5 0.2
TIMP3 0.02 0.6 0.04
1113 0.08 0.2 0.4
COL1A2 0.006 0.8 0.009
COL2A1 0.006 0.005 O.OOOlt
COL10A1 0.4 0.8 0.1
ACAN 1 0.4 0.9
BGN 0.0044' 0.0024' 0.5
Table 7.4: Significance of differences in gene expression in subchondral bone of Grades 1, 2 and 3 
POD for each gene examined as compared to Grade 0 POD subchondral bone, as calculated using 
mixed effects linear regression, significance level P<0.004. Arrows show whether gene expression 
was up- or down- regulated.
Synovial Membrane
No significant differences were found in expression of any genes examined in synovial membrane, as 
shown in Table 7.5.
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Synovial Membrane
Gene POD Grade 1 POD Grade 2 POD Grade 3
ADAMTS4 0.3 0.5 0.06
ADAMTS5 0.9 0.03 0.5
MMP1 0.7 0.9 0.2
MMP3 0.4 0.8 0.3
MMP13 0.3 0.08 0.9
TIMP3 0.7 0.4 0.9
ILlp 0.1 0.4 0.2
Table 7.5: Significance of differences in gene expression in synovial membrane of Grades 1, 2 and 3 
POD for each gene examined as compared to Grade 0 POD synovial membrane, os calculated using 
mixed effects linear regression, significance level P<0.007.
7.3.3 Correlation in Expression of Genes between Tissues
In synovial membrane and SCB, a significant correlation was found between expression of IL1B 
(P=0.01, r=0.3) (Figure 7.7). In synovial membrane and cartilage, a significant correlation was found 
between expression of MM PI (P=0.002, r=0.4) and ADAMTS4 (PcO.OOl, r=0.5). In subchondral bone 
and cartilage, significant correlations were found between expression of: MMP1 (P=0.02, r=0.4); 
MMP3 (PcO.OOl, r=0.5); ADAMTS4 (P<0.001, r=0.6); ADAMTS5 (P=0.001, r=0.4); COL1A2 (P=0.04, 
r=0.3); COL2A1 (P<0.001, r=0.5); COL10A1 (P=0.008, r=0.3) and BGN (P<0,001, r=0.8). The 
correlation between SCB and cartilage biglycan expression is shown in Figure 7.8.
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Figure 7.7: Scatterplot showing significant correlation between I LIB expression in synovial membrane 
and subchondral bone (P=0.01, r=0.3).
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Figure 7.8 Scatterplot showing significant correlation between biglycan expression in cartilage and 
subchondral bone (P<0.001, r=0.8).
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7.4 Discussion
By quantifying and comparing the gene expression of various proteolytic enzymes and structural 
proteins, it has been shown that there are alterations in gene expression in both the cartilage and 
SCB of condyles affected by palmar osteochondral disease as compared to those unaffected by 
pathology. Further, scoring the condyles at post-mortem examination using a well-defined system 
gave some indication as to the severity and stage of the disease. It is proposed that the Grade 1 POD 
samples represent the result of early disease where the SCB is bruised and may be mildly 
fragmented but the HAC is intact. Grade 2 a middle stage of disease where the SCB has failed but 
there is not yet collapse of the overlying HAC, and Grade 3 POD samples an end-stage or severe 
disease where both the SCB and HAC have failed. By analysing gene expression data separately for 
each grade of POD it was possible to consider stages of disease separately and crucially to allow the 
possibility of identifying biomarkers for the early potentially reversible stages of disease. This data 
may give some further understanding as to the pathogenesis of this debilitating racehorse condition.
MMP13 expression was significantly increased in the HAC of condyles affected by Grade 3 POD, with 
a trend toward increased expression in Grade 2 POD samples. MMP13 is often cited as one of the 
most important mammalian collagenases and is known to be important in the pathophysiology of 
osteoarthritis (Cawston and Wilson 2006) and it would appear to be involved only in the later and 
more severe stages of disease in the articular cartilage of horses affected by POD. There are obvious 
limitations in looking at quantitative gene expression of MMPs in isolation and attempting to draw 
conclusions as to the levels of active enzymes in the tissue. This is because after gene transcription, 
the proteins must first be translated and then cleaved before secretion in their active form.
The failure to identify any alteration in expression of various matrix metalloproteinases in the 
synovial membrane differs to previous findings in synovium from osteoarthritic joints by Davidson et 
al. (2006). This may be explained by species differences, the small panel of biomarkers examined in
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this study as compared to microarray studies and to differences in controls i.e. our POD negative 
horses had also been in training and therefore may have had underlying joint pathology.
ACAN expression was found to be significantly decreased in all grades (1, 2 and 3) of POD. Aggrecan 
is the major proteoglycan in cartilage and in arthritic cartilage aggrecan and type II collagen are 
degraded and then lost, resulting in a thin and mechanically weakened tissue. Aggrecan loss from 
cartilage is considered to be an early (Pond and Nuki 1973) and reversible (Thomas 1956) event in 
the pathogenesis in OA and aggrecan may have a protective role in preventing collagen degradation 
(Pratta et al. 2003). It is interesting that in this disease aggrecan synthesis of HAC as measured by 
gene expression, was found to be decreased at all stages of disease.
Recently much research interest has been generated by the identification of the A Disintegrin and 
Metalloproteinase with Thrombo Spondin motifs (ADAMTS) gene family. The purification of 
ADAMTS4 from bovine cartilage (Tortorella et al. 1999) was closely followed by the identification of 
ADAMTS5 (Abbaszade et al. 1999). There remains some debate as to the relative importance of 
each aggrecanase in the pathogenesis of OA, and to some extent this appears to vary with species 
(Fosang et al. 2008; Huang and Wu 2008). I showed that neither ADAMTS4 nor ADAMTS5 expression 
were altered in either the HAC or SCB in POD and this may be surprising given previous evidence as 
to the importance of aggrecanase activity in OA. Potentially this may be explained either by the 
constraints of the technique of looking at relative quantification of gene expression in isolation, with 
identification of neoepitopes of aggrecan in cartilage and subchondral bone possibly being a more 
accurate means of identifying ADAMTS activity in the samples.
It was also interesting that although ADAMTS4 and ADAMTS5 gene expression were not altered in 
disease, there was a significant correlation between their expression in SCB and HAC, which may 
suggest a similar mechanism of regulation in these osteochondral tissues. There was also correlation
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in expression of other proteolytic enzymes (MMP1, MMP3) and of structural proteins {C0L1A2, 
COL2A1, COL10A1 and BGN) in cartilage and SCB which further demonstrates an apparent synchrony 
in gene expression between HAC and SCB, not necessarily associated with disease.
There was a significant increase in expression in C0L1A2 expression in POD Grade 2 and 3 cartilage 
and a trend towards increased expression of COL1A2 in POD Grade 1 and 3 SCB. This may suggest 
that the cartilage in late stage disease is attempting to heal by fibrocartilage formation. In the 
subchondral bone, there is a biphasic response whereby the bone is attempting healing in the early 
stages, and then again in the late stages of disease.
There was a significant increase in COL2A1 expression in the SCB of POD Grade 3 samples and a 
trend towards an increase in COL2A1 expression in the subchondral bone of Grade 1 and Grade 2 
SCB. COL2A1 expression was not altered in HAC of any grade of POD. This may suggest that in all 
stages of diseases, but particularly in late stage disease, there is an attempt by the subchondral 
bone to heal by fibrocartilage and callus formation. These findings correspond with the histological 
appearance of the disease as described in Chapter 6 (Histology of Palmar Osteochondral Disease).
A reduction in biglycan expression in SCB with POD grades 1 and 2 may indicate a reduction in matrix 
synthesis in SCB in early stage disease. Biglycan, along with other proteins such as decorin, lumican 
and fibromodulin, is a small leucine-rich proteoglycan (SLRP) and has been found to interact with 
collagens (Raspanti et al. 2008; Sugars et al. 2003; Vynios et al. 2001). Biglycan has also been found 
to be important in the mineralisation of bone with the biglycan knock-out mouse showing an 
osteoporosis-like phenotype with a decreased growth rate and decreased bone mass compared to 
the wild type (Xu et al. 1998). More recently, biglycan has also been shown to have the ability to 
bind, but not activate complement (Sjoberg et al. 2009) and the authors proposed the role of SLRPs 
in the regulation of complement activation in diseases involving extracellular matrix, particularly
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those characterised by chronic inflammation, such as osteoarthritis. Our finding of reduced biglycan 
expression in SCB affected with palmar osteochondral disease contradicts the previous findings of 
Young et al. (2005) who showed that in an ovine meniscectomy model of osteoarthritis there was 
upregulation of expression of biglycan. This may be due to species difference, or to the differences in 
the stage of disease, or indeed to differences in pathogenesis of POD as a manifestation of 
osteoarthritis.
7.5 Conclusion
This data gives further evidence of the importance of subchondral bone disease in the 
pathophysiology of OA and is of interest since in this naturally occurring model of OA both grossly 
and histologically the SCB is affected earlier in the course of disease than the overlying hyaline 
articular cartilage. Differences in gene expression in cartilage and SCB at different stages and 
severities of disease were identified. The finding of correlation in gene expression of various 
structural proteins and proteolytic enzymes in SCB and HAC is also of interest as this data suggests 
synchrony between expression of certain genes in the two closely associated joint structures.
208
7.6 References
Abbaszade, I., Liu, R.Q.., Yang, F., Rosenfeld, S.A., Ross, O.H., Link, J.R., Ellis, D.M., Tortorella, M.D., 
Pratta, MA, Hollis, J.M., Wynn, R., Duke, J.L., George, H.J., Hillman, M.C, Jr., Murphy, K., 
Wiswall, B.H., Copeland, RA, Decicco, C.P., Bruckner, R., Nagase, H., Itoh, Y., Newton, R.C., 
Magolda, R.L., Trzaskos, J.M., Burn, T.C and et al. (1999) Cloning and characterization of 
ADAMTS11, an aggrecanase from the ADAMTS family. The Journal of biological chemistry 
274, 23443-23450.
Barr, E.D., Pinchbeck, G.L., Clegg, P.D., Boyde, A. and Riggs, C.M. (2009) Post mortem evaluation of 
palmar osteochondral disease (traumatic osteochondrosis) of the metacarpo/ 
metatarsophalangeal joint in Thoroughbred racehorses. Equine Veterinary Journal 41, 366- 
371.
Cawston, T.E. and Wilson, A.J. (2006) Understanding the role of tissue degrading enzymes and their 
inhibitors in development and disease. Best practice & research 20, 983-1002.
Davidson, R.K., Waters, J.G., Kevorkian, L., Darrah, C, Cooper, A., Donell, S.T. and Clark, I.M. (2006) 
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. 
Arthritis research & therapy 8, R124.
Eyre, D.R. (2004) Collagens and cartilage matrix homeostasis. Clinical orthopaedics and related 
research, S118-122.
Fosang, A.J., Rogerson, F.M., East, C.J. and Stanton, H. (2008) ADAMTS-5: the story so far. European 
cells & materials 15,11-26.
Huang, K. and Wu, L.D. (2008) Aggrecanase and aggrecan degradation in osteoarthritis: a review. The 
Journal of international medical research 36,1149-1160.
Pond, MJ. and Nuki, G. (1973) Experimentally-induced osteoarthritis in the dog. Annals of the 
rheumatic diseases 32, 387-388.
Pool, R.R. (1996) Pathologic manifestations of joint disease in the athletic horse. In: Joint Disease in 
the Horse, Eds: C.W. Mcllwraith and G.W. Trotter, W.B. Saunders, Philadelphia, pp 87-104.
Poole, A.R., Guilak, F. and Abramson, S.B. (2007) Etipathogenesis of Osteoarthritis. In: Osteoarthritis 
Diagnosis and Medical/Surgical Management, Fourth edn., Eds: R.W. Moskowitz, R.D. 
Altman, M.C. Hochberg, J.A. Buckwalter and V.M. Goldberg, Lippincott Williams and Wilkins, 
Philadelphia, pp 27-51.
Pratta, MA, Yao, W., Decicco, C, Tortorella, M.D., Liu, R.Q., Copeland, R.A., Magolda, R., Newton, 
R.C., Trzaskos, J.M. and Arner, E.C. (2003) Aggrecan protects cartilage collagen from 
proteolytic cleavage. The Journal of biological chemistry 278,45539-45545.
Raspanti, M., Viola, M., Forlino, A., Tenni, R., Gruppi, C. and Tira, M.E. (2008) Glycosaminoglycans 
show a specific periodic interaction with type I collagen fibrils. Journal of structural biology 
164,134-139.
Riggs, C.M. (2006) Osteochondral injury and joint disease in the athletic horse. Equine Veterinary 
Education 18,100-112.
209
Rozen, S. and Skaletsky, H. (2000) PrimerB on the WWW for general users and for biologist 
programmers. Methods in molecular biology (Clifton, N.J 132, 365-386.
Sidak, Z. (1967) Rectangular Confidence Regions For The Means Of Multivariate Normal 
Distributions. Journal of American Statistical Association 62, 626-633.
Sjoberg, A.P., Manderson, G.A., Morgelin, M., Day, A.J., Heinegard, D. and Blom, A.M. (2009) Short 
leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement 
interaction and activation. Molecular immunology 46, 830-839.
Sugars, R.V., Milan, A.M., Brown, J.O., Waddington, R.J., Hall, R.C. and Embery, G. (2003) Molecular 
interaction of recombinant decorin and biglycan with type I collagen influences crystal 
growth. Connective tissue research 44 Suppl 1,189-195.
Thomas, L. (1956) Reversible collapse of rabbit ears after intravenous papain, and prevention of 
recovery by cortisone. The Journal of experimental medicine 104, 245-252.
Tortorella, M.D., Burn, T.C., Pratta, M.A., Abbaszade, I., Hollis, J.M., Liu, R., Rosenfeld, S.A., Copeland, 
R.A., Decicco, C.P., Wynn, R., Rockwell, A., Yang, F., Duke, J.L., Solomon, K., George, H., 
Bruckner, R., Nagase, H., Itoh, Y., Ellis, D.M., Ross, H., Wiswall, B.H., Murphy, K., Hillman, 
M.C., Jr., Hollis, G.F., Newton, R.C., Magolda, R.L., Trzaskos, J.M. and Arner, E.C. (1999) 
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. 
Science (New York, /V.K284, 1664-1666.
Vynios, D.H., Papageorgakopoulou, N., Sazakli, H. and Tsiganos, C.P. (2001) The interactions of 
cartilage proteoglycans with collagens are determined by their structures. Biochimie 83, 899- 
906.
Xu, T., Bianco, P., Fisher, L.W., Longenecker, G., Smith, E., Goldstein, S., Bonadio, J., Boskey, A., 
Heegaard, A.M., Sommer, B., Satomura, K., Dominguez, P., Zhao, C, Kulkarni, A.B., Robey, 
P.G. and Young, M.F. (1998) Targeted disruption of the biglycan gene leads to an 
osteoporosis-like phenotype in mice. Nature genetics 20, 78-82.
Young, A.A., Smith, M.M., Smith, S.M., Cake, M.A., Ghosh, P., Read, R.A., Melrose, J., Sonnabend, 
D.H., Roughley, P.J. and Little, C.B. (2005) Regional assessment of articular cartilage gene 
expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis 
research & therapy 7, R852-861.
210
Measurement of Markers of Osteogenesis and Osteoclastic Activity in the Subchondral Bone of
Horses Affected bv Palmar Osteochondral Disease
8.1 introduction
The results of quantification of gene expression of various enzymes involved in matrix proteolysis 
and of various matrix proteins in the hyaline articular cartilage, subchondral bone and synovial 
membrane have been presented in Chapter 7 (Association Between Markers of Osteoarthritis in 
Subchondral Bone, Cartilage and Synovial Membrane in Horses with Palmar Osteochondral Disease). 
As I had previously found evidence of alterations in the expression of various bone matrix proteins 
[COL2A1, COL1A2 and BGN) in subchondral bone from condyles affected by palmar osteochondral 
disease (POD), and because POD is considered to be a form of osteoarthritis in which pathology is 
first manifested in the subchondral bone (SCB), the quantitative mRNA expression of a further panel 
of genes involved in osteogenesis and osteoclastic activity in samples of SCB was measured in an 
attempt to investigate further the pathogenesis of this condition.
Like cartilage, bone is composed of cells and their associated extracellular matrix. Bone extracellular 
matrix comprises organic (35%) and inorganic (65%) components. The organic component includes 
predominantly type I collagen (90%), non-collagenous proteins, glycosaminoglycans and lipids. The 
inorganic component consists mainly of crystalline calcium and phosphate present in the form of 
hydroxyapatite (Martin et al. 1988). Non mineralised bone matrix is synthesised by osteoblasts, cells 
derived from mesenchymal origin (Martin et al. 1988). When matrix synthesis is no longer required, 
the osteoblast loses its synthetic ability and either becomes entombed in its lacuna within the 
mineralised bone matrix as an osteocyte; transforms into an inactive osteoblast and becomes a bone 
“lining cell; undergoes apoptosis; or transdifferentiates into cells that deposit chondroid (Franz- 
Odendaal et al. 2006).
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There are a number of non-collagenous bone matrix proteins and only a sample of those will be 
considered further here. Bone y-carboxyglutamate protein (BGLAP), also known as osteocalcin, is a 
small protein synthesised by mature osteoblasts which has three residues of the calcium-binding 
amino acid y-carboxyglutamic acid (Poser et al. 1980). BGLAP is thought to interact directly with 
hydroxy a petite through its Gla residue (Hauschka etol. 1989). Osteomodulin (OMD), also known as 
osteoadherin, is a small leucine-rich proteoglycan thought to mediate cell attachment via the amino 
acid sequence Arg-Gly-Asp (RGD) (Sommarin et al. 1998; Wendel et al. 1998). Secreted 
phosphoprotein 1 (SPP1), also known as osteopontin and bone sialoprotein I, is a bone matrix 
protein containing relatively large amounts of sialic acid as well as the RGD cell attachment 
sequence and is a member of the Small Integrin-Binding Ligands with N-linked Glycosylation 
(SIBLINGS) family. SPP1 binds with high affinity to hydroxyapatite and it has been suggested that it 
participates in tissue mineralisation (Oldberg et al. 1986). Like SPP1, integrin-binding sialoprotein 
(IBSP), also known as bone sialoprotein II, is a member of the SIBLINGS family. In contrast to SPP1, 
IBSP exhibits a more limited pattern of expression and is thought to mark a late stage of osteoblastic 
differentiation and early tissue mineralisation (Bianco et al. 1991).
While excessive bone resorption may be pathological, a balance between bone formation and 
resorption is necessary for effective bone homeostasis and physiological adaptation of the bone to 
the stresses applied by load and exercise. As described above, osteoblasts have a primary function 
in bone formation, whereas bone resorption is effected primarily through the osteoclast. 
Osteoclasts are derived from mononuclear precursors and are formed by the fusion of cells of the 
monocyte-macrophage line (Martin et al. 1988). Osteoclasts are richly endowed with lysosomal 
enzymes, especially acid phosphatase 5 tartrate resistant (ACP5), also known as tartrate-resistant 
acid phosphtase, which is considered to be specific for osteoclasts (Eggert 1980; Minkin 1982) and 
thus ACP5 is used widely as a marker of osteoclasts. Although less tissue specific in its expression 
than ACP5, cathepsin K (CTSK) is a cysteine proteinase which has also been shown to be highly 
expressed in osteoclasts (Bossard et al. 1996; Drake et al. 1996). The role of the osteoclast in bone
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resorption was further defined in the mid to late 1990s when the identification of the receptor 
activator of nuclear factor-Kp ligand (RANKL)/RANK/osteoprotegerin (OPG) signalling system clarified 
the means by which the osteoblast was able to regulate osteoclast formation (Anderson et al. 1997; 
Lacey et al. 1998; Simonet et al. 1997; Yasuda et al. 1998a; Yasuda et al. 1998b).
The aim of the following experiment was to investigate the pathogenesis of POD further by 
comparing the expression of various genes involved in osteogenesis and osteoclastic activity in the 
subchondral bone (SCB) of condyles from Thoroughbred racehorses at various stages of disease. It 
was hypothesised that there would be an increase in expression of non-collagenous matrix protein 
genes in early disease (Grade 1 POD) with a reduction in expression of non-collagenous matrix 
protein genes in later/more severely affected SCB (Grades 2 and 3). It was also hypothesised that 
there would be an increase in expression of genes involved in osteoclastic activity in SCB affected by 
POD, particularly more severe grades of POD (Grades 2 and 3), as compared to SCB unaffected by 
POD (Grade 0).
8.2 Materials and Methods
Tissue collection, RNA extraction, reverse transcription and quantitative real-time PCR were 
performed as before (Chapter 7). cDNA from SCB derived from those previous samples was used 
again in this set of experiments. Gene expression of BGLAP, OMD, SPP1, IBSP, RANK, RANKL, OPG, 
CTSK and ACP5 were measured relative to GAPDH as a housekeeping gene. Primers used for target 
and housekeeping genes are as shown in Table 8.1.
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Gene Primer Sequence Accession Code Efficiency
GAPDH F: GCATCGTGGAGGGACTCA
R: GCCACATCTTCCCAGAGG
AF157626 -3.32
BGLAP F: TCAACCCAGACTGTGACGAG
R: CAGCTAGGGACGATGAGGAC
XM_001915727 -3.80
OMD F: CAAATTCATCAACCCCTGAAA
R: CTTCATCTGGCTCTTGGTCA
NM_005014 -3.19
SPP F: CCAGGAAGTTTCGCAGATCTG
R: CACAGGTGATGTGAGGTCCTCTT
XMJD01496152 -3.36
IBSP F: TTATCCTCCTCTAAAACGATTTCCA
R: CTATCACCATCTCCATTTTCTTCAGA
XM_001496125 -3.25
RANK F: GCTTCACTGGGACAGAGAACATG
R: GCGCTCGGCGAAGTTG
NM„003839 -3.49
RANKL F: CCGTGGAAGGTTCTTGGTTA
R: AT GAT G GCGAAAG CAAATGT
XM„001915535 -3.87
OPG F: AGTG AAT CA ACT CAG AAAT GT G G A AT
R: AG G AACAGCAAACCT G A AG AAT G
NM_002546 -3.20
CTSK F: ATGGGATCCAGAAGGGAAAC
R: TGGCTGAAGTCACATCTTGG
XM_001490599 -3.3
ACP5 F: ACCCACTGCG'CGTCAAG
R: GTCGAGGGGTCCATGAAGT
XM_001490293 -3.33
Table 8.1: Primer sequences used for quantitative real-time PCR
F= Forward primer, R= Reverse primer
Samples were scored grossly for grade of POD at post mortem examination as described previously 
(see Chapters 5 and 7) and grouped according to this classification for further statistical analysis. 
Data was plotted and tested for normality using the Kolmogorov-Smirnov test (Minitab v.15, Minitab 
Inc., Pennsylvania, USA) and mixed effects linear regression (SPIus v6.1, TIBCO Software Inc., 
California, USA) was used to test for significant differences between groups while allowing for 
clustering within horse. To allow for testing of multiple genes on the same sample, the P value was 
adjusted using Sidak's formula (Sidak 1967):
OCpT = 1 ~ (l-ctpF)lj/c
as described in full in Chapter 7.
Gene expression data are presented as previously as a box and whisker chart, with tops and bottoms 
of boxes demonstrating third and first quartiles respectively. The line within the box indicates the 
median value. Whiskers extend to the highest and lowest data values.
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8.3 Results
As in Chapter 7, samples of SCB from 70 distal metacarpal and metatarsal condyles (35 left fore 
medial and 35 left hind lateral) were collected at post mortem examination from 35 horses. All 
horses were Thoroughbred geldings which had been in flat race training. Thirty four condyles 
(48.6%) had Grade 0 POD, 18 condyles (25.7%) had Grade 1 POD, 11 condyles (15.7%) had Grade 2 
POD and 7 condyles (10%) had Grade 3 POD.
Nine genes were measured in each sample of SCB, giving a Sidak corrected significance level of 
P<0.006.
In SCB affected with Grade 2 POD, BGLAP expression was found to be significantly reduced (P=0.005) 
as compared to Grade 0 (POD unaffected) samples (Figure 8.1). There was no statistically significant 
difference (P>0.006) between grades 1 and 3 POD samples and unaffected samples on BGLAP 
expression or on any grade of POD affected sample and unaffected groups on expression of OMD, 
SPP1, RANK, RANKL, OPG, CTSK and ACP5 in subchondral bone.
-i.o-
POD grade
Figure 8.1: Box and whisker plot of Osteocalcin (BGLAP) expression in subchondral bone affected by 
each grade of POD. BGLAP expression was significantly reduced in subchondral bone affected by 
Grade 2 POD as compared to Grade 0 POD (P=0.005), marked by letter (a).
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Gene POD Grade 1 POD Grade 2 POD Grade 3
BGLAP P=0.02 P=0.005 4/ P=0.1
OMD P=0.3 P=0.1 P=0.3
SPP1 P=0.8 P=0.8 P=0.4
RANK P=0.5 P=0.02 P=0.3
RANKL P=0.2 P=0.4 P=0.3
OPG P=0.2 P=1 P=0.2
CTSK P=0.2 P=0.5 P=0.1
ACP5 P=0.3 P=0.02 P=0.2
Table 8.2: Significance of differences in gene expression in subchondral bone of Grades 1, 2 and 3 
POD for each gene examined as compared to Grade 0 POD subchondral bone. Arrows show whether 
gene expression was up- or down-regulated.
8.4 Discussion
Alterations in expression of the genes involved in bone matrix synthesis and osteoclastic activity 
measured in this series of experiments were less extensive than was hypothesised. In the panel of 
genes examined, each comparing Grades 1, 2 and 3 POD to Grade 0 POD, the only significant finding 
was that BGLAP expression was decreased in subchondral bone from Grade 2 POD samples. BGLAP 
expression was also reduced in Grade 1 SCB POD samples, but this failed to reach statistical 
significance. The failure to identify extensive alterations in the expression of the other non- 
collagenous matrix proteins measured (OMD and SPP1) in SCB at any stage of disease or BGLAP in 
Grades 1 and 3 POD SCB, may indicate that alterations in bone matrix synthesis are not involved in 
the pathogenesis of POD. This finding is in contrast to previous studies in osteoarthritis in humans 
which have shown an elevation in mRNA expression of BGLAP and SPP1 in the subchondral bone of 
the proximal femur affected by OA (Truong et al. 2006).
Clinically POD has been reported to be a difficult condition to treat (Ross 2003) with an apparent 
slow healing rate of subchondral lesions, if indeed the subchondral bone does heal at all. The lack of 
alteration in expression of genes involved in non-collagenous matrix synthesis may reflect an 
inability of the osteoblasts in SCB to respond to insult at the early, mid or late stages of POD. It is
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suggested therefore that the lack of increased synthetic activity of the osteoblasts may explain the 
apparent failure of healing of the subchondral bone in this disease. Another explanation for the lack 
of alterations in expression of non-collagenous matrix proteins is that alterations in synthesis of 
bone matrix are not a feature of the pathogenesis of POD. This data may therefore support the 
hypothesis of previous authors that POD is a structural disease resulting from functional adaptation 
of the subchondral bone and the development of fatigue microcracking (Muir eta/. 2008; Norrdin et 
al. 1998; Norrdin and Stover 2006).
Differences in expression of any of the genes involved in osteoclastic activity measured (RANK, 
RANKL, OPG, CTSK, ACP5) were not identified. This may indicate that increased osteoclastic activity 
is not a feature of the pathogenesis of POD. This may be surprising as although the involvement of 
the RANKL/RANK/OPG system in the pathogenesis of bone disease in the equine has not been 
previously reported, the importance of increases in the RANKL: OPG ratio are known to be critical in 
the pathogenesis of numerous human bone diseases resulting from increased bone resorption 
including osteoporosis, Paget disease, rheumatoid arthritis and meyeloma (Hofbauer and Schoppet 
2004). Likewise, there has also been recent evidence of the importance of CTSK in bone resorption 
and osteoarthritis with involvement of cathepsins in bone resorption having been indicated in 
inhibition studies (Delaisse et al. 1984; Montenez et al. 1994). More specifically, CTSK knock-out 
mice were found to have an osteopetrotic phenotype (Saftig et al. 2000; Saftig et al. 1998). In the 
equine, as in other species, CTSK has been immunolocalised not just to the osteoclast but also to 
articular chondrocytes (Gray et al. 2002), and more recently CTSK has been shown to degrade 
articular cartilage in naturally occurring equine osteoarthritis (Vinardell et al. 2009). ACP5 
expression may have been expected to be altered in POD where subchondral bone lysis is a feature 
of disease. However, although gene expression of ACP5 in the equine has not been described, our 
findings are supported by a previous study comparing osteoarthritic to osteoporotic subchondral
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bone in humans where no significant differences in expression of either ACP5 or CTSK were found
between groups (Logar et al. 2007).
Another possible reason for failing to find statistically significant differences between groups in 
expression of genes involved in bone matrix synthesis and osteoclastic activity in subchondral bone, 
is that samples sizes were too small, resulting in a lack of power in the study and therefore a failure 
to identify significant differences between groups. In addition, by adjusting the significance level 
using Sidak's method to allow for multiple comparisons, and thereby reducing the type I error, the 
type II error has been inadvertently increased (Rothman 1990). A type II error occurs where the null 
hypothesis (the hypothesis that two factors are unrelated and any apparent relation in the data is 
attributable to chance) is not rejected despite the presence of a true difference between groups.
In this chapter bone matrix synthesis and osteoclastic activity in subchondral bone were examined at 
gene expression level only, and significant differences were not identified between many of the 
groups. It may have been useful also to have considered protein levels (e.g. using Western blots) as 
due to post-translational control there is not necessarily a linear relationship between mRNA and 
protein levels. The subchondral bone was dismembranated as the first step in mRNA extraction, 
therefore average gene expression of all the cells in subchondral bone was attained. Since 
osteoclasts make up only a small percentage of these cells, techniques such as 
immunohistochemistry or in-situ hybridisation may have been more sensitive in detecting cells with 
osteoclastic phenotypes.
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8,5 Conclusion
It has been shown that the subchondral bone of horses affected with POD at various stages of 
disease compared to horses not affected with POD show a reduction in BGLAP expression in Grade 2 
POD SCB. Otherwise there were no alterations in expression of various non-collagenous bone matrix 
proteins; nor of various genes associated with osteoclastic activity. This would suggest that there is 
little alteration of the biosynthetic activity of osteoblasts and osteoclasts at any stage of disease. 
Furthermore, it may be concluded that the changes in the subchondral bone in POD occur as a result 
of structural alterations of the bone rather than due to metabolic alterations in the cells associated 
with the bone matrix.
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Concluding Remarks
The thesis had two main themes, the first being the development of an in vitro co-culture system for 
equine osteoblasts and chondrocytes and the second the investigation of various aspects (post 
mortem findings, histology, and gene expression of chondrocytes, synovial membrane and 
subchondral bone) of palmar osteochondral disease, a naturally occurring equine disease which 
affects both bone and cartilage.
In Vitro Co-Culture
Ideally, the pathogenesis of osteoarthritis, or indeed any of any disease, would be investigated in the 
species of interest. However, in the study of human osteoarthritis normal or mildly affected tissue is 
rarely available, with most tissue being harvested at joint prosthesis surgery and therefore by 
definition is severely affected end-stage tissue. While the disease process in distinct species will not 
necessarily follow exactly the same physiological pathways, very often cross- species comparisons 
are necessary and in vitro animal models are invaluable in OA research because a range of stages of 
disease and severities of disease can be re-created.
Unlike in the human field, in equine OA research the sourcing of mildly affected and normal tissue is 
more readily achievable. Various equine models of osteoarthritis have been described previously 
(Frisbie et ai. 2002; Gustafson et ai. 1992; Simmons et al. 1999; Todhunter et al. 1996) but have 
disadvantages in terms of expense and morbidity of horses. Further, these models of OA are in 
general more aggressive than the naturally occurring disease and therefore do not necessarily 
replicate clinical OA. Various in vitro cell culture systems for equine chondrocytes have been 
described e.g. suspension (Richardson and Dodge 2000), monolayer (David et al. 2007) or explant 
(Busschers et al. 2010) cultures and these are attractive as material may be collected from normal 
horses, either euthanased for other reasons, or obtained from abattoirs. The possibility of passaging
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or storing frozen cells for use in suspension cultures means that a large amount of material may be 
harvested from one animal, thus reducing mortality.
Shortcomings of the Equine Osteoblast and Chondrocyte Co-Culture System
The rate-limiting step in the setting up of the equine osteoblast and chondrocyte co-culture system 
was found to be the growth of primary cells from bone explants (data not shown). The time for the 
cells to grow out of the explants was found to be highly variable between donors, taking on average 
2-4 weeks. This variability in outgrowth of primary ceils had no obvious reason (e.g. age of donor) 
and this variability unrelated to age of donor was also described by McDuffee et al. (2006).
Increased tissue availability can be achieved by cryopreservation of cells. This technique has been 
utilised with success in other cell culture systems e.g. chondrocytes (Tomford et al. 1984). Various 
cryopreservative procedures for human articular cartilage chondrocytes have been optimised (van 
Steensel et al. 1994). Cryopreservation of osteoblast-like cells has been described with regards to 
autogenous bone grafts, where the cells were stored within the bone explants (Reuther et al. 2006). 
However, there is a paucity of data regarding cryopreservation of primary cells grown from bone 
explants. Because the outgrowth of primary cells from the bone explants is the rate-limiting step as 
discussed above, during the course of the development of the co-culture system it was attempted to 
cryopreserve the primary cells at first passage after outgrowth from bone explants using standard 
freezing medium (DMEM, 10% PCS and 10% dimethyl sulphoxide) and slow freezing techniques 
(Rendal-Vazquez et al. 2001). After such cryopreservation the cells failed to grow when culture in 
monolayer was attempted (data not shown). Therefore for each co-culture experiment osteoblasts 
had to be differentiated from primary cells grown from bone explants.
Because the osteoblasts had to be grown from primary explants and this took on average 3-4 weeks, 
it was not possible to use autologous cartilage explants, because the cartilage explants would have
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been non-viable by the time they were to be used in the co-culture system if harvested at death of 
the donor and at the same time as the subchondral bone explants. It would have been possible to 
cryopreserve the cartilage explants, however ultrastructural changes have been described in 
articular cartilage chondrocytes associated with freeze thawing (Tavakol et al. 1993) therefore it was 
considered more appropriate to use fresh cartilage explants. For practical reasons outlined above, it 
was therefore necessary to utilise allogeneic cartilage explants and osteoblasts in the co-culture 
system. While it may be proposed that this experimental design may result in donor effects and 
possible aberrant results with regards to expression of proteolytic enzymes as an effect of 
immunological response against allogeneic tissue, this is unlikely in an in vitro system as there is no 
humoral or cellular response present. Further, because cartilage is devoid of blood vessels in vivo it 
is regarded as immune privileged tissue (Bolano and Kopta 1991) and chondrocytes have been 
shown to express factors related to immune privilege including; macrophage migration inhibitory 
factor, Fas ligand, transforming growth factor (5 and neuropepetides (Fujihara etal. 2010). Therefore 
the experimental design utilising allogeneic osteoblasts and cartilage explants is unlikely to have 
changed the experimental results and outcomes.
This thesis has outlined the development and validation of a novel osteoblast and cartilage explant 
co-culture model. It was proposed that this system may serve as an in vitro model of equine 
osteochondral disease, of particular interest given the emphasis of the later part of the thesis 
regarding the naturally occurring condition of palmar osteochondral disease (POD). Although the 
system generated interesting data, as an in vitro system the co-culture could never absolutely 
recreate the natural disease process in vivo. Flowever, in vitro models have advantages over in vivo 
or ex vivo studies with regards to minimising morbidity of donor animals, which is of practical benefit 
with regards to both animal welfare and economics.
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Potential for Further Work Utilising the Osteoblast and Chondrocyte Co-Culture System
It is believed that this model may be utilised in the further investigation of osteochondral disease 
and in the validation of drugs used in treatment of equine joint disease. It is also possible to extend 
the model to direct co-culture. Indirect co-culture was used here as this is thought to correspond 
most closely to the situation in vivo. It was shown that soluble factors produced by osteoblasts into 
the culture medium altered chondrocyte phenotype and resulted in cartilage matrix breakdown 
effected via the live chondrocyte, most likely via local chondrocyte production of proteolytic 
enzymes. Another potentially interesting future study would be the comparison of direct to indirect 
co-culture, particularly with regards to the magnitude of matrix degradation measured by GAG 
release from the system. Further work is also required to more accurately identify the soluble 
factors produced by the osteoblasts which drive the altered phenotype.
In this system I utilised ILip to pre-treat the osteoblasts, thus driving them towards an osteoarthritic 
phenotype. While ILlp is an important cytokine in the pathogenesis of osteoarthritis, by no means 
does it act in isolation, and in vivo it is likely that a wide variety of cytokines are involved in the 
disease process. Therefore, use of IL1(3 alone was potentially an overly simplistic model. Other 
cytokines which have been shown to be implicated in osteoarthritis include tumour necrosis factor 
a, IL6, members of the IL6 protein superfamily, IL7, IL17 and IL18 (Malemud 2010). These cytokines, 
either alone or in combination, could be utilised to drive an osteoarthritic phenotype in the 
osteoblasts in future experiments.
The co-culture system could be utilised to validate and determine the in vitro modes of action of 
drugs used therapeutically in osteoarthritis, e.g. non steroidal anti-inflammatory drugs, 
corticosteroids, autologous serum and hyaluronic acid, as well as various nutraceuticals e.g. 
glycosaminoglycan and chondroitin sulphate. While the use of these agents is well-established, and 
their mechanisms of action on chondrocytes and cartilage matrix have been defined, few studies
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have shown their concurrent effect on osteoblasts and chondrocytes. If osteoarthritis is to be 
considered as a form of "organ failure" affecting not only the articular cartilage, but also the 
subchondral bone and synovial membrane, then this data is likely to be extremely useful and 
clinically relevant.
The technique of metabolomics was used to identify changes in conditioned culture media from the 
co-cultures and yielded some interesting results. It would have been possible to extend this 
experiment to identify changes in cartilage alone either treated or not with IL1(3, and not just 
considered the co-culture studies as this work has not to our knowledge been performed previously.
Potential for Further Work Involving the Metabolomic Analysis of Biological Fluids in Osteoarthritis
As stated above, metabolomic analysis was utilised in analysis of conditioned culture media from in 
vitro experiments. Metabolomics however has the scope not only to be used in vitro, but also in in 
vivo through analysis of biological fluids. Previously a urinary metabolite profile has been identified 
in the guinea pig spontaneous OA model (Lamers et al. 2005). Similarly, metabolic profiling of 
synovial fluid in osteoarthritis has been described in canine experimental models of osteoarthritis 
(Damyanovich et al. 1999a; Damyanovich et al. 1999b) and in a guinea pig experimental model of 
osteoarthritis (Borel et al. 2009). There is comparatively less data on naturally occurring 
osteoarthritis, although there is one recently published paper looking at the lipidomics of plasma 
from human osteoarthritis patients (Castro-Perez etal. 2010).
In a future study, it would be interesting to analyse further samples, either of plasma or of synovial 
fluid, from naturally occurring equine osteoarthritis/joint disease. As detailed in later chapters of 
the PhD, samples from the palmar condyle of the distal metacarpus and metatarsus were obtained 
at post mortem examination from a population of Thoroughbred racehorses. Samples of synovial 
fluid and blood were also obtained at the time of euthanasia in these horses, it will be interesting in
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future studies to evaluate the metabolic profile of these samples and to assess whether from these 
results it is possible to conclude whether horses are suffering from osteoarthritis. This would 
provide a useful pre-mortem test, particularly in those conditions, such as palmar osteochondral 
disease, which may appear normal on radiographic and arthroscopic examination, and therefore 
may pose a diagnostic problem for the clinician.
It was found that in the samples of conditioned culture medium from the in vitro co-cultures, there 
were very few peaks after retention times of 15 minutes, indicating that no lipophilic compounds in 
the media. In comparison, Castro-Perez et al. (2010) identified changes in the lipid profiles of plasma 
from osteoarthritic patients, and suggested that there was an altered lipid metabolism associated 
with osteoarthritis and the release of arachidonic acid from phospholipids. The differences between 
our results are likely to reflect differences in fluids analysed and also differences between naturally 
occurring and in vitro cell culture models of OA. It will be interesting to evaluate the lipophilic 
compounds in the plasma and synovial fluid samples from the horses affected by naturally occurring 
joint disease in future experiments extending on from this thesis.
Palmar Osteochondral Disease
The post-mortem evaluation of distal metacarpal and metatarsal condyles from a population of 
Thoroughbreds which had been in race training showed that the condition of palmar osteochondral 
disease (POD) was more common than possibly first thought. Further epidemiological studies are 
required to identify the risk factors for this condition and therefore to aid in its prevention. 
However, it is unclear whether the mild lesions are clinically significant or performance limiting in 
any way. If post-mortem, histology and training and performance data were considered from each 
horse, it may be possible to assess whether the severity of lesion has an effect on limitation of 
performance. Histology allows more objective and quantitative analysis of the osteochondral 
lesions, particularly given our findings that supported the usefulness of both the Mankin and
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OOCHAS scoring systems. While the information regarding performance was available for the horses 
examined grossly at post mortem and histologically here, the numbers were too small to draw any 
statistically significant conclusions. Therefore, a larger study is required, although it is suggested 
that analysis of this data will be complicated by a plethora of other confounding factors which may 
result in poor performance in the Thoroughbred racehorse.
It was also not possible to determine whether the lesions identified at post mortem were 
progressive, from the mild to the severely affected forms of disease although this was assumed to be 
the case. The only way of determining this would be to perform a longitudinal study on a cohort of 
Thoroughbreds in training, and because it is readily apparent that post-mortem evaluation is useless 
in such a study design, this would require other means of identifying the disease. At present, the 
preferred means of diagnosing palmar osteochondral disease would appear to be magnetic 
resonance imaging (MRI) given that the condition is often not evident on radiography. While a 
longitudinal MRI study would be possible, it may be prohibitively expensive. Further, there are 
ethical issues to consider regarding whether it would be appropriate to identify a subchondral lesion 
on MRI (i.e. a Grade 1 or Grade 2 POD lesion) and subsequently allow that horse to continue in 
training without treatment as would be required to monitor the progression of disease.
Gene Expression
In all qRT-PCR analysis (both for POD samples and samples obtained from the in vitro co-culture 
systems) GAPDH was chosen as the housekeeping gene based on the majority of previous studies on 
chondrocyte gene expression. Gene expression measurements may vary as a result of number/type 
of cells in the tissue, the method and efficiency of mRNA extraction, mRNA handling techniques, 
mRNA integrity, method of reverse transcription and analytical detection chemistry method (Bustin 
2002; Bustin and Nolan 2004; Lekanne Deprez et al. 2002). A means of addressing these potential 
variations is to compare the expression of genes of interest to an internal standard or "house-
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keeping" gene. Ideally this house-keeping gene would be constitutively expressed, such that the 
RNA products of such genes would be at constant levels at all times, irrespective of growth 
conditions (Avison 2007). However, although previously it was thought that genes such as GAPDH 
and (3-actin fulfilled these criteria, there is mounting evidence that in reality there is no single perfect 
control for any gene expression study as even housekeeping genes are expressed at different levels 
under different conditions. Further, the RNA products of housekeeping genes are generally 
abundant, meaning that differential amounts of degradation between RNA samples may have a 
smaller impact on housekeeping gene mRNA levels than on the target mRNA (Avison 2007). More 
recently, authors have described the use of statistical algorithms for the optimisation of reference 
gene selection including geNorm (Vandesompele et al. 2002), Global Pattern Recognition (Akilesh et 
al. 2003), Bestkeeper (Pfaffl et al. 2004), equivalence testing (Haller et al. 2004) and NormFinder 
(Andersen et al. 2004). Use of these methods would potentially have allowed increased specificity 
and sensitivity of the technique; however they do also add considerably increased complexity and 
expense to experiments and their use may be precluded by practical constraints in using a 96 well 
plate system.
Gene Expression in Palmar Osteochondral Disease
The results of gene expression in subchondral bone (SCB), hyaline articular cartilage and synovial 
membrane from the metacarpo- and metatarsophalangeal joints of Thoroughbred racehorses were 
shown and discussed in the thesis. Correlations in gene expression in cartilage and SCB were shown, 
thus suggesting synchrony between expression of certain genes. In further experiments examining 
subchondral bone of horses affected by POD at various stages of disease as compared to the SCB of 
horses that had been in training not affected by POD, there was little evidence of changes in 
expression in various non-collagenous bone matrix proteins, nor of various genes associated with 
osteoclastic activity. This was concluded to potentially reflect an unaltered biosynthetic activity of 
osteoblasts and osteoclasts in disease and it was suggested that the pathogenesis of POD is more
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likely to reflect structural alterations of the bone as opposed to metabolic alterations in the cells 
associated with the bone matrix. It is believed that these structural alterations may be further 
characterised by ongoing scanning electron microscopy studies.
Despite the negative results, it is important to consider bone as a dynamic and living tissue and to 
consider the responses of its cell population. Although it is widely recognised that bone has the 
ability to adapt to physiological stresses, and this has been particularly well-described structurally in 
the equine metacarpophalangeal joint (Easton and Kawcak 2007; Firth et al. 2009; Muir et a!. 2008), 
there is comparatively less data on the biosynthetic activity of the osteocytes, osteoblasts and 
osteoclasts. This may in part be due to the difficulties in processing bone as compared to other, 
more pliable tissues. However, it was found that it was possible to extract mRNA from even very 
dense equine subchondral bone using the techniques as outlined in the body of the thesis. Although 
I failed to show changes in expression of non-collagenous proteins, other synthetic properties of the 
cells in bone may well be important in subchondral bone injury and worthy of future investigation 
e.g. cell signalling mechanisms in response to exercise and/or subchondral bone injury.
Conclusion
In the introduction of this thesis, various hypotheses were proposed. These are repeated with an 
outcome as to whether proven or disproven:
1) osteoblasts could be isolated from equine SCB, undergo reliable proliferation and 
differentiation and respond to IL1(3 such that the osteoblasts showed an osteoarthritic 
phenotype in vitro (PROVEN)
2) co-culture of equine osteoblasts pre-treated with 111(3 with cartilage explants from joints 
unaffected by OA would result in an altered chondrocyte phenotype and evidence of 
cartilage matrix degradation (PROVEN)
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3) there would be detectable differences in the metabolic profiles of conditioned culture media 
from various equine osteoblast and equine osteoblast and chondrocyte co-culture models, 
and that useful biomarkers could be identified after analysis of the spectra (PROVEN)
4) POD would have a high prevalence at post mortem examination of a population of 
intensively raced Thoroughbreds with a predilection sites for these pathologies. Further, 
that there would be an association between POD and other pathologies affecting the distal 
condyles of MC/MTIII and a correlation between prevalence of POD and pathologies of the 
dorsodistal aspect of MC/MTIII, suggestive of MCP/MTP joint hyperextension (PROVEN)
5) POD would have a characteristic and well-defined histological appearance (PROVEN) and 
that the OOCHAS scoring system would be more reliable in analysis of cartilage pathology in 
samples of condyles affected by POD (DISPROVEN)
6) there would be increases in gene expression of matrix proteinases in SCB, hyaline articular 
cartilage (MAC) and synovial membrane affected by POD and alterations in expression of 
genes involved in matrix synthesis in SCB and MAC (PROVEN IN PART)
7) there would be correlations between expression of genes in the various articular tissues 
(SCB, HAC and synovial membrane) (PROVEN)
8) there would be an increase in expression of non-collagenous matrix protein genes in early 
disease (Grade 1 POD) with a reduction in expression of non-collagenous matrix protein 
genes in later/more severely affected SCB (Grades 2 and 3) (DISPROVEN)
9) there would be an increase in expression of genes involved in osteoclastic activity in SCB 
affected by POD, particularly more severe grades of POD (Grades 2 and 3), as compared to 
SCB unaffected by POD (Grade 0) (DISPROVEN)
Therefore it is hoped that the work contained in this thesis will go somewhere to improving 
knowledge of the role of subchondral bone damage in joint disease and to increasing understanding 
of a debilitating racehorse condition. Perhaps as with any body of scientific work, all questions
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cannot yet be met with answers, and in digging deeper it seems that yet more questions have been
unearthed.
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